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Abstract 
 
A wide variety of silica based nanoparticles (NPs) were synthesised to engineer materials 
with properties for specific applications by manipulating the nanoparticle composition. 
These include luminescent core shell NPs and luminescent mesoporous silica which have 
been successfully synthesised. The particle size distribution and characteristics of the NPs 
were determined by photon correlation spectroscopy. The laser Doppler velocimetry was 
used to determine the NPs stability in suspension. Transmission and scanning electron 
microscopy analysis were used to assess morphology and size of the NPs. Diffuse 
reflectance infra-red Fourier transform spectroscopy was used to study the template 
removal to produce porous NPs.  
 
The particles were then utilized for assessing different applications. A novel dual oxygen 
(O2) and sulphur dioxide (SO2) gas sensor was produced by incorporating fluorophores 
within SiNPs. The fluorophore rhodamine B isothiocyanate (RBITC) was encapsulated 
within SiNPs (208±9 nm) to produce a nanosensor that is sensitive to SO2, while 
ruthenium-tris(4,7-diphenyl-1,10-phenanthroline) dichloride (Ru(dpp)3) was encapsulated 
within SiNPs (192±8 nm) to sense O2. The sensor utilises the fluorescence quenching 
phenomena as a detection mechanism and had high sensitivity for detection of low O2 gas 
concentrations (0.018 %). These novel nanosensors demonstrate potential to develop 
multisensor systems to capable of detecting multiple gasses simultaneously in a single 
matrix for a magnitude of future applications that require small robust gas sensing. 
Biocompatibility of SiNP number, size (smaller than 100 nm), and dye encapsulation on 
conduit arterial function, in vitro was assessed. Their effects on endothelial-dependent 
[acetylcholine (ACh); 0.01-200 M] and independent [sodium nitroprusside (SNP); 0.001-
10 M] dilator responses were examined. When incubated with 1.96×1012 NP/ mL, both 
30 nm, 70 nm SiNPs and RBITC encapsulated in silica nanoparticles (SiRBITC NPs) 
significantly reduced endothelium-dependent, but not independent vasodilation. 
Furthermore, attenuated dilation due to SiRBITC NPs, but not SiNPs, could be partially 
restored using superoxide dismutase. Our results suggest that the mechanism of attenuated 
dilation is different for SiNPs and SiRBITC NPs which has implications for the future 
fabrication of biocompatible nanoparticles for imaging diagnostics. Spherical mesoporous 
nanoparticles (MNP) and dye encapsulated MNP were synthesised via a sol-gel method in 
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the presences of organic template. The template was removed using an acidic extraction. 
The average diameters of the MNP were 100 nm. The interior pores were loaded with 
SNP, these drug loaded MNP were placed in live tissue and release in real-time was 
observed, in vitro. We demonstrate that the initial instantaneous release is due to the 
surface adsorption of the drug followed by released from the pores. Furthermore, these 
drug loaded MNP were placed in live tissue and release in real-time was observed, in vitro. 
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The aim of this thesis is to fabricate silica base nanoparticles and utilise them for potential 
sensor and bioapplications.   
 
Objective 1 -  Fabrication of nanoparticles. 
To determine suitable methods for synthesis of amorphous and porous fluorescent silica 
nanoparticles of various monodispersed sizes. To achieve nanoparticle surface 
functionalisation to enable them to be utilised for their purpose built applications.  
 
Objective 2 -  Characterisation of the nanoparticles.  
The size and characteristics of nanoparticles will be determined by the use of specialist 
analytical apparatus such as the Malvern Zetasizer, to measure the zeta potential. 
 
Objective 3 -  Gas sensing via fluorescent core shell silica nanoparticles.  
These nanoparticles will be utilized as gas sensors through the fluorescence quenching 
phenomena. The nanoparticles interaction with gaseous molecules will be examined with 
real-time fluorescence spectrophotometer.  
 
Objective 4 -  Biocompatibility of fluorescent silica nanoparticles.  
Their toxicological influence on the live aortic blood vessels will be determined by 
assessing their effect on the vascular function. This will be conducted with a specialist 
organ-bath system for the in vitro studies, whereby transmission electron microscopy will 
determine uptake within the ultra-structure.   
 
Objective 5 -  Drug delivery system using fluorescent mesoporous nanoparticles.  
Determine the parameters for optimal drug loading, release and decomposition protection 
under simulated biological conditions. Determine the dynamics of drug release by drug-
loaded nanoparticles using isolated live blood vessels in vitro. 
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1) Particle Synthesis and Characterisation 
A. To fabricate monodispersed nanoparticles (NPs), via sol-gel precipitation 
technique, and the sizes will be determined with electron microscopy and 
photon correlation spectrophotometer.  
B. NPs stability will be determine through the laser Doppler velocimetry.  
C. Characterisation of NPs will be conducted with thermogravimetric analysis for 
decomposition analysis, infra-red spectroscopy for surface groups attachment 
or removal, quantification of dye molecules within NPs via fluorescence 
spectroscopy, surface area and porosity quantification with N2 sorption and 
atomic absorption spectroscopy for quantification of Fe from the drug release 
profile of mesoporous NPs. 
  
2) Gas Sensor Application 
 Introduction to fluorescence 
 Experimentation 
 
Aims 
 Produce a film consisting of 
both Ru(dpp)3 core and silica 
shell and RBITC core and silica 
shell NPs.  
 Determine Ru(dpp)3 NPs 
sensitivity to gaeous O2 and 
RBITC NPs sensitivity to SO2. 
 
3) Biological Application 
 Introduction to aortic vessel structure and 
function 
 Experimentation  
Aims 
 Determine the influence of size and 
concentration of silica NPs with and 
without dye molecules on vascular 
function.  
 Determine the dynamic of drug release by 
drug-loaded mesoporous nanoparticles in 
vitro. 
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1 
1. INTRODUCTION 
1.1. Nanotechnology 
Nanotechnology is the assembly of materials under control conditions to manipulate the 
dimensions in the nanoscale range (0.1-100 nm) [1]. The widely held description of 
nanoparticles (NPs) has been scrutinised for not having a set definition, thus resulting in 
the continuous improved definitions where currently particles with a surface area less than 
60 m
2
/ cm
3
 is used for the description instead of diameter [2]. From its original notion, 
nanotechnology, refers to nanomaterials fabricated from the bottom-up technique [3, 4]. 
Furthermore this technology that lies within the atomic and molecular level dates back to 
1959 as it was envisioned by Richard Feynman‟s speech; „There is plenty of room at the 
bottom‟ [3]. The continuous exploitation of nanoscale material has led to interdisciplinary 
research where chemistry, biology and physics have been combined to manufacture 
enhanced tools for intended purposes. Nanomaterials offer a great alternative to the bulk 
materials for use in various fields. Refined synthesis techniques that manipulate 
dimensions and properties of materials has escalated research for numerous applications, 
including electronic [5], pharmaceutical [6], environmental [7], imaging diagnostics [8] 
and drug therapy [9] in biomedical applications. Nanomaterials encompass a wide variety 
of structures, including NPs, nanoparticulate films as well as complex, often bio-inspired, 
nanostructures. Dimensions are a key indicator in defining the material.  NPs particularly 
refer to particle between 1-100 nm [10]. Decreasing the particle size from micron to nano-
size drastically increases the surface area of the material and changes its properties. NPs 
are particularly useful for the construction of two-dimensional and three-dimensional 
nanostructures for various applications. In addition, the surface of the NPs can be 
functionalized to further tailor the properties of the final product.    
 
The production of nanomaterials is dependent on factors such as growth media, the 
temperature, the concentration of reactants and the reaction time. NPs can be classified as 
carbon-based (carbon nanotubes and fullerenes), inorganic (zinc oxide and cerium oxide), 
metal (gold and silver) and quantum dots (zinc sulphide) [11]. The uses of NPs in 
industrial applications require production of material at a nanoscale maintaining the size 
distribution and the morphology of the nanomaterial. Furthermore, most applications 
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2 
require both the crystal structure and the chemical composition of the product to be the 
same.  Finally there should be no aggregation of the nanomaterial [11].   
 
Research development has resulted in the fabrication of new types of devices using 
nanomaterials. NPs may have enhanced capabilities, such as luminescence molecules 
encapsulated in silica shell to reduce photo-degradation of dye molecules. Roche et al. [12] 
used luminescence molecules incorporated within organically modified sol-gel film to 
detect oxygen gas. However, the introduction of silica shell would prolong the luminescent 
intensity of the luminescence molecules. The material has the ability to quantify the 
amount of gas via the gas quenching the molecules‟ luminescence. There are also profound 
advantages of the use of nanomaterials in biomedicine. Generally for these applications, 
the NPs have to be biocompatible.  Silica NPs (SiNPs) are of particular interest for 
bioapplications due to their biocompatibility, easy synthesis and possible manipulations to 
obtain the desired sizes and porosities. Additionally, the external surface can be modified 
with biomolecules to target specific sites. The versatility for fabricating purpose-built NPs 
have resulted in silica being the material of choice for application in the area of medical 
imaging [13] and drug delivery [14].     
 
1.2. Synthesis Methods of Silica Nanoparticles 
Silica materials contain a molecular formula of silicon dioxide. Its structure can either be 
crystalline, where the atoms or molecules are arranged in an ordered array in liquid or 
solid, or amorphous containing a non-crystalline structure (Figure 1.1). Furthermore, the 
versatility of this material allows silica to be either porous or non-porous.   
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Figure 1.1:  Diagram of A) crystalline silicon dioxide in a quartz structure and B) amorphous structure.  
 
1.2.1. The Sol-gel method 
The conventional precipitation method used for synthesis of NPs by the preparation of a 
solution that contains relevant inorganic precursors is referred to as the sol-gel method. 
This method is favoured over other synthetic routes as it allows particle size control by 
altering the pH, temperature, dispersants and precursor concentrations. It also allows 
production of porous materials using surfactants, mixed metal oxides and metals and the 
addition of surface functional groups all within a single synthetic step. The inorganic 
precursors used normally are metal salts, metal halides and alkoxides (M(OR)x). The 
inorganic alkoxide is firstly hydrolysed followed by condensation to synthesize the metal 
oxide. The reaction rate and in turn growth rate can be manipulated by the use of 
mineralizers (acids or bases) to affect the hydrolysis or condensation rate.  
 
The sol-gel method has been used for the fabrication of colloidal systems. In colloidal 
silica, the synthesis entails the production of siloxane polymer from organosilica 
compounds. The term sol-gel refers to the production of either gel or monodispersed 
solution of particles. Reaction conditions with low pH result in fast hydrolysis and in turn 
slow condensation to form a gel. High pH conditions result in slow hydrolysis and fast 
condensation forming a monodispersed solution [15]. The well known sol-gel method for 
the fabrication of monodispersed silica colloid was first published by Stöber et al. in 1968 
[16]. In this work, the influence of the solution concentration on the size and 
monodispersity of SiNPs, which ranged from 50 nm to 2 µm was studied. Furthermore, the 
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4 
effect of the temperature on the rate of nucleation was studied. This method entailed the 
hydrolysis of a silica precursor, such as tetraethyl orthosilicate (TEOS), in alcohol solution, 
which is catalysed by ammonia as shown in Figure 1.2, followed by a condensation 
reaction which may either occur by alcohol or water molecules [17].        
 
 
Si OR OH2+ Si OH ROH+
     
      
Si OH+ Si O Si ROH+Si OR
   
                
Si OH+ + OH2Si OH Si O Si
   
 
Si(OR)4 2H2O+ SiO2 4ROH+
OH-
     
Figure 1.2:  The reaction scheme for the fabrication of silica nanoparticle; where (1) is the initial 
hydrolysis reaction step, (2) is the alcohol condensation reaction step and (3) is the water condensation 
reaction step. The overall reaction is given in step (4), where R denotes C2H5. 
  
 
   
  
(1) 
(2) 
(3) 
(4) 
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5 
Initially, there is a hydrolysis followed by condensation of the alkoxide silica (Si(OR)4) to 
fabricate monodispersed silica spheres, as shown in Figure 1.3. 
 
 
 
 
 
 
   
 
  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3:  Schematic illustration of the Stöber sol-gel reaction for the production of silica spheres. 
 
 
1.2.1.1. Controlled growth of silica nanoparticles  
The Stöber et al. method has been extensively studied to further minimize the size of the 
silica particles produced [18, 19]. Production of monodispersive silica particles below 100 
nm is desirable for bioapplications. The desired silica particle size can be obtained by 
altering the reagent concentration (such as TEOS, water and NH3) along with changing the 
temperature. Stöber et al. constructed a graphical representation of the relationship 
between particle diameter and reactant (water and ammonia) concentration, when 
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tetraethyl silicate concentration is 0.28 mol dm
-3
 and the reaction occurs at room 
temperature. However, using the Stöber method to fabricate larger particles (1-2 µm) tends 
to yield a poor size distribution.  
 
Bogush et al. has expressed the relationship between reactant concentration and particle 
diameter through a simplified Equation 1.1, which was derived through the fabrication of 
over 100 samples at 25 °C [18].  
 
                                              𝒅 = 𝑨  𝐇𝟐𝐎 
𝟐𝐞𝐱𝐩 −𝑩 𝐇𝟐𝐎 
𝟏/𝟐                       (1.1) 
 
Where, d is the average particle diameter with units of nanometer (nm) and the reactant 
concentrations has units of mol dm
-3
. The term A is specified in Equation 1.2, which was 
corrected by Razink et al. [20].  
 
           𝑨 =  𝐓𝐄𝐎𝐒 𝟏/𝟐 𝟖𝟐 + 𝟏𝟓𝟏 𝐍𝐇𝟑 + 𝟏𝟐𝟎𝟎 𝐍𝐇𝟑 
𝟐 − 𝟑𝟔𝟔 𝐍𝐇𝟑 
𝟑          (1.2) 
 
Where, the term B within Equation 1.1 is expressed in Equation 1.3. 
 
      𝑩 = 𝟏.𝟎𝟓 + 𝟎.𝟓𝟐𝟑 𝐍𝐇𝟑 − 𝟎.𝟏𝟐𝟖 𝐍𝐇𝟑 
𝟐           (1.3) 
 
Bogush et al. have succeeded in enhancing the monodispersity by initially synthesizing 
small core SiNPs, known as seeds, and then coating them with TEOS. It was found that as 
particle size increased, the aggregation between particles of the same size was reduced 
[21]. Alternatively to the “aggregation-only” model, the “growth-only” model, suggests 
that an initial nucleation occurs followed by a diffusion-limited growth [21, 22]. Once the 
initial seeds have formed and the starting materials have fully reacted, the seeding growth 
may be conducted. The molar ratio for the addition of TEOS to water is 1:2 in order for the 
seeded growth. Thus, the relationship between the particle size and the total volume of 
TEOS added during the seeded growth was derived (Equation 1.4) [18].  
 
                                                             𝒅 = 𝒅𝟎  
𝑽
𝑽𝟎
 
𝟏/𝟑
                                                           (1.4) 
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Where, d is the average particle diameter in nm, d0 is the average diameter of the seeds, V0 
is the moles of TEOS used to synthesise the seed, V is the total moles of TEOS used for the 
fabrication of the particles.  
 
Achieving smooth monodispersive silica particles within the size range from 10-100 nm is 
difficult, the particles tend to be granular in appearance, a far more successful method has 
been developed involving the production of a microemulsion. 
 
1.2.2. Microemulsion method 
Microemulsions are a type of colloidal system where there are two phases, an oily 
substance and a water-based substance. The two are not miscible but with the aid of a 
surfactant they may become miscible. The oil and water mixture of microemulsion are 
known to be thermodynamically stabilised when a surfactant is present. A surfactant 
molecule has a long chain with a hydrophobic tail and a hydrophilic head, its structure 
allows it to dissolve in both water and in organic solvents. Surfactant molecules form 
micelles or reverse-micelles, which have spherical structure. There is an interfacial tension 
between the water and the oil that is lowered by the surfactant because the surfactants 
hydrophilic head will adsorb in the water and the hydrophobic tail will adsorb in the oil. 
Above certain surfactant concentrations, micelles are formed in the water phase where the 
tails are in the core and the heads are facing outwards. Reverse-micelles are formed in the 
oil phase with the tails facing outwards and the heads in the core, as illustrated by Figure 
1.4.   
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Figure 1.4:  Schematic illustration of the micelle and reversed micelle. 
 
 
The difference between a microemulsion and emulsion is the transparency, the 
thermodynamic stability and the heterogeneity. Due to the microemulsion being optically 
isotropic, it is transparent. Also, unlike microemulsion, emulsions are thermodynamically 
unstable.  
 
The characteristics of the microemulsion medium has caused researchers to use this 
technique to synthesise various materials, such as metals, metal halides, chalcogenides, 
carbonates, organic polymers and SiNPs [23, 24]. When this technique is used to form NPs 
the reactants maybe contained in separate aqueous microemulsion. The two are mixed and 
due to Brownian motion they react to form small NPs.   
 
In order to fabricate SiNPs via microemulsion, the preparation involves alkoxide 
hydrolysis of a silica precursor, such as TEOS, in water-in-oil microemulsion (Figure 1.5) 
[24]. The reversed micelles consist of water nanodroplets in an organic medium in order to 
be utilised as nanoreactors for the fabrication of NPs. The particle size may be adjusted by 
altering the ratio of water to oil [25].The water-to-surfactant molar ratio (R) and ammonia 
concentration has been shown to have an effect on the particle size [23, 24]. The early 
stage of the reaction is a first order with respect to TEOS concentration and as R increases 
the first order kinetics decrease. Initially, the reaction entails a hydrolysis of TEOS in 
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alcohol, such as ethanol, which is catalysed by ammonium hydroxide-base in water 
solution. This follows a first order kinetics reaction with respect to ammonia and TEOS 
concentrations [24]. In the work of Kay et al. it has been concluded that independently of 
the catalyst used for TEOS hydrolysis, acid or base the reaction will still remain first order 
with respect to the water concentration (1:2 molar ratio of TEOS:H2O) [26]. The water 
concentration has been found to play an important role in the base-catalysed hydrolysis 
rate [22].  The type of solvent mixed with TEOS also has an effect on the rate of hydrolysis 
[22, 27-30]. If the solvent has long alkyl chains, then the rate of hydrolysis decreases due 
to steric stabilisation. The rate of hydrolysis also decreases if the solvent has a tendency to 
form hydrogen bonds with water [22, 28, 29].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 1.5:  An illustration of the silica nanoparticle formation from microemulsion reaction.  
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1.3. Stability of Colloidal Silica 
The term colloidal dispersion refers to a system that contains immiscible particles which 
are suspended in a continuous medium. The silica suspensions are known as lyophobic 
colloid, in which the dispersed phase is solvent hating, thus leading to minimal interaction 
between the particles and continuous phase [31]. Furthermore, in order for the system to be 
termed colloidal the particle size should range between 1-1000 nm [32]. The random 
movement of particles within a solution is due to the natural kinetic energy known as 
Brownian motion. Thus, causing particle collision and depending on the forces between 
them they can either attract or repel [33]. A silica solution is considered stable if the 
particles remain disperse and do not rapidly settle or aggregate. Theoretically, when only 
taking into account the gravity and viscous drag force, smaller particles are better dispersed 
in solution and will take longer to settle. In a stable colloidal suspension the electrostatic 
repulsive forces should be greater than the attractive forces (van der Waals forces) in order 
to prevent the particles from aggregating. Furthermore, the pH and ionic strength of the 
solution in which the particles are held influence particle stability [34]. Depending on the 
application, it can be desirable for the particles to be well dispersed or aggregated. For 
instance, in bioapplications where the initialisation of the nanoparticle (NP) into cells is 
vital then a stable colloidal suspension is preferred [35], while in water treatment the 
problem encountered is that these NPs can be very stable in natural water and with aid of 
coagulant polymers the NPs aggregates and sediments so they can be easily removed via 
the purification process [36]. The different types of aggregation are conservation, gelation, 
coagulation and flocculation (Figure 1.6). Conservation is the process where concentrated 
liquid phase is formed which is immiscible in the aqueous phase, as the absorption of 
material on the particle surface leads to its reduced hydrophilicity. Gelation is the 
formation of a three-dimensional network in which particles are linked into branches. This 
results in an increased viscosity followed by the formation of a solidified network that 
retains the liquid. In coagulation the particles form closely packed clumps with each 
another, while in flocculation the particles form bridges together that links them [37, 38].                  
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Figure 1.6:  Stable colloidal nanoparticles undergoing the flocculation and coagulation process of 
aggregation.  
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1.3.1. Stabilisation 
NPs may be stabilised via steric stabilisation or by creating a surface charge on the NPs 
(Figure 1.7). 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7:  Stabilisation process of nanoparticles, where C abbreviates capping agent.  
 
 
Capping agents can be a very valuable tool for the production of monodispersed NPs; 
however they themselves have properties which in turn make it difficult to distinguish 
between the properties of the NPs and capping agent.    
 
1.3.1.1. Surface charge 
A major factor determining the surface properties is the overall surface charge of the NPs. 
The surface charge gives an insight into the interaction between particles; so gaining 
greater understanding of the dispersion characteristics, for example dispersive stability, the 
viscosity, flocculation and film forming abilities. Alternatively, by creating a surface 
charge on the NPs one can overcome this problem of aggregation [11]. The stability of 
lyophobic colloids has been described by the well-known Debye Landau Verwey 
Overbeek (DLVO) theory. The electrochemical double layer (EDL) is a term used to 
describe the structure that coats an object when it is placed in a solution. The interface 
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between two phases, whether it is solid/ liquid, liquid/ liquid or liquid/ gas, is different in 
comparison to properties in the bulk phase. This can be explained by the phase boundary 
having different distribution of electrical charges, therefore producing an electrical double 
layer which has a potential that is different to both phases. This electrochemical double 
layer can be described by the Stern model. This model is illustrated in Figure 1.8, showing 
the charge distribution of particles in electrolyte solutions. A monolayer of the electrolyte 
is adsorbed onto the particle surface causing it to become negatively charged. This is 
known as dehydrated ions and the area of the monolayer of ions is known as the inner 
Helmholtz plane (IHP). This adsorb monolayer may be anions or cations, depending on if 
they are “indifferent” or “specifically adsorbed” ions. There is a chemical interaction 
between the particle surfaces when the ions are specifically adsorbed, such as proton 
interacting with particle surface containing carboxylic groups. Charge reversal can occur 
because the interaction of ions with surface is very strong. However, if the surface and ions 
have the same charge it will lead to a higher overall potential. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8:  Electrochemical double layer on a particle surface in a solution containing electrolytes.  
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If specifically adsorbed ions were not present then there would be partially or fully 
dehydrated counter-ions in the inner layer. If the particles with a negative surface were in a 
solution of NaCl, it would be the Na ions that lead to a potential (i). 
 
The second layer of ions is known as the outer Helmholtz plane (OHP); it consists of 
hydrated rigidly bound counter-ions that cause the potential to decrease (). These two 
planes (IHP and OHP) with a thickness () are called the Stern layer.  
 
The sol-gel method is the favoured precipitation method as there are various ways of 
controlling the properties of the NPs, although in mass production it is often difficult to 
control the kinetics of the crystal growth resulting in particle aggregation along with poly-
distribution [39, 40]. The discovery of developing an organised array of monodispersed 
SiNPs has caused substantial impact in research, leading researchers to refine Stöber 
method in order to obtain small NPs [19], dye incorporated silica [41] and coating them 
with inorganic groups. 
 
1.3.1.1.1. Debye Landau Verwey Overbeek theory 
The DLVO theory is the basis for the understanding of colloid and interface science. 
Originally Derjaguin and Landau in 1941 developed the theory of stability of colloidal 
solutions, which was dependent on van der Waals attraction and electrostatic repulsion. 
The colloidal stability theory was further confirmed by Verwey and Overbeek. An 
advantage of working in the nano-scale is the higher surface area per unit mass in 
comparison to bulk materials. So when reducing the particle size or volume it in turn 
increases the surface area. This generally leads to high surface energy which can cause the 
NPs to react with each other resulting in aggregation [11]. The DLVO theory determines 
the interaction between charged surfaces in a liquid environment. A basic explanation of 
the DLVO theory is the sum of attractive and repulsive forces because of double layer of 
counterions, where the attractive forces (VTotal) are the van der Waals attraction (VA) and 
the repulsive forces are original electrostatic forces (VR) (Equation 1.5) [42, 43].
  
 
𝑽𝑻𝒐𝒕𝒂𝒍 = 𝑽𝑹 + 𝑽𝑨              (1.5) 
 
     Chapter 1 
  Introduction  
  
 
15 
In colloidal suspension, the charged particle surface forms a rich surrounding diffuse layer 
of oppositely charged ions. Both the charged particle surface and the diffuse layer result in 
an electro-neutral entity. When two charged surfaces come close to each another the 
diffuse layer overlaps forming an osmotic pressure between the surfaces, this result in an 
electrostatic repulsive force that keeps the particles apart. Increasing the electrolyte 
concentration within a colloidal suspension leads to the compression of the diffused layer, 
causing the particle surface potential to decrease and hence the repulsive forces to reduce. 
The reduction in the repulsive forces may result in the particles being able ot overcome the 
electrostatic energy barrier thus leading to aggregation, as illustrated in the potential 
energy curves (Figure 1.9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 1.9:  The total energy of interaction (V(1),  V(2) and V(3) ) between two particles, acquired from 
the sum of attraction curve (VA) and repulsion curves (VR(1), VR(2) and VR(3)).                                                                              
  
 
Where, V (1) corresponds to the total potential energy curve for a lyophobic colloid that 
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The addition of electrolytes into the colloidal solution, total potential energy curve V (2), 
results in the van der Waals attraction predominating the repulsive energy (VR (2)) as the 
energy barrier has just been removed. As this is the minimal amount of reduction in 
repulsive force to remove the energy barrier it is therefore also referred to as the critical 
coagulation concentration. On addition of higher concentration of electrolytes the energy 
barrier is further reduced resulting in a faster aggregation, the total potential energy curve 
V (3) [31]. 
 
1.3.1.1.2. Non-DLVO Interactions 
The well-known DLVO theory, which is used to describe the stability of particles within 
numerous colloidal systems [44-48], fails to recognized additional interactions within some 
colloidal systems such as silica solutions [49-51]. Firstly, the solvent is considered to be a 
dielectric continuum and any interaction between the surfaces to solvent and solvent to 
solvent is disregarded. Therefore, any additional repulsion (VSolv) caused by a highly 
structured hydration layer surrounding the particle surface is ignored. The steric repulsion 
(VSter) is also ignored, such as when surfaces containing grafted polymers come close to 
each another. Furthermore, ionic species are considered as point charges. Point charge is 
the dimensions of the charge become smaller according to the distance of the charge or at 
any distance point from the charge, thus this is an inaccurate estimation of any interaction 
between the ions to surface, solvent or ion. The DLVO theory considers ions to be 
infinitely interacting with particle surfaces and at an equal concentration and equal charged 
ions should have identical influences on the systems. Furthermore, not only the charge but 
also the type of electrolyte influences the system (known as ion specificity).  
 
This theory is valid for silica particles in the presence of alkali and for larger particles. 
According to the DLVO theory silica particles at pH 2, which have no charge, should be in 
the least stable region. However, this is contrary to previous studies due to the possibility 
of steric stabilisation as the water molecules produce a monolayer via hydrogen bonding to 
the particle surface attached hydroxyl groups [37, 38, 52]. 
 
In order to produce well dispersed NPs it is important to understand the surface properties, 
which in turn affect the dispersion characteristics. 
 
     Chapter 1 
  Introduction  
  
 
17 
1.3.1.1.3. Ion specificity 
In colloidal systems the ion specific adsorption influences the stability of the dispersion. 
Ions that are closer to the particle surface have a greater screening efficiency and thus 
lower concentrations of electrolyte are capable of destabilising the dispersion [53]. The 
Stern model describes the ion absorbability; where the size and charge influence the ions 
adsorption. For instance, highly charged ions have greater absorbability and in the case of 
equally charged ions the smaller sized [54, 55]. Ions can be categorised depending on how 
they interact with the solvent [56, 57]. Structure-marker ions, such as Li
+
 and Na
+
, are 
referred to as ions that cause structure water forming in their presence. While in structure-
breaker ions the ion cause the solvent to become less structured compared to the bulk 
phase. Therefore, the particle surface can be referred to as structure-marker and structure-
breaker surface as they can promote or destroy water structures [58, 59]. The adsorption 
due to numerous oxides can be described as like seeks like. Oxides that have a high 
isoelectric point (IEP), such as aluminium, are structure-marker surface and thus the 
structure-marker ions will adsorb on their surface, while structure-breaker surfaces have 
low IEP such as silica [58, 60].  
 
The ion to ion interaction in the double layer may result in an attractive electrostatic 
pressure between two surfaces [53, 61]. If this attractive electrostatic pressure is more 
dominant than ion to ion correlation interaction occurs. This is a result of charge 
fluctuations in the system, which is similar to dispersion interactions; however the 
attraction is stronger than the van der Waals attractive forces [61, 62]. When two 
approaching surfaces containing high ion density results in a double layer interaction it is 
repulsion. Although, when the ions are adsorbed close to the surface than this results in 
lower ion density at the midplane and thus the attractive force predominate.   
 
1.3.1.2. Surface stabilisation 
To prevent sedimentation, to maintain the NPs in dispersed form the surface may be 
modified with molecules. These molecules that surround the NP are known as capping 
agents. Capping agents can be categorised as polymers, biological or organic molecules.   
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1.3.1.2.1. Hairy model theory 
A previous study, conducted by Kobayashi et al. [52] confirms that larger SiNPs follow the 
DLVO theory. At low ionic strengths and increasing pH the rate constant decreases, while 
at high ionic strength the aggregation becomes fast. Also, at low pH and high ionic 
strength the aggregation rate is slower and in these conditions the 30 nm and 50 nm SiNPs 
are well dispersed. Furthermore, it was observed that at higher pH the smaller SiNPs 
remained completely stable. Therefore, this concludes that smaller SiNPs, less than 80 nm, 
contain additional repulsive forces. These forces are described as postulating hairy layers 
comprising of poly (silicilic acid) chains surrounding the particle surface [52]. 
 
1.4. Mesoporous nanoparticles  
Porous materials are predominately synthesised via sol-gel precipitation method contain 
surfactant molecules that behave as a template for the growth of material around them. 
Porous materials may be macroporous if the pore sizes are greater than 50 nm.  If the pore 
sizes are between 2 to 50 nm then the materials is mesoporous, while pore sizes smaller 
than 2 nm are known as microporous.           
 
In 1992 Beck et al. discovered that these mesoporous materials consisted of ordered porous 
structures. This allows mesoporous nanoparticles (MNP) to be used in sensing and drug 
delivery applications. However, the precipitations of these porous NPs alone do not make 
them a sufficient vehicle for drug delivery systems. In order for these particles to be 
effective in these systems the internal channel must be surfactant free to produce a porous 
network [63]. The main focus of investigation for MNP is silica based, this is because they 
are inexpensive, chemically inert, thermally stable and known for having no toxicological 
side effects [64].  
 
1.4.1. M41S family 
The synthesis of mesoporous silica materials of various morphologies have been reported, 
the two main families are M41S (Figure 1.10) and SBA.     
 
Mobil Research and Development Corporation in 1990‟s were the first to report the 
synthesis of the MCM-41, which is the most common of the M41S family and is produced 
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with aid of a cationic surfactant [64, 65]. The extensive use of these MNP in various 
applications, such as catalytic sieves, is due to the regular arrangement of pores within the 
NPs, thermal stability and large surface area [65].   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10:  Illustration for the fabrication of mesoporous nanoparticles (MCM-41). 
 
 
The discovery of this series has caused researchers to alter the structure directing agent 
(surfactant) and see how it affects the pore channels, such as the use of anionic surfactant 
like quaternary ammonium salts or non-ionic polyethylene oxide surfactant [66]. The SBA-
15 MNP has uniform hexagonal pores that range between 5-15 nm. The SBA-15 are 
synthesised with aid of copolymer Pluronic 123 (EO20PO70EO20) acting as the template 
under acidic conditions in the presence of silica precursor (such as TEOS) [67]. The pore 
sizes for this MCM-41 are hexagonal and normally smaller than 5 nm. These synthetic 
reactions commonly require the aid of an organic template (such as 
hexadecyltrimethyammonium bromide). Depending on the molecules that are placed into 
the pores, for it diffusivity application, the pore diameter may be tuned. Nandiyanto et al. 
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fabricated spherical silica MNP with pore sizes between 4-15 nm by changing the styrene 
(template) and hydrophobic molecule concentration [64].     
 
1.5. Characterisation 
A variety of different techniques were used to characterise the NPs as described in the 
following section. The NPs sizes were determined by electron microscopy. The 
hydrodynamic size and stability were tested based on their Brownian motion in suspension. 
Furthermore, porous NPs were analysed by nitrogen (N2) sorption and diffuse reflectance 
infra-red Fourier transform spectroscopy (DRIFTS). It is important to fully characterise 
NPs before utiliseing them in their particular application as it allows for a greater 
understanding of the underlying factors which may affect potential applications.  
 
1.5.1. Electron Microscopy  
High magnified images of specimens are produced with electron microscopy. Depending 
on the instrumentation, the electron beam may either travel through or on the surface of the 
specimen as shown Figure 1.11. The two types of electron microscopes are scanning and 
transmission electron microscope.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11:  Illustration of the difference between the imaging process of scanning electron and 
transmission electron microscope. 
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1.5.1.1. Scanning electron microscopy  
The JEOL 5600LV scanning electron microscope (SEM) was used for measuring the 
particle sizes (Figure 1.12). This instrument produces images of both conductive and non-
conductive materials. Samples which are non-conductive are usually coated with metal to 
prevent the material from charging under the microscope. As this SEM had low vacuum 
capabilities it is able to image samples which are non-conductive and contain either 
moisture or oily residues. The acceleration voltage of the instrument is between 0.5 to 30 
kV and has a resolution of 3.5 nm when optimum conditions are achieved.   
 
The SEM contains a tungsten filament which produces high energy electron beam that 
images the sample in a raster fashion. The electrons produce signal of the surface 
topography by interacting with the atoms in the sample. The two types of signals produced 
by this SEM are secondary electron and back-scattered electrons (BSE). The most common 
detection is secondary electron imaging where electrons produced by the ionisation of the 
atoms in the sample. The term „secondary‟ refers to the electrons not being generated by 
the primary source of radiation. For instance the primary source of radiation is from the 
electron beam generated by the tungsten filament and it ionises the surface atoms on the 
sample to produce secondary electrons. BSE are detected by reflection of electron wave 
into the direction they commenced from. As the electrons are scattered the reflection is 
diffused [68].   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12:  Image of a scanning electron microscope (JEOL 5600LV). 
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1.5.1.2. Transmission electron microscopy  
Transmission electron microscopy (TEM) was used to measure particles diameter along 
with observing particle morphology (Figure 1.13). Unlike SEM where the electrons 
interact on the surface or near surface of the specimen, TEM detects the electrons which 
are transmited through the specimen. The interaction of the electron beam as it passes 
through the specimen generates an image [68]. 
 
 
 
 
Figure 1.13:   Image of a transmission electron microscope (Philips Technai 12 Biotwin TEM). 
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1.5.2. Photon correlation spectroscopy 
Photon correlation spectroscopy (PCS) measurements were carried out using Malvern 
Zetasizer Nano ZS (Figure 1.14). PCS is also known as dynamic light scattering and quasi 
elastic light scattering.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14:  Image of Malvern zetasizer used for photon correlation spectroscopy and zeta potential.  
 
 
The instrument measures the Brownian motion and relates this to the particle size. This is 
conducted by a laser illuminating the sample and analysing the intensity fluctuation of 
scattered light. For instance, when particles are illuminated with the light it results in the 
scattering of light in all directions. Furthermore, if there were a screen near the particle it 
would be illuminated by the scattered light. As there are thousands of particles in the 
solution, instead of a single particle illuminating the screen there will be thousand 
producing a speckle pattern. The bright areas in the speckle pattern are the illuminated 
light and the dark areas are where no light has been detected. The propagation waves of the 
light being scattered by the particle are illustrated in Figure 1.15. The bright area is of the 
scattered light from the particle being displayed on the screen as the same phase is 
constructively forms the bright light, while the dark areas occur as the phase addition is 
destructive and they cancel out [31].    
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Figure 1.15:  The scattering of light being detected as it interacts with the particle. 
 
 
However, a suspension of particles will never be stationary and constantly move due to the 
Brownian motion. Furthermore, in accordance with the Brownian motion the smaller 
particles will move faster in the solution in comparison to larger ones. The relationship 
between particle size and motion is known as the Stokes-Einstein equation. The movement 
of the particles will result in the speckle pattern to move, and thus the constructive and 
destructive phase will result in the dark and light areas to increase and diminish. In simple 
terms the light intensity seems to fluctuate and the Zetasizer measures the rate of intensity 
fluctuation and converts this into particle size [31].      
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1.5.3. Laser Doppler velocimetry 
The Zeta potentials of dispersed colloidal nanoparticles were obtained using Malvern 
Zetasizer Nano ZS. The Zeta potential is a measurement of the magnitude of forces 
between particles and is determined by electrophoretic mobility. The sample undergoes 
electrophoresis and using laser Doppler velocimetry (LDV) and the velocity is measured. 
For well dispersed suspension of nanoparticles it is necessary for there to be relevant 
amount repulsive forces between them. Alternatively, there may be attractive forces 
between the NPs leading to aggregation [31].    
 
1.5.3.1. Electrical double layer   
The net charge of the particle influences the ions which will surround the interfacial 
region, and thus causes concentrated counter ions surrounding the surface. This is known 
as the electrical double layer which surrounds each particle. As previously describe 
(Chapter 1; Section 1.3.1.1), the ions which are closely attached to the particle surface are 
referred to as the Stern layer. In the outer region the ions are less firmly attached and this is 
referred to as the diffused region. There is a natural boundary which exists within the 
diffused layer, and as the particle moves so do the ions that are within this boundary. 
However, ions that are beyond this boundary do not move with the particle. This boundary 
is called the surface of hydrodynamic shear or the slipping plane and the potential which 
exist at this boundary is referred to as the zeta potential (Figure 1.16). In order for particle 
to be well dispersed in solution the zeta potential must be largely negative or positive, as 
particles will repel each another. The zeta potential value for dividing stable particles from 
unstable is +30 mV or -30 mV. Therefore, particle with a greater zeta potential than +30 
mV or more negative value than -30 mV is considered stable [31].            
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Figure 1.16:  Zeta potential gives an indication of the colloidal systems stability.    
 
 
The zeta potential is calculated from the measurement of the solutions electrophoretic 
mobility (Figure 1.17). This is conducted by placing the sample in a cell with electrodes at 
each side in order to apply the potential. The particle will move towards the electrode of 
opposite charge and measure its velocity, which will be converted into unit field strength 
of mobility [31].        
 
  
 
 
 
 
 
 
Figure 1.17:  Micro-electrophoresis cell attachment used to measure the samples velocity by a laser 
Doppler velocimetry within the Malvern Zetasizer Nano series.   
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1.5.4. Diffuse reflectance infra-red Fourier transform 
spectroscopy 
DRIFTS analysis was conducted using a Thermo Nicolet NEXUS 670 FTIR spectrometer 
(Figure 1.18). Infra-red spectroscopy is a vital analytical tool for acquiring the specific 
chemical functional groups present within the sample. The instrument detects vibrations 
caused by the infra-red beam interacting with the matter. Different chemical functional 
groups result in the infra-red light being adsorbed at a specific wavenumber which causes 
vibrations. The vibration corresponds to stretching, bending or contraction of the specific 
groups within the sample. The wavenumber band identifies the relevant functional groups 
present and is not altered by the other chemical groups within the molecules, temperature 
or pressure. DRIFTS is a infra-red technique where data collection is conducted with ease 
as no sample preparation is required because the powder sample is directly analysed. The 
infra-red beam is reflected and transmitted at various intensities from the sample 
depending on the chemical groups within the molecule. The term diffuse reflectance refers 
to the infra-red light being reflected from the roughness of the sample‟s surface and 
collected by either an ellipsoid or paraboloid mirror [69].          
 
 
 
Figure 1.18:  Image of diffuse reflectance infra-red Fourier transform spectroscopy.  
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1.5.5. Thermogravimetric analysis 
The thermogravimetric analysis (TGA) is a thermal method use for the determination of 
mass loss as function of temperature (Figure 1.19). The thermogravimetric (TG) curve is 
mass change against temperature, where the temperature increases uniformly or is kept 
constant. This is an important analytical technique for determining the purity of the sample 
and its specific modes of transformation, which is dependent on the temperature range. A 
TG curve with a sample that has single stage decomposition will contain two characteristic 
temperatures, Ti and Tf. Ti is the lowest temperature at which the mass change is detectable 
by the thermobalance under the selected settings, while Tf is the temperature when the 
decomposition has been completed. The difference between these two parameters, Ti and 
Tf, is known as the reaction interval. The mass change of a sample due to the increase in 
temperature, normally linear with time, is known as dynamic thermogravimetry. 
Alternatively, when temperature is kept constant and the change of mass is measured it is 
known as isothermal or static thermogravimetry [69].           
 
 
Figure 1.19:  Image of thermogravimetric analysis set-up.  
 
 
The TG instrumentation normally consists of four components; the furnace, sample holder, 
the sensors which detects the sample properties dependent on temperature and the data 
acquisition system (Figure 1.20). Commonly, the furnace is operated electrically and upon 
sample analysis it is purged with appropriate gases to allow the sample to decompose as it 
reacts and/ or burns. The temperature is either measured by a thermocouple or resistance 
sensor, while mass is measured by a thermobalance. The thermobalance is a highly 
sensitive electrical device which is capable of measuring small changes in mass (1 µg). 
The sample is placed in an inert crucible, such as aluminium, platinum or ceramic [69].   
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Figure 1.20:  An illustration of the components within the thermogravimetric instrument.     
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1.5.6. Nitrogen sorption  
Commonly, for gas adsorption measurements of solid materials they must initially undergo 
a process whereby majority of previously adsorbed gases and vapours are removed. This 
process is referred to evacuation where the solid is outgassed to c. 10
-4
 Torr for several 
hours in order to remove the physical adsorbed gas and majority of the chemisorbed gas. It 
is possible to completely remove the total chemisorbed gasses from the solid material by 
heating the sample to high temperature (100-400 °C), however this may cause the solid to 
become sintered and thus altering the sorption capacity [31]. 
 
The adsorption of gas or vapour onto the sample is measured by introducing a known 
volume of adsorbate, which is then determined using volumetric or gravimetric analysis. 
The gas is held within a burette and the pressure is measured using a manometer (Figure 
1.21). The volumes within the apparatus are calibrated in order for the amount of gas 
adsorbed by the absorbent sample to be determined via the pressure at equilibrium. The 
adsorption isotherm is calculated from a progression of readings obtained at different 
pressures.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.21:  An illustration of a volumetric apparatus setup when measuring gas adsorption at 350 °C. 
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Physical adsorption may involve three phenomena; which are monomolecular adsorption, 
multimolecular adsorption and condensation in pores or capillaries. Adsorption isotherms 
have been categorised into five different types (Figure 1.22). Type I isotherm also known 
as the Langmuir-type isotherm; as pressure increases the adsorption rapidly rise until the 
limiting pressure is reached. Furthermore, for this isotherm there is a monolayer during 
adsorption. Previously shown, the physical adsorption on solids that contain fine porous 
structure, such as adsorption of nitrogen on microporous carbon at 350 °C, have type I 
isotherm trend. Type II isotherm also known as the sigmoid isotherm; is the multilayer 
physical adsorption onto a non-porous solid. For instance, the adsorption of nitrogen onto 
silica gel at 350 °C, have type II isotherm trend. Type IV isotherm undergo a condensation 
within the capillaries of porous solid samples, followed by the saturation vapour pressure 
levels off towards the end of the isotherm. The isotherms for theses adsorbent have an 
effective pore diameter in the range of 2-20 nm. The upper limit of the isotherm trend 
indicates the adsorption is caused by the total pore volume. Type III and V isotherm are 
similar are both rare, initially there is an initial slow uptake of gas. These isotherms occur 
when there is a relatively weak adsorption forces within the first monolayer [31].    
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.22:  Classification of Brunauer’s isotherm. 
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The surface area analyses of solid materials are commonly measured by the Brunauer-
Emmett-Teller (BET) isotherm via volumetric analysis. The porous sample is degassed and 
exposed to known volume of a particular gas. The amount of gas absorbed by the sample 
can be quantified by subtracting the volume of gas once the pressure is equilibrated from 
the initial volume of gas injected within the system. The N2 sorption analysis was 
conducted with BET surface area and porosity instrumentation (Figure 1.23) [31]. 
 
 
 
 
 
 
 
 
 
 
Figure 1.23:  Image of the Brunauer-Emmett-Teller nitrogen sorption instrumentation. 
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1.5.7. Atomic absorption spectroscopy   
The atomic absorption spectroscopy is a technique used for the determination of metal 
concentrations. This is conducted by the light at a particular wavelength passing through a 
cloud of atoms. The light source is from a hollow cathode lamp and is absorbed by 
unexcited atoms. Therefore, the amount of light absorbed is proportional to the amount of 
unexcited atoms, the relationship is described as the Beer-Lambert law (Equation 1.6).  
 
𝐀𝐛𝐬𝐨𝐫𝐛𝐚𝐧𝐜𝐞 = 𝒍𝒐𝒈  
𝐈𝟎
𝐈
        (1.6) 
 
Where, I0 is the incident intensity and I represents the transmitted intensity. Absorbance 
can also be expressed as Equation 1.7. 
 
𝐀𝐛𝐬𝐨𝐫𝐛𝐚𝐧𝐜𝐞 = 𝛆𝐜𝐋                           (1.7) 
 
Where, ε is the absorption coefficient, L is the length of the absorption path and c 
represents the concentration of absorbing atoms. Equation 1.7, shows that if the terms ε 
and L are kept constant than absorbance is directly proportional to the concentration of 
absorbing atoms. Furthermore, as the terms ε and L are constant then measurement of the 
absorbance should give the atom concentration [69]. Atomic absorption spectroscopy may 
be analysed using various techniques, such as flame atomic absorption spectroscopy 
(FAAS) and graphite furnace atomic absorption spectroscopy (GFAAS). Alternative 
technique commonly used to determine metal concentration within samples is inductively 
coupled plasma emission spectroscopy (ICP-ES), for instance inductively coupled plasma 
optical emission spectroscopy (ICP-OES) and inductively coupled plasma mass 
spectroscopy (ICP-MS). The difference between the two techniques is that one is 
dependent on atomic absorption while the latter is on atomic/ ionic emission spectroscopic 
technique. Furthermore, they differ by the way the atomic or ionic species is produced, 
where atomic absorption uses a combustion flame or graphite furnace and ICP-ES requires 
plasma. 
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Table 1.1:  The limit of detection for Fe using different atomic absorption techniques, 
values obtained from the Perkin Elmer guide for selecting the appropriate techniques 
and systems.     
Element Atomic absorption Spectroscopy (µg L
-1
) 
FAAS GFAAS ICP-OES ICP-MS 
Fe 5 0.06 0.1 0.0003 
 
From the limit of detection values [70] the methods used to analyse the samples was 
GFAAS (Figure 1.24), this is due to the high limit of detection along with the low volume 
of unknown sample required.  
  
 
 
Figure 1.24:  Image of A) the graphite furnace atomic absorption spectroscopy and B) the sample loading 
bay. 
 
 
The sample is placed into the graphite tube and heated in a series of steps to up to 3000 °C 
in order to remove components such as the solvent and atomize the sample. The analyte is 
atomized and retained inside the tube for certain period of time at which light path passes 
through the sample to produce an absorption spectra (Figure 1.25).     
 
 
 
 
 
 
 
 
 
Figure 1.25:  Simplified illustration of the graphite furnace atomic absorption set-up. 
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1.5.8. Fluorescence spectroscopy  
The excitation of fluorescent molecules leads to the energy being lost as heat or emitted 
through fluorescence. The wavelength of the light (emission wavelength) is longer than the 
wavelength for the excited molecule, due to the loss of vibrational energy as heat. The 
fluorescence of samples was measured using a Hitachi fluorescence spectrophotometer F-
2500 (Figure 1.26).      
 
 
Figure 1.26:  An image of A) fluorescence spectrophotometer F-2500 and B) the sample holder where the 
cuvette is held. 
 
  
Simplified schematic of the fluorescence spectrophotometer is illustrated in Figure 1.27. 
The light produces a high energy radiation which passes through a monochromator, at 
which the excitation wavelength of the beam may be selected and it passes through the 
cuvette containing the sample. Upon excitation the sample fluorescence radiation occurs in 
all directions. The radiation passes through a second monochromator which is held at right 
angles to the sample, which allows the fluorescence emitted light to enter the detector [69, 
71].        
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Figure 1.27:  An illustration of the components within a fluorescence spectrophotometer. 
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2. NANOPARTICLE PREPARATION 
The nanoparticles synthesised and characterised in the following chapter is summarised 
below (Table 2.1).  
 
Table 2.1:  Overview of the types of nanoparticles fabricated in this Chapter. 
Nanoparticle 
type 
Nanoparticle reaction scheme 
Amorphous silica 
(Sol-gel) 
 
RBITC 
encapsulate silica 
(Sol-gel) 
 
 
 
 
 
 
 
Silica 
(Microemulsion) 
 
 
 
 
 
 
 
 
 
 
SiRBITC 
encapsulate silica 
with silica shell 
(Sol-gel) 
 
 
 
TEOS 
NH4OH 
H2O EtOH + + 
TEOS Cyclohexane + H2O + n-hexanol Triton-X APS + + + 
Step 2: 
+ APS APS 
Step 1: 
RBITC 
Step 3: 
Acetone 
Step 2: 
APS TEOS 
NH4OH 
H2O EtOH + + + 
+ APS APS 
Step 1: 
RBITC 
H2O + + TEOS APS EtOH + 
NH4OH 
Step 2: 
H2O 
Step 3: 
TEOS + + 
+ APS APS 
Step 1: 
RBITC 
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Nanoparticle 
type 
Nanoparticle reaction 
SiRu(dpp)3 
encapsulate silica 
with silica shell 
(Sol-gel) 
 
 
 
 
 
 
 
 
 
 
 
MNP 
(Sol-gel) 
 
Fluorescent MNP 
(Sol-gel) 
 
 
 
 
 
Silicate-1 
(Sol-gel) 
 
+ APS APS 
Step 1: 
Step 2: 
H2O 
Step 3: 
TEOS + + 
H2O + + TEOS APS EtOH + 
NH4OH 
Step 2: 
Ru(dpp)3 
HCl EtOH 
 
+ + 
 
+ APS APS 
Step 1: 
 
 
H2O 
CTAB 
TEOS NaOH + APS + + + 
Step 2: 
Step 3: 
HCl EtOH 
 
+ + 
 
RBITC 
TEOS NaOH + 
 
H2O 
CTAB 
+ + 
 
Step 1: 
 
 
APS 
 
TEOS + 
 
H2O 
TPAOH 
+ + IP + 
Step 1: 
Step 2: 
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2.1. Amorphous Silica Nanoparticles via Sol-gel 
2.1.1. Materials 
Absolute ethanol (EtOH), ammonium hydroxide (NH4OH) and tetraethyl orthosilicate 
(TEOS) were purchased from Sigma-Aldrich (UK). Salt solutions were prepared using 
sodium chloride (NaCl), potassium chloride (KCl), magnesium sulphate heptahydrate 
(MgSO4.7H2O), sodium bicarbonate (NaHCO3), potassium phosphate monobasic 
(KH2PO4), calcium chloride (CaCl2.2H2O), ethylenediaminetetraacetic acid dipotassium 
salt dihydrate (K2EDTA.2H2O) were purchased from Fisher-Scientific (UK). Millipore 
water was used throughout the experimentation.   
 
2.1.2. Methodology 
Silica nanoparticles (SiNPs) were synthesised via Stöber et al. sol-gel precipitation method 
[16], as illustrated in Figure 2.1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1:  Schematic illustration of the experimental set-up for the silica nanoparticles synthesis.  
 
 
SiNPs of two size ranges were fabricated; 27±7 and 71±6 nm. For the synthesis of 71±6 
nm SiNPs, 6.53 mL of NH4OH was added to a solution containing 88.3 mL of EtOH and 
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1.91 mL of distilled water and heated to 60
 oC. Separately, a solution containing 2.27 mL 
of TEOS and 2.23 mL of EtOH were mixed. The resulting TEOS solution was added drop-
wise to the NH4OH mixture while under vigorous stirring for 21 hours. Finally, the SiNPs 
were collected by centrifugation at 6000 rpm for 30 minutes and washed with EtOH and 
distilled water several times. The same procedure was used to synthesis small-size SiNPs, 
although the chemical amount and temperature differed (Table 2.2). 
 
Table 2.2:  The solution amounts of the reagent required to synthesise silica 
nanoparticles of a given composition and size.   
H2O 
(mL) 
NH4OH 
(mL) 
EtOH 
(mL) 
TEOS 
(mL) 
Temperature 
(°C) 
Particle Size 
(nm) 
Reaction time  
(hours) 
1.91 6.53 90.53 2.27 60 72 21 
17.16 1.38 79.31 2.23 60 24 29 
 
2.1.3. Physiological salt solution preparation 
Physiological salt solution (PSS) was prepared using the following chemical composition 
[mM]:  119 NaCl, 4.7 KCl, 1.2 MgSO4.7H2O, 25 NaHCO3, 1.17 KH2PO4, 0.03 
K2EDTA.2H2O, 5.5 glucose and 1.6 CaCl2.2H2O; pH 7.4. Potassium physiological salt 
solution (KPSS-60 mM) was prepared using the following chemical composition [mM]:  
78.2 NaCl, 60 KCl, 1.2 MgSO4.7H2O, 25 NaHCO3, 1.17 KH2PO4, 0.03 K2EDTA.2H2O, 
5.5 glucose and 1.6 CaCl2.2H2O; pH 7.4 [36].     
 
2.1.4. Characterisation 
The SiNPs hydrodynamic size was determined by photon correlation spectroscopy (PCS, 
Malvern Zetasizer nano ZS instrument, UK). Briefly, the suspended nanoparticles (NPs) 
were placed in a polystyrene cuvette to give 0.02 % solution (1 mL). PCS of NPs were 
measured in distilled water and also in PSS solution. The hydrodynamic size was measured 
by an infra-red light passing through the sample and the resulting scattered light was 
detected. The SiNPs sizes were further confirmed using transmission electron microscopy 
(TEM, JEOL JEM-200) analysis along with obtaining the morphology of the particles. 
Zeta potential (zetasizer nano ZS Malvern Instrument, UK) of the SiNPs was measured by 
placing the suspension containing 0.02 % solution in the disposable zeta capillary cell. The 
zeta potential was obtained in the automatic mode by detecting the electrophoretic mobility 
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produced by the laser Doppler velocimetry. The potentials were determined for NPs in 
both distilled water and PSS.  
 
2.1.5. Results 
The TEM images of the SiNPs prepared using sol-gel methods show spherical 
monodispersed particles (Figure 2.2). The SiNPs sizes were identified as 27±7 and 71±6 
nm in diameter.  
 
 
   
Figure 2.2:  Transmission electron microscope images of A) 71±6 nm silica nanoparticles and B) 27±7 nm 
silica nanoparticles. 
 
 
The hydrodynamic sizes were in close agreement to the average diameter determined by 
TEM (Figure 2.3).  
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Figure 2.3:  Photon correlation spectroscopy analysis of A) 71±6 nm silica nanoparticles  in water (dotted) 
and in PSS (straight), and B) 27±7 nm silica nanoparticles  in water (dotted) and in PSS (straight). 
 
 
PCS analyses for the medium-sized NPs were approximately 30 nm greater than the actual 
size, while the smaller NPs were approximately 10 nm greater. SiNPs with a diameter of 
71±6 and 27±7 nm had a hydrodynamic diameter of 103.8 and 34.27 nm in water 
respectively (Table 2.3).  
 
TABLE 2.3:  Hydrodynamic size and stability measurements of silica nanoparticles, 
in water and physiological salt solution. 
Nanoparticles 
type 
Primary diameter
 a
 
(nm) 
Hydrodynamic diameter
b
 
(nm) 
ζ potential 
(mV) 
In water In PSS In water In PSS 
medium-size SiNPs 71±6 103.8 96.6 -59.1 -26.8 
small-size SiNPs 27±7 34.3 555 -25.1 -5.7 
a
 Mean (±SD) diameter determined by TEM. 
b
Mean PCS measurement. 
 
Medium-size SiNPs (71±6 nm) remained stable after dispersion in PSS as the 
hydrodynamic diameters did not significantly change; however, the smaller particles 
aggregated in ionic salt solution (PSS) (the hydrodynamic diameter of the small-sized 
SiNPs in water was 34.27 nm). Small-sized SiNPs (27±7 nm) aggregated by 91.5 % to 555 
nm, in accordance with the distribution results shown by the PCS analysis (Figure 2 in the 
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appendix). The concentration of SiNPs placed in the solution for PCS analysis was 0.02 %, 
while for the organ-bath experiment the concentration was far smaller. The zeta potential 
values for the NPs confirm their stability in both water and PSS. Generally, the 
suspensions of the SiNPs in ionic salt solution (PSS) led to the slight increase in potential 
as compared to that in water.     
    
2.1.6. Discussion 
The SiNPs were fabricated and carefully characterised. The zeta potential values 
demonstrate that the SiNPs were stable in both water and PSS. When the silica 
nanoparticle (SiNP) suspensions were placed in PSS the potential slightly decreased, as 
compared to the suspension in water, due to their presence in high ionic solution (PSS). 
Briefly, when these SiNPs are in water, the counter ions (water molecules) surround the 
particle‟s surface and produce a structured hydration layer, known as the Stern layer. Other 
counter-ions that are not directly bound to the particle surface are still attracted to the 
negative particle, even though there is repulsion from the „Stern layer‟ as well as other 
counter-ions attracted towards the particle, known as the diffuse layer. The electrical 
potential at the point where the Stern layer meets the diffused layer is known as the zeta 
potential. However, the introduction of ions into the solution (PSS) not only reduced the 
amount of water molecules but results in a competition between the ions and silica surface 
for the water molecules. This leads to a less structured hydration layer as the positively 
charged salt counter-ions and water molecules surround the SiNP, causing the short-range 
repulsive forces to reduce, thus lowering the zeta potential [36, 52]. The smaller SiNPs 
demonstrate non-Debye Landau Verwey Overbeek (DLVO) behaviour with additional 
forces present. It has been proposed that there is short range repulsion from a hairy layer 
present on the surface of small-size SiNPs. The layer is thought to consist of covalently 
bonded polymeric chains of silicilic acid protruding from the surface [52]. The 
hydrodynamic diameter was approximately 7 nm above the actual size measured from the 
TEM image. 
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2.2. Dye Encapsulated Silica Nanoparticles via Sol-gel 
2.2.1. Materials 
Absolute ethanol (EtOH), ammonium hydroxide (NH4OH), tetraethyl orthosilicate 
(TEOS), 3-aminopropyl trimethoxysilane (APS), (3-aminopropyl)triethoxysilane (APTES), 
rhodamine B isothiocyanate (RBITC), ruthenium-tris(4, 7-diphenyl-1, 10-phenanthroline) 
dichloride (Ru(dpp)3), N, N-dimethylformamide (DMF), succinic anhydride, 
methyltriethoxysilane (MTEOS) and octyltriethoxysilane (OTEOS) were purchased from 
Sigma-Aldrich (UK). Salt solutions were prepared using sodium chloride (NaCl), 
potassium chloride (KCl), magnesium sulphate heptahydrate (MgSO4.7H2O), sodium 
bicarbonate (NaHCO3), potassium phosphate monobasic (KH2PO4), calcium chloride 
(CaCl2.2H2O), ethylenediaminetetraacetic acid dipotassium salt dihydrate 
(K2EDTA.2H2O) purchased from Fisher-Scientific (UK). Millipore water was used 
throughout the experimentation.   
 
2.2.2. Methodology  
2.2.2.1. Sol-gel precipitation of fluorophore encapsulated silica 
nanoparticles 
Rhodamine B isothiocyanate encapsulated silica nanoparticles (SiRBITC NPs) were 
prepared via a modified Stöber et al. [16] method, which was developed by Verhaegh et al. 
[72] (Table 2.4). The preparation of medium-size SiRBITC NPs (approximately 70 nm) 
was previously described by Ying et al. [73]. Briefly, a mixture of EtOH (0.8 mL), RBITC 
(5.36 mg) and APTES (13.6 µL) were stirred overnight under a nitrogen atmosphere in 
dark conditions. EtOH (30 mL) and NH4OH (2 mL) were added to the mixture and stirred 
vigorously for 20 hours, followed by addition of TEOS (558 µL) and stirring for 24 hours. 
A further addition of TEOS (13.8 µl) was made and stirred for 5 hours. The resulting 
precipitate was collected by centrifugation at 6000 rpm for 30 minutes and washed with 
EtOH and distilled water several times. 
 
Small-size SiRBITC NPs (approximately 30 nm) were synthesised by coupling APTMS 
(10 µL) to the RBITC (1.2 mg) dye molecule in a nitrogen atmosphere under dark 
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conditions. Briefly, 1.38 ml of a NH4OH was added to a solution containing 77.08 ml of 
EtOH and 17.16 ml of distilled water and was heated to 60 oC.  Separately, a solution 
containing 2.23 ml of TEOS and 2.23 ml EtOH were mixed. The resulting TEOS solution 
was added drop-wise to the NH4OH mixture while under vigorous stirring. After 15 
minutes the dye mixture was added and stirred for 29 hours. Finally, the SiNPs were 
collected by centrifugation at 6000 rpm for 30 min and washed with EtOH and distilled 
water several times. 
 
2.2.2.2. Silica coating of fluorophore encapsulated silica seeds 
All the experiments were carried out under dark conditions due to the photosensitivity of 
the fluorescent dye molecules. SiNPs were synthesised using Stöber et al. method [16]. 
The reaction entailed the hydrolysis and condensation of TEOS in aqueous solution of 
EtOH and water. The SiRBITC NPs were synthesised using the procedure describe by 
Verhaegh et al. [72]. These were then used as seeds to coat with a silica shell in order to 
obtain the required size [74]. The RBITC dye (1 mg) and APS (0.01 mL) mixture, 
previously stirred for a few hours in N2 atmosphere, were placed in a solution of NH4OH 
(2 mL) in EtOH (24 mL) and stirred. Finally, a solution of TEOS (1.5 mL) and EtOH (6 
mL) was added to mixture and stirred for 24 hours, resulting in an opaque pink solution. 
TEOS (5.4 mL) and water (2.2 mL) were added gradually to create silica shells on the dye 
seeds, which produced a paler pink solution (Figure 2.4). 
 
The ruthenium-tris(4, 7-diphenyl-1, 10-phenanthroline) dichloride encapsulated silica 
nanoparticles (SiRu(dpp)3 NPs) were also synthesised using the sol-gel technique. 
Ruthenium-tris(4, 7-diphenyl-1, 10-phenanthroline) dichloride (Ru(dpp)3) dye (0.4 mg) 
was dispersed in EtOH (20 mL), followed by addition of NH4OH (2 mL) solution and the 
resulting mixture was stirred. Finally, a solution of TEOS (1.5 mL) and EtOH (6 mL) was 
added to mixture and stirred for 24 hours, resulting in an opaque orange solution. TEOS 
(5.4 mL) and water (2.2 mL) was added gradually to coat with a silica shell, which 
produced a paler orange solution (Figure 2.4). 
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Figure 2.4:  An image of the fluorophore encapsulated silica nanoparticles of A) the seeds, B) half way 
through the silica shell formation and C) nanoparticles when the desired size have been reached, with 
their SEM images indicated below (                ). The pink solution is of the rhodamine B isothiocyanate 
encapsulated silica nanoparticles and orange solution is of the ruthenium-tris (4, 7-diphenyl-1, 10-
phenanthroline) dichloride encapsulated silica nanoparticles. 
 
 
2.2.2.3. Functionalising silica nanoparticles with carboxylic acid 
groups 
The carboxylic acid functionalised SiNPs were prepared using the method described by An 
et al. [75]. APS (0.4 mL) was added to the RBITC core-shell SiNPs and stirred for 20 
hours. The NPs were collected by centrifugation to remove any unreacted reagents. A 
solution of succinic anhydride (0.25 g) in DMF (25 mL) was prepared, to which the NPs 
solution was added. The solution was stirred for 24 hours and the product was collected by 
centrifugation. The ring opening elongation reaction with succinic anhydride is shown in 
Figure 2.5. The functionalisation procedure was separately carried out for the Ru(dpp)3 
encapsulated SiNPs.   
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500 nm 
                     Chapter 2        
                                  Nanoparticle Preparation 
  
 
47 
 
 
Figure 2.5:  Schematic illustration of the surface modification of silica nanoparticles with carboxylic acid 
group. 
 
 
2.2.2.4. Quantifying the amount of fluorophore within the 
nanoparticles  
The amounts of dye molecules encapsulated within the NPs were quantified using 
fluorescence spectroscopy (Hitachi fluorescence spectrophotometer, F-2500). Initially, a 
calibration graph of fluorescence intensity against fluorophore concentration was 
produced. The excitation of RBITC was 540 nm with an emission at 573 nm, while 
Ru(dpp)3 excitation was 490 nm with emission at 591 nm. For the RBITC calibration 
graph the fluorophore concentration  range was 2.19×10-8 to 7.00×10-7 mol dm-3, while for 
the Ru(dpp)3 calibration graph the fluorophore concentration  range was 9.00×10
-7
 to 
1.44×10-5 mol dm-3.   
 
2.2.3. Results 
2.2.3.1. Nanoparticles prepared using the sol-gel method   
The TEM images of the SiNPs prepared using sol-gel methods show spherical 
monodispersed NPs (Figure 2.6). The medium-size SiRBITC NPs were 61±7 nm in 
diameter, while the small-size SiRBITC NPs were 31±10 nm in diameter.  
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Figure 2.6:  Transmission electron microscope images of A) 61±7 nm rhodamine B isothiocyanate 
encapsulated silica nanoparticles and B) 31±10 nm rhodamine B isothiocyanate encapsulated silica 
nanoparticles. 
 
 
The hydrodynamic sizes were in close agreement to the average diameter determined by 
TEM (Figure 2.7).  
 
TABLE 2.4:  Hydrodynamic size and stability measurements of rhodamine B 
isothiocyanate encapsulated silica nanoparticles, in water and physiological salt 
solution. 
Nanoparticles 
type 
Primary diameter
 a
 
(nm) 
Hydrodynamic diameter
b
 
(nm) 
ζ potential 
(mV) 
In water In PSS In water In PSS 
medium-size 
SiRBITC NPs 
61±7 97.8 99.0 -57.7 -25.9 
small-size 
SiRBITC NPs 
31±10 42.2 410.2 -29.8 -14.5 
a
 Mean (±SD) diameter determined by TEM. 
b
Mean PCS measurement. 
 
The PCS analyses for the medium-sized SiRBITC NPs were approximately 30 nm greater 
than the actual size, while the small-sized SiRBITC NPs were approximately 10 nm 
greater. SiRBITC NPs with a diameter of 61±7 and 31±10 nm had hydrodynamic 
diameters of 98 and 42 nm, respectively. Medium-size SiRBITC NPs (61±7 nm) remained 
stable after dispersion in PSS as the hydrodynamic diameters did not significantly change; 
however, the smaller particles aggregated in ionic salt solution (PSS). Small SiRBITC NPs 
(31±10 nm) aggregated by 81.9 % to 410.2 nm, in accordance with the distribution results 
shown by the PCS analysis (Figure 4 in the appendix). It is noted, however, that the 
concentration of SiRBITC NPs placed in the solution for PCS analysis was 0.02 % 
solution, while for the organ-bath experiment the concentration was far smaller (refer to 
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Chapter 2, Section 2.1.6). The zeta potential values for the SiRBITC NPs confirm their 
stability in both water and PSS. Generally, suspensions of SiRBITC NPs in ionic solution 
(PSS) led to the slight increase in potential as compared to that in water. 
 
 
 
Figure 2.7:  Photon correlation spectroscopy analysis of A) 61±7 nm rhodamine B isothiocyanate 
encapsulated silica nanoparticles in water (dotted) and in PSS (straight), and B) 31±10 nm rhodamine B 
isothiocyanate encapsulated silica nanoparticles in water (dotted) and in PSS (straight). 
 
 
2.2.3.2. Nanoparticle seeds coated with silica shell  
The TEM, Figure 2.8, confirm the synthesis of monodispersed SiNPs. SiRu(dpp)3 NPs 
have an average diameter of 192±8 nm (Figure 2.8A) and SiRBITC NPs have an average 
diameter of 208±9 nm (Figure 2.8B). 
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Figure 2.8:  Transmission electron microscope images of A) ruthenium-tris (4, 7-diphenyl-1, 10-
phenanthroline) dichloride encapsulated silica nanoparticles and B) rhodamine B isothiocyanate 
encapsulated silica nanoparticles. 
 
 
The PCS analysis further confirm the average diameter of the silica dye encapsulated NPs 
to be approximately 200 nm, where SiRu(dpp)3 NPs are 194 nm and SiRBITC NPs are 197 
nm (Figure 2.9).  
 
 
 
Figure 2.9:  Photon correlation spectroscopy analysis of ruthenium-tris (4, 7-diphenyl-1, 10-
phenanthroline) dichloride encapsulated silica nanoparticles and rhodamine B isothiocyanate 
encapsulated silica nanoparticles. 
 
 
The SiNP synthesis consisted of TEOS, which has four „ethoxy‟ groups that render it 
hydrophobic (Figure 2.10). These were then hydrolysed in water causing the „ethoxy‟ 
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groups to be substituted for hydroxyl groups. This hydrolysis reaction caused the molecule 
to become hydrophilic.  
 
 
 
Figure 2.10:  Schematic illustration of the hydrolysis of TEOS causing it to become hydrophilic. 
 
 
The nanoparticle (NP) surface modification was confirmed with zeta potential 
measurements (Figure 2.11; Table 2.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11:  Bar chart graph illustrating the surface modification of silica dye encapsulated 
nanoparticles by change in zeta potential. 
 
 
The addition of amine groups caused the zeta potential to become more positive while the 
carboxylic acid functionalisation caused the zeta potential to become more negative, as 
anticipated [75].  
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TABLE 2.5:  Hydrodynamic size and stability measurements of silica dye 
encapsulated nanoparticles and their surface modification with amine and carboxylic 
acid groups. 
 
a
 Mean (±SD) diameter determined by TEM. 
b
Mean PCS measurement. 
 
The amounts of dye molecules encapsulated within the NPs were quantified using 
fluorescence spectroscopy. Initially, the fluorescence spectra of known concentrations of 
fluorophores were carried out (Figure 9 and 11 in the appendix) in order to produce the 
calibration graphs (Figure 2.12).  
 
 
 
 
 
 
 
 
 
 
Figure 2.12:  Fluorescence calibration graph of A) rhodamine B isothiocyanate and B) ruthenium-tris (4, 
7-diphenyl-1, 10-phenanthroline) dichloride dye molecules. 
 
 
These calibrations graphs allow for the quantification of dye molecules within the NPs via 
the attainment of the fluorescence graphs of their supernatant. Thus, the dye concentration 
within the NPs was calculated by subtracting the concentration within the supernatant from 
the actual concentration of dye used (Table 2.6). The mass of RBITC dye molecules within 
SiRBITC NPs was 999.72 µg, while Ru(dpp)3 fluorophore within the SiRu(dpp)3 NPs was 
323.88 µg.  
Nanoparticles 
type 
Primary 
diameter
 a
 
(nm) 
Hydrodynamic 
diameter
b
 
(nm) 
ζ potential 
(mV) 
Un-
modified 
Amine 
functionalised 
Carboxylic 
acid 
functionalised 
SiRBITC NPs 208±9 197.2 -45.9 -16.3 -37.9 
SiRu(dpp)3 
NPs 
192±8 194.9 -64.5 -28 -41.6 
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TABLE 2.6:  Quantifying the amount of dye molecules within the nanoparticles. 
Dyes 
Concentration 
of supernatant   
(mol dm
-3
) 
Moles of 
supernatant 
(mol) 
Mass of dye within 
supernatant       
(µg) 
Mass of dye 
within NPs 
(µg) 
RBITC 1.94×10-8 5.25×10-10 0.28 999.72 
Ru(dpp)3 2.96×10
-6
 6.51×10-8 76.12 323.88 
 
2.2.4. Discussion 
2.2.4.1. Nanoparticles prepared using the sol-gel method 
The medium and small-sized SiRBITC NPs were stable in both water and PSS as 
demonstrated by the zeta potential values. In the case of SiRBITC NPs the zeta potential in 
water was more negative than the non-dye encapsulated SiNPs. As previously noted for the 
SiNPs, when SiRBITC NPs are suspended in PSS, attraction of salt ions led to reduced 
negativity. Such charge attraction may have led to modification of the surface chemistry of 
the SiRBITC NPs, in comparison to the SiNPs. The hydrodynamic diameter of our 
fabricated medium-sized SiRBITC NPs was approximately 40 nm above the actual size 
measured from the TEM images. The zeta potentials of medium-sized SiRBITC NPs 
confirm it is stable in both water and PSS. The ions within the PSS media causes the 
SiRBITC NPs suspensions zeta potential to slightly decrease, as compared to the 
suspension in water, as previously explained in Chapter 2, Section 2.1.6. Briefly, a less 
structured hydration layer is formed around the NP, resulting in the short-range repulsive 
forces to reduce, thus lowering the zeta potential. However, we suggest that the small-sized 
SiRBITC NPs demonstrate non-DLVO behaviour with additional forces present known as 
the hairy layer, refer to Chapter 2, Section 2.1.6.  
 
2.2.4.2. Nanoparticle seeds coated with silica shell 
The TEM images confirm for the synthesis of monodispersed dye encapsulated SiNPs. The 
PCS analysis was in agreement with the particle size for both SiRu(dpp)3 NPs and 
SiRBITC NPs.  
 
Verhaegh et al. [72], suggested that if the RBITC dye was not functionalised with APS and 
used in an alcohol solution, it would not incorporate into the silica and would leach out of 
the NPs into the solution. APS was added to the RBITC dye in order to act as a coupling 
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agent, and allow the siloxyl groups to anchor to the silica core and the amine group to bind 
to the dye [76]. After stirring under a nitrogen atmosphere under dark conditions the colour 
changed from intense purple to orange as self-quenching had occurred [72]. The synthesis 
of SiRu(dpp)3 NPs occurs as the silica is negatively charged, while the Ru(dpp)3 dye is 
positively charged. This causes electrostatic interaction to occur between the dye and the 
silica and therefore leading to an ionic bond. The NPs were successfully functionalised 
with carboxylic acid as confirmed with the zeta potential measurements. Previous studies, 
have reported possible types of interaction between the aminosilane molecules and the 
silica surface. The amine may produce hydrogen bonds with the surface hydroxyl groups. 
Alternatively, the amine may abstract a proton from the silanol group resulting in the 
formation of an ionic bond; this is a more stable interaction as compared to the first 
interaction. Furthermore, it is possible for the hydrogen bonded molecules to self-catalyse 
the condensation reaction of the silicon groups within the silane molecule, thus forming a 
covalent siloxane bond [77]. The carboxylic acid group covalently bond to the NP surface 
via an interaction between the amine group and succinic anhydride [75]. Furthermore, the 
volume of dye molecules within the SiRBITC NPs is approximately twice the amount as 
compared to the SiRu(dpp)3 NPs. 
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2.3. Silica Nanoparticles via Microemulsion 
2.3.1. Materials 
Triton X-100, cyclohexane, n-hexanol, ammonium hydroxide (NH4OH), tetraethyl 
orthosilicate (TEOS), rhodamine B isothiocyanate (RBITC), (3-
aminopropyl)triethoxysilane (APTES) and absolute ethanol (EtOH) were purchased from 
Sigma-Aldrich (UK). Millipore water was used throughout the experimentation.   
 
2.3.2. Methodology 
SiRBITC NPs were synthesised via a reverse microemulsion method, where reactant 
concentrations were altered according to Table 2.7 [78]. Initially, RBITC dye molecules 
were coupled with equimolar concentration of APTES by stirring the resulting solution 
overnight in a nitrogen atmosphere under dark conditions. Briefly, for the synthesis of 
sample 1, 1.77 mL of Triton X-100, 7.5 mL of cyclohexane, 1.8 mL of n-hexanol, 400 µL 
of water and 10 µL of RBITC-APTES solution were stirred for 1 hour to produce the 
water-in-oil microemulsion. This was followed by the addition of 200 µL of TEOS and 
100 µL of NH4OH. The resulting mixture was stirred for 24 hours. The microemulsion was 
broken with acetone and the SiNPs were collected and washed with centrifugation (6000 
rpm/ 30 minutes) using ethanol several times. 
 
The same procedure was utilized to synthesised SiRBITC NPs of different size ranges, 
however for sample 4 the RBITC-APTES was added to the reaction mixture after the 
TEOS and catalyst addition.          
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Table 2.7:  The solution amounts of the reagent required to synthesise rhodamine B 
isothiocyanate encapsulated silica nanoparticles of a given composition and size.   
Triton-X 
(mL) 
Cyclohexane 
(mL) 
n-hexanol 
(mL) 
Water 
(mL) 
RBITC-
APTES 
(µL) 
TEOS 
(µL) 
NH4OH 
(µL) 
Particle Size 
(nm) 
Sample 
1.77 7.5 1.8 0.4 10 200 100 44±5 1 
1.77 7.5 1.8 0.4 5 200 100 53±8 2 
7 30 7.2 1.6 10 800 400 66±3 3 
7 30 7.2 1.6 10 800 400 64±4 4 
  
2.3.3. Characterisation 
The SiRBITC NP hydrodynamic size was determined by PCS (Malvern Zetasizer nano ZS 
instrument, UK). Briefly, the suspended NPs were placed in a polystyrene cuvette to give 
0.02 % solution (1 mL). PCS of NPs were measured in distilled water and also in PSS 
solution. The hydrodynamic size was measured by an infra-red light passing through the 
sample and the resulting scattered light was detected. The SiNPs sizes were further 
confirmed using TEM (JEOL JEM-200) analysis along with obtaining the morphology of 
the particles. Zeta potential (zetasizer nano ZS Malvern Instrument, UK) of the SiNPs was 
measured by placing the suspension containing 0.02 % solution in the disposable zeta 
capillary cell. The zeta potential was obtained in the automatic mode by detecting the 
electrophoretic mobility produced by the laser Doppler velocimetry. 
 
2.3.4. Results 
The TEM images of the SiRBITC NPs prepared via microemulsion methods show 
spherical monodispersed particles (Figure 2.13). The Sample 1 sizes were identified as 
48±4 nm in diameter, while the sample 2 were 54±9 nm, sample 3 were 66±4 nm and 
sample 4 were 65±5 nm.     
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Figure 2.13:  Transmission electron microscope images of rhodamine B isothiocyanate encapsulated silica 
nanoparticles; A) sample 1, B) sample 2, C) sample 3 and D) sample 4. 
 
 
The hydrodynamic sizes were in close agreement to the average diameter determined by 
TEM (Figure 2.14).  
 
 
Figure 2.14:  Photon correlation spectroscopy analysis of rhodamine B isothiocyanate encapsulated silica 
nanoparticles synthesised via microemulsion precipitation process. 
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PCS analyses for the SiRBITC NPs shows the hydrodynamic diameter is approximately 
double than the actual size. SiRBITC NPs with a diameter of 48±4, 54±9, 66±4 and 65±5 
nm have a hydrodynamic diameter of 125.4, 88.08, 124.0 and 120.2 nm in water 
respectively (Table 2.8). 
 
TABLE 2.8:  Hydrodynamic size and stability measurements of silica nanoparticles in 
water media. 
Sample 
Primary 
diameter
 a
 
(nm) 
Hydrodynamic diameter
b
 
(nm) 
ζ potential 
(mV) 
1 48±4 125.4 -36.7 
2 54±9 88.1 -30.3 
3 66±4 124.0 -46.9 
4 65±5 120.2 -40.8 
a
 Mean (±SD) diameter determined by TEM. 
b
Mean PCS measurement. 
 
The majority of SiRBITC NPs (48±4 nm) remained bimodal by 97.2 % to 125.4 nm and 
2.8 % aggregated to 4038 nm, in accordance with the distribution results shown by the 
PCS analysis (Figure 13 in the appendix). The zeta potential values for the NPs confirm 
their stability in water.  
 
2.3.5. Discussion 
The SiRBITC NPs were synthesised using the method described by Shi et al, and the 
fabrication of the NPs were of similar size ranges to their method [78]. Interestingly, 
reducing the volume of dye mix added to the reaction mixture does not reduce the NP 
diameter. Imhof et al; has demonstrated that increasing the concentration dye coupled to 
the amino propyl groups leads to increased NP size [79], however the similar size range 
may be due to the amino propyl being diluted in large volume of solvent. Furthermore, 
when increasing the volume of reactants while the concentration remains the same 
increases the NP diameter. The addition of dye mixture after silica precursor addition does 
not alter the NP size. The PCS analysis demonstrates that these NPs synthesised by 
microemulsion are approximately double in size. This may be due to the NP surface 
containing oily residues that are attracted to each another. The zeta potentials for SiRBITC 
NPs confirm it is stable in water.   
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2.4. Mesoporous Nanoparticles 
2.4.1. Materials 
Rhodamine B isothiocyanate (RBITC), (3-Aminopropyl)trimethoxysilane (APTMS), 
fluorescein isothiocyanate (FITC), tetraethyl orthosilicate (TEOS), ammonium hydroxide 
solution (NH4OH), ammonium nitrate (NH4NO3) and concentrated hydrochloric acid (HCl, 
37 %) were purchased from Sigma-Aldrich (UK). Absolute ethanol (EtOH), 
hexadecyltrimethyammonium bromide (CTMAB), ethylene glycol (EG; 99.8 % 
anhydrous), dimethylformamide (DMF), sodium hydroxide (NaOH), methanol (MeOH) 
and isopropanol (IP) were purchased from Fisher-Scientific (UK). Millipore water was 
used for all the experimentation. 
 
2.4.2. Methodology 
2.4.2.1. RBITC encapsulated mesoporous synthetic route 1 (sample 1)  
The mesoporous nanoparticles (MNP) (sample 1) were prepared using Lin et al. [80] 
method, although RBITC dye was used instead of fluorescein isothiocyanate (FITC). 
Initially, 4.77 g of EtOH was sonicated with 1.20 g of TEOS at 50 °C. Briefly, 1 mg of 
RBITC was reacted under dark conditions with 10 µL of APTMS in an N2 atmosphere by 
stirring the mixture overnight; leading to a colour change from pink to orange. The RBITC 
MNP was prepared by a co-condensation reaction where 0.65 g of 
hexadecyltrimethyammonium bromide (CTMAB) was dissolved in 294 mL of H2O and 
10.18 g of NH4OH solution at 50 °C. To the resulting solution 4.88 mL of TEOS and 
EtOH solution was pipetted in the mixture and stirred vigorously for 5 hours. The 
remaining TEOS and EtOH solution was mixed with the RBITC dye and added drop wise 
to the mixture and allowed to stir vigorously for 1 hour. The resulting mixture was aged at 
50 °C for 24 hours giving an opaque pink precipitate. The RBITC MNP was collected and 
washed three times by centrifugation. Initially, the mixture was centrifuged (15000 rpm/ 10 
minutes) with distilled water and this was repeated at a lower speed (6000 rpm/ 30 
minutes). Finally, it was centrifuged (6000 rpm/ 30 minutes) with EtOH and dried 
overnight at 50 °C. The surfactant template was extracted from the as-synthesised product 
by calcinations. The product was place in a pre-heated furnace at 300 °C and heated to 550 
°C for 3 hours at the rate of 5 °C per minute.   
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2.4.2.2. Mesoporous synthetic route 2 (sample 2-7) 
MNP prepared by synthetic route 2 were synthesised using Gu et al. [81] method (Table 
2.9).  
 
Table 2.9:  The solution amounts of the reagent required to synthesise mesoporous 
nanoparticles of required composition and size.   
 
 
 
 
 
 
 
 
 
 
 
 
 
a
 Mean (±SD) diameter determined by TEM. 
b
Abbreviation for the solvent isopropanol. 
 
2.4.2.2.1. Amorphous mesoporous nanoparticles (samples 2-6) 
Briefly, for the synthesis of 160 nm MNP, MNP was prepared by a co-condensation 
reaction where 1.17 g of CTMAB was dissolved in 180 mL of H2O, 30 mL of ethylene 
glycol (EG) and 7.2 mL of NH4OH solution at 50 °C by stirring vigorously. To the 
resulting solution 1430 µL of TEOS was added followed by the addition of APTMS (265 
µL). The resulting mixture was stirred vigorously at 50 °C for 2 hours and allowed to age 
for 20 hours at the same temperature. The MNP were collected and washed three times by 
centrifugation (20,000 rpm/ 10 minutes) with distilled water and dried in an oven at 60 °C. 
The surfactant template was extracted from the template intact MNP by dissolving the 
product (1 g) and ammonium nitrate (NH4NO3) in ethanol (EtOH; 40 mL) at 60 °C for 18 
hours. The template free MNP were washed several times using EtOH (14,000 rpm/ 15 
minutes).   
 
Sample 
Size
 a
 
(nm) 
Water 
(mL) 
EG 
(mL) 
CTAB 
(g) 
NH4OH 
(mL) 
TEOS 
(mL) 
APS 
(µL) 
IP
 b
 
(mL) 
Dyes 
(mg) 
2 
100±9 & 
137±9 
180 0 1.17 7.2 1.43 265 30 0 
3 
182±9 
&140±5 
180 30 1.17 10 1.43 265 0 0 
4 
268±5, 
232±13, 
182±9 & 
423±14 
180 30 1.17 7.2 1.43 265 0 0 
5 
87±5 & 
59±5 
180 30 1.17 4 1.43 265 0 0 
6 50±5 180 30 1.17 2 1.43 265 0 0 
7 73±9 180 30 1.17 4 1.43 265 0 7.95 
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2.4.2.2.2. Synthesis of mesoporous nanoparticles with RBITC dye      
(sample 7) 
Briefly, 8 mg of RBITC was reacted with 265 µL of APTMS by stirring the mixture 
overnight. The RBITC MNP was prepared by a co-condensation reaction where 1.17 g of 
CTMAB was dissolved in 180 mL H2O, EG (30 mL) and 4 mL of NH4OH solution at 50 
°C. To the resulting solution 1430 µL of TEOS was added, followed by the addition of 265 
µL of the dye mixture. The resulting mixture was stirred vigorously at 50 °C for 2 hours 
and aged for 20 hours at the same temperature producing an opaque pink precipitate. The 
RBITC MNP was collected and washed three times by centrifugation (20,000 rpm/ 30 
minutes) with EtOH. The surfactant template was extracted from the template intact MNP 
by dissolving the product (1 g) and NH4NO3 in EtOH (40 mL) at 60 °C for 18 hours. The 
template free MNP were washed several times using EtOH (14,000 rpm/ 15 minutes).   
 
2.4.2.3. Mesoporous synthetic route 3 (samples 8-12) 
MNP were synthesised via the self-assembly method as previously described by Slowing et 
al. [82], where FITC dye molecules were encapsulated within MNP. In this study, different 
types and combinations (RBITC and FITC) of fluorophores have been encapsulated within 
the mesoporous matrix (Table 2.10). 
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Table 2.10:  Overview of the amount of reactants needed to synthesise mesoporous 
nanoparticles. 
 
a
 Mean (±SD) diameter determined by TEM. 
b
Abbreviation for the solvent dimethylformamide. 
 
2.4.2.3.1. RBITC encapsulated mesoporous nanoparticles (sample 8) 
Briefly, 1.5 mg of RBITC was reacted with 50 µL of APTMS in N2 atmosphere for 3 
hours. The RBITC MNP was prepared by a co-condensation reaction where 1 g of 
CTMAB was dissolved in 480 mL H2O and 3.5 mL of 2 M NaOH solution at 80 °C. To the 
resulting solution 5 mL of TEOS was added followed by the addition of 50 µL of coupled 
dye mixture. The resulting mixture was stirred vigorously at 80 °C for 2 hours producing 
an opaque pink precipitate. The RBITC MNP was collected and washed twice by 
centrifugation (14,000 rpm/ 15 minutes) with methanol (MeOH). The surfactant template 
was extracted from the as-synthesised product by dispersing the template intact MNP in 
MeOH (200 mL) and concentrated HCl (2 mL) at 60 °C for 18 hours. The FITC MNP was 
washed several times using MeOH (14,000 rpm/ 15 minutes). 
 
2.4.2.3.2. Mesoporous nanoparticles (Sample 9) 
Briefly, 5 mL of anhydrous DMF was mixed with 50 µL of APTMS. The MNP was 
prepared by a co-condensation reaction where 1 g of CTMAB was dissolved in 480 mL of 
H2O and 3.5 mL of 2 M NaOH solution at 80 °C. To the resulting solution 4 mL of TEOS 
was added followed by the addition of 500 µL of APTMS mixture. The resulting mixture 
Sample 
Size
 a
 
(nm) 
Water 
(mL) 
DMF
 b
 
(µL) 
CTAB 
(g) 
NaOH 
(mL) 
TEOS 
(mL) 
APS 
(µL) 
Dyes 
(mg) 
8 
104±13, 
266±11, 
300 & 
436 
480 0 1 3.5 5 50 
1.5 
(RBITC) 
9 95±13 480 495 1 3.5 4 5 0 
10 105±13 480 495 1 3.5 4 5 
0.2 
(RBITC) 
11 109±18 480 495 1 3.5 4 5 
0.2  
(FITC) 
12 105±13 480 495 1 3.5 4 5 
0.1:0.1 
(RBITC/ 
FITC) 
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was stirred vigorously at 80 °C for 2 hours producing an opaque white precipitate. The 
MNP was collected and washed twice by centrifugation (14,000 rpm/ 15 minutes) with 
MeOH. The surfactant template was extracted from the as-synthesised product by 
dispersing the template intact MNP in MeOH (100 mL) and concentrated HCl (1mL) at 60 
°C for 18 hours. The acid extraction step was repeated twice. The MNP was washed 
several times using MeOH (14,000 rpm/ 15 minutes) (Figure 2.15).   
 
 
 
Figure 2.15:  Image of mesoporous nanoparticles A) before and B) after acid template extraction. 
 
 
2.4.2.3.3. RBITC encapsulated mesoporous nanoparticles (sample 10) 
Briefly, 2 mg of RBITC was reacted with a mixture of 5 mL of anhydrous DMF and 50 µL 
of APTMS for 3 hours. The RBITC MNP was prepared by a co-condensation reaction 
where 1 g of CTMAB was dissolved in 480 mL of H2O and 3.5 mL of 2 M NaOH solution 
at 80 °C. To the resulting solution 4 mL of TEOS was added followed by the addition of 
500 µL of dye mixture. The resulting mixture was stirred vigorously at 80 °C for 2 hours 
giving an opaque pink precipitate. The RBITC MNP was collected and washed twice by 
centrifugation (14,000 rpm/ 15 minutes) with MeOH. The surfactant template was 
extracted from the as-synthesised product by dispersing the template intact MNP in MeOH 
(200 mL) and concentrated HCl (2 mL) at 60 °C for 18 hours. The acid extraction step was 
repeated twice. The MNP was washed several times using MeOH (14,000 rpm/ 15 
minutes) (Figure 2.16).   
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Figure 2.16:  Image of rhodamine B isothiocyanate encapsulated mesoporous nanoparticles A) before and 
B) after acid template extraction. 
 
 
2.4.2.3.4. FITC encapsulated mesoporous nanoparticles (Sample 11) 
Briefly, 2 mg of FITC was reacted with a mixture of 5 mL of anhydrous DMF and 50 µL 
of APTMS for 3 hours. The FITC MNP was prepared by a co-condensation reaction where 
1 g of CTMAB was dissolved in 480 mL of H2O and 3.5 mL of 2 M NaOH solution at 80 
°C. To the resulting solution 4 mL of TEOS was added followed by the addition of 500 µL 
of dye mixture. The resulting mixture was stirred vigorously at 80 °C for 2 hours giving an 
opaque yellow/ orange precipitate (Figure 2.17A). The FITC MNP was collected and 
washed twice by centrifugation (14,000 rpm/ 15 minutes) with MeOH. The surfactant 
template was extracted from the as-synthesised product by dispersing the template intact 
MNP in MeOH (200 mL) and concentrated HCl (2 mL) at 60 °C for 18 hours. The acid 
extraction step was repeated twice resulting in a yellow solution (Figure 2.17B). The FITC 
MNP was washed several times using MeOH (14,000 rpm/ 15 min). 
    
 
 
Figure 2.17:  Image of fluoroscein isothiocyanate encapsulated mesoporous nanoparticles A) before and 
B) after acid template extraction. 
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2.4.2.3.5. RBITC/FITC encapsulated mesoporous nanoparticles (sample 12) 
Briefly, 2 mg of RBITC was reacted with a mixture of 5 mL of anhydrous DMF and 50 µL 
of APTMS for 3 hours in N2 atmosphere. Separately, 2 mg of FITC was reacted with a 
mixture of 5 mL of anhydrous DMF and 50 µL of APTMS for 3 hours under N2 
atmosphere. RBITC/APS/DMF solution (250 µL) was mixed with FITC/APS/DMF 
solution (250 µL) by being stirred vigorously for the dye mixture to become homogeneous. 
 
The RBITC/ FITC MNP were prepared by a co-condensation reaction where 1 g of 
CTMAB was dissolved in 480 mL of H2O and 3.5 mL of 2 M NaOH solution at 80 °C. To 
the resulting solution 4 mL of TEOS was added followed by the addition of 500 µL of dye 
mixture. The resulting mixture was stirred vigorously at 80 °C for 2 hours giving an 
opaque pinkish/ orange precipitate (Figure 2.18A). The RBITC/ FITC MNP was collected 
and washed twice by centrifugation (14,000 rpm/ 15 minutes) with MeOH. The surfactant 
template was extracted from the as-synthesised product by dispersing the template intact 
MNP in MeOH (200 mL) and concentrated HCl (2 mL) at 60 °C for 18 hours. The acid 
extraction step was repeated twice resulting in an orange solution (Figure 2.18B). The 
FITC MNP was washed several times using MeOH (14,000 rpm/ 15 minutes). 
 
 
 
Figure 2.18:  Image of rhodamine B isothiocyanate/ fluoroscein isothiocyanate encapsulated mesoporous 
nanoparticles A) before and B) after acid template extraction. 
 
 
After purification of the MNP they were dispersed in a minimal amount of MeOH and 
dried in an oven set to 60 °C for several hours. The resulting powders were collected as 
shown in Figure 2.19. The RBITC incorporated MNP powder was used in the drug release 
study, refer to Chapter 3; Section 3.6. 
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Figure 2.19:  Image of A) silica mesoporous nanoparticles, B) fluoroscein isothiocyanate encapsulated 
mesoporous nanoparticles; C) rhodamine B isothiocyanate encapsulated mesoporous nanoparticles and 
D) rhodamine B isothiocyanate/ fluoroscein isothiocyanate encapsulated mesoporous nanoparticles. 
 
 
2.4.3. Results 
Initially, MNP were prepared using Lin et al. method with RBITC dye molecules 
incorporated within the NPs [80]. They have reported the synthesis of hexagonal MNP of 
approximately 110 nm with FITC dye. The PCS measurements of the RBITC MNP 
(sample 1), shown in Figure 2.20, has a hydrodynamic size of 847.3 nm, which is much 
larger than the expected 110 nm diameter.     
      
 
 
Figure 2.20:  Photon correlation spectroscopy analysis of rhodamine B isothiocyanate encapsulated 
mesoporous nanoparticles; sample 1. 
 
 
Sample 1 has a zeta potential of +42.1 mV indicating the MNP are stable as the zeta 
potential value is above +30 mV. Further confirmation of the MNP size was determined by 
TEM with an average diameter of 265, 225 and 124±15 nm; and length of 1142, 1060±6 
and 494 nm (Figure 2.21).   
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Figure 2.21:  Transmission electron microscope image of rhodamine B isothiocyanate encapsulated 
mesoporous nanoparticles; sample 1 where A) is at 46000 magnification and B) is at 10500 magnification. 
 
 
It is of interest to synthesise smaller MNP for the biological application, as a comparison to 
previous in vitro studies [83]. Therefore an alternative experimental method was 
implemented, synthetic route 2, to attempt to produce smaller MNP. With the second 
synthetic route smaller template intact MNP were successfully synthesised, as 
demonstrated by the PCS (Figure 2.22).     
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Figure 2.22:  Photon correlation spectroscopy analysis of mesoporous nanoparticles; sample 2 was 292.3 
nm, sample 3 was 173.6 nm, sample 4 was 160.1 nm, sample 5 was 106.7 nm and sample 6 was 123.2 nm. 
 
 
The hydrodynamic diameter of sample 2 was 292.3 nm, although when EG was used as the 
media for nucleation instead of isopropanol (IP) the MNP size dramatically decreased to 
160.7 nm (sample 4). Sample 3 demonstrates that by keeping the volume of EG (30 mL) 
constant and increasing the amount of catalyst (10 mL) the MNP size increase by 14 nm. 
However, sample 6 demonstrates that as the concentration of the catalyst was decreased to 
2 mL, in comparison to sample 3, then smaller MNP with an average size of 123.2 nm 
were produced. Sample 5 demonstrates that as the catalyst amount was double in 
comparison to sample 6 it further causes smaller MNP to be produced with a 
hydrodynamic diameter of 106.7 nm. The stability for sample 5 and 6 was determined with 
the zeta potential, +30.4 and +27.1 mV respectively.   
 
Furthermore, the MNP diameters were confirmed with TEM (Figure 2.23). Sample 2 was 
bimodal with diameters of 100±9 and 137±9 nm (Figure 2.23A). Figure 2.23B (sample 3) 
was also bimodal and has MNP size of 182±9 and 140±5 nm. Sample 4 was polydispersed 
and has sizes of 268±5, 232±13 and 182±9 nm, with length of 423±14 nm (Figure 2.23C). 
Figure 2.23D (sample 5) was bimodal with an average size of 87±5 and 59±5 nm. Figure 
2.23E (sample 6) have an average size of 50±5 nm. Sample 7, has an average MNP 
diameter of 73±9 nm (Figure 2.23F). The general trend suggests that as the catalyst 
concentration increases there is an increase in MNP sizes.  
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Figure 2.23:  Scanning electron microscope images of mesoporous nanoparticles of A) sample 2, B) 
sample 3, C) sample 4, D) sample 5, E) sample 6 and F) sample 7. 
 
 
The MNP size required for the biological application was successfully synthesised, sample 
5. In order to produce a surfactant free MNP the template must be removed. There are 
numerous methods for template removal, such as acidic or basic template extraction in an 
alcoholic solution. Alternatively, the template can be removed by calcinations, which is a 
simple and easy method. However, when sample 5 was calcined it caused the MNP to 
aggregate, as demonstrated from the PCS analysis in Figure 2.24. 
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Figure 2.24:  Photon correlation spectroscopy analysis of mesoporous nanoparticles, sample 5, with a 
hydrodynamic diameter of 106.7 nm and is increased to 8139 nm when calcined.    
 
   
The zeta potential for template free sample 5 is -19.8 mV. The aggregated MNP was also 
confirmed by TEM image (Figure 2.25).  
 
 
  
Figure 2.25:  Transmission electron microscope image of template removed mesoporous nanoparticles, 
sample 5, at A) lower magnification and B) higher magnification. 
 
 
Although, the MNP are aggregated, the N2 sorption analysis was conducted to confirm the 
porosity of the sample (Figure 2.26).  
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Figure 2.26:  Nitrogen sorption isotherm, of absorption (diamond curve) and desorption (circle curve), 
and pore distribution (insert) for mesoporous nanoparticles (sample5). 
 
 
Sample 5, has a large surface area of 1222.8±63.0 m²/g. Figure 2.26 shows an initial sharp 
peak, representing that the majority of sample 5 has pore size of 2.6 nm, and smaller 
volume of 13 nm pores. The objective of synthesising porous NPs has been achieved and 
an advantage with this methodology is producing MNP with large surface area. However, 
the main objective was synthesising MNP of approximately 100 nm that are aggregation 
free. The biological testing will show whether the MNP have a toxicological effect on 
tissue via in vitro studies. Furthermore, the incorporating of dye molecules within the MNP 
can be tested for biocompatibility and would be advantageous as it would allow imaging 
abilities in biological systems. Therefore MNP were prepared using the procedure carried 
out for sample 5 but RBITC coupled with APTMS were used to synthesise sample 7 
(Figure 2.23).  
 
However, when the MNP were placed in water the sample rapidly sedimented, therefore an 
alternative synthetic route was examined.  
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The SEM, Figure 2.27, shows that RBITC MNP was polydispersed with a diameter of 
104±13, 266±11, 300 and 436 nm. The polydispersion in the sample may be due to the 
APS molecules reacting instantaneously with the silica seeds it comes into contact with.     
 
 
 
Figure 2.27:  Scanning electron microscope image of rhodamine B isothiocyanate encapsulated 
mesoporous nanoparticles (sample 8).  
 
 
In order to overcome the polydispersity problem APTMS molecules was diluted in 
anhydrous DMF solution. The SEM images in Figure 2.28 confirm the synthesis of well 
dispersed MNP of close size distribution. The SEM images of silica MNP, Figure 2.28A, 
show the product is well dispersed of 95±13 nm. Figure 2.28B, the RBITC MNP (sample 
10) is well dispersed of 105±13 nm. The FITC MNP has size distribution of 109±18 nm 
(Figure 2.28C). The RBITC/ FITC MNP are well dispersed with an average diameter of 
105±13 nm (Figure 2.28D).  
  
1 µm 
                     Chapter 2        
                                  Nanoparticle Preparation 
  
 
73 
 
 
 
Figure 2.28:  Scanning electron microscope image of A) mesoporous nanoparticles (sample 9), B) 
rhodamine B isothiocyanate encapsulated mesoporous nanoparticles (sample 10), C) fluorescein 
isothiocyanate encapsulated mesoporous nanoparticles (sample 11) and D) rhodamine B isothiocyanate/ 
fluorescein encapsulated isothiocyanate mesoporous nanoparticles (sample 12). 
 
 
Diffuse reflectance infra-red Fourier transform spectroscopy (DRIFTS) analysis was 
carried out to determine the successful removal of the CTMAB molecules from the MNP 
matrix (Figure 2.29).  
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Figure 2.29:  Diffuse reflectance infra-red Fourier transform spectroscopy of template intact (dotted) and 
template removed (straight line) mesoporous nanoparticles; where A) mesoporous nanoparticles (sample 
9), B) rhodamine B isothiocyanate mesoporous nanoparticles (sample 10), C) fluorescein isothiocyanate 
mesoporous nanoparticles (sample 11) and D) rhodamine B isothiocyanate/ fluorescein isothiocyanate 
mesoporous nanoparticles (sample 12).  
 
 
From the DRIFTS analysis the peaks referring to groups contained within the MNP was 
placed in Table 2.11, where all types of MNP; A) silica MNP (sample 9), B) RBITC MNP 
(sample 10), C) FITC MNP (sample 11) and D) RBITC/ FITC MNP (sample 12), show 
similar peaks. 
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TABLE 2.11:  Diffuse reflectance infra-red Fourier transform spectroscopy analysis 
of the functional groups within the mesoporous nanoparticles. 
MNP (template intact) MNP (template removed) 
Wavenumber (cm
-1
) Bond Wavenumber (cm
-1
) Bond 
2924 
sharp C-H 
stretching 
2957 
weak C-H 
stretching 
2854 
sharp C-H 
stretching 
2856 
weak C-H 
stretching 
1062 
Si-O-Si 
stretching 
1080 Si-O-Si stretching 
824 
Si-O-H 
deformation 
 
The broad band for the asymmetric Si-O-Si stretching vibration peak of the MNP with 
template is at 1065 cm
-1
. This is also observed for the template removed MNP at 1062 cm
-
1
. The band at approximately 800 cm
-1
 represents the symmetrical stretching vibration of 
Si-O bond. The band at 957 and 496 cm
-1
 for template removed product has occurred 
because of the surface Si-O
-
 groups stretching and bending vibration. These bands are also 
seen in the template intact MNP at 941 and 455 cm
-1
 respectively [84]. The two sharp 
peaks observed at 2853 and 2923 cm
-1
 for the MNP sample with template is due to the 
presence of the organic surfactant CTMAB [85]. The removal of CTMAB molecules has 
significantly reduced by acidic extraction as the CTMAB peaks have become very small at 
2856 and 2956 cm
-1
.  
 
Thermogravimetric analysis (TGA) was used to determine the presence of dye molecules 
by their thermal decomposition. Figure 2.30 is the TGA for A) silica MNP and B) RBITC 
MNP, C) FITC MNP and D) RBITC/ FITC MNP. The weight loss (4 %) from room 
temperature to 110 °C was due to water molecules being evaporated from the pores. The 
weight loss of 7 % from 110-400 °C was due to the decomposition of CTMAB molecules 
that are still within the MNP. The amine group of CTMAB will react to produce tertiary 
amine and alkene side group, known as Hoffmann elimination. The tertiary amine will 
react with CO2 via a combustion and oxidation reaction. The weight loss above 400 °C 
may due to condensation of water from the silanol groups [72].        
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Figure 2.30:  Thermogravimetric analysis (solid line) and derivative thermogravimetric curve (dotted line) 
of A) mesoporous nanoparticles (sample 9), B) rhodamine B isothiocyanate mesoporous nanoparticle 
(sample 10), C) fluorescein isothiocyanate mesoporous nanoparticles (sample 11) and D) rhodamine B 
isothiocyanate/ fluorescein isothiocyanate mesoporous nanoparticles (sample 12). 
 
 
Figure 2.31 is of the N2 sorption of MNP with and without dye molecules after their 
template was removed. The isotherm curve follows the general type-IV trend of 
mesoporous materials.  
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Figure 2.31:  Nitrogen sorption isotherm for gas adsorption (diamond curve) and desorption (circle curve) 
of A) mesoporous nanoparticles (sample 9), B) rhodamine B isothiocyanate mesoporous nanoparticles 
(sample 10), C) fluorescein isothiocyanate mesoporous nanoparticles (sample 11) and D) rhodamine B 
isothiocyanate/ fluorescein isothiocyanate mesoporous nanoparticles (sample 12).  
 
 
The silica MNP has a pore diameter of 2.9 nm as shown in the pore size distribution graph 
(Figure 2.31A). The sharp peak confirms the ordered mesoporous nanoparticles have a 
narrow size distribution. The large surface area (853.3 ± 9.0 m²/g) along with narrow pore 
distribution is successfully synthesised. The N2 sorption analysis for RBITC MNP is 
shown in Figure 2.31B, with a surface area of 1032.6±3.5 m²/g which is larger than the 
silica MNP. Furthermore, the insert confirms for the pore size of RBITC MNP to be 2.6 
nm, smaller than the silica MNP. FITC MNP has a surface area of 1154.5±2.1 m²/g, which 
is larger than the silica MNP, while the insert confirm the pore size to be 2.8 nm, similar to 
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the silica MNP (Figure 2.31C). RBITC/ FITC MNP have a surface area of 1252.5±1.9 
m²/g, which is larger than the silica MNP, while the insert confirm the pore size of 2.8 nm 
(Figure 2.31D).         
 
Furthermore, the TEM images confirm the synthesis of porous monodispersed MNP of 
narrow size distribution (Figure 2.32), where A) the silica MNP size are 95±13 nm and B) 
magnified image of silica MNP. The template removal was performed by refluxing the 
MNP in acidified ethanol solution.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.32:  Transmission electron microscope image of A) mesoporous nanoparticles, B) side-view of 
the mesopore channels and C) front-view of the mesopores. 
 
 
The PCS measurements of the MNP and dye encapsulated MNP were determined in water 
and high salt solution (Figure 2.33). 
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Figure 2.33:  Photon correlation spectroscopy analysis of mesoporous nanoparticles with and without dye 
molecules in water and potassium physiological salt solution media.  
 
 
The hydrodynamic diameter of the template intact MNP show a large aggregation as the 
CTMAB molecules causes the MNP to clump together, however after removal of the 
template they became well dispersed and are dimers with 190.7 nm. The zeta potential 
further confirms the stability of these MNP within their suspension when template was 
removed (Table 2.12). Furthermore, when MNP were placed in high potassium 
physiological salt solution (KPSS) the hydrodynamic diameter increased to 247.3 nm from 
182.9 nm with the zeta potential values increasing to -13.8 mV from -30.0 mV, due to the 
high ionic salt solution (refer to Chapter 2, Section 2.1.6). RBITC MNP in KPSS media 
causes the hydrodynamic diameter to increase to 215.5 nm from 185.8 nm, along with the 
increase in the zeta potential values to -17.0 mV from –32.8 mV due to the high ionic salt 
solution. FITC MNP in KPSS media causes the hydrodynamic diameter to increase to 
227.8 nm from 183.9 nm, along with the increase in the zeta potential values to -15.6 mV 
from –30.0 mV due to the high ionic salt solution. RBITC/ FITC MNP in KPSS media 
causes the hydrodynamic diameter to increase to 227.8 nm from 202.1 nm, along with the 
increase in the zeta potential values to -16.0 mV from –31.7 mV due to the high ionic salt 
solution.  
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TABLE 2.12:  Hydrodynamic size and stability measurements of mesoporous 
nanoparticles, in water and high potassium physiological salt solution. 
Nanoparticles 
type 
Primary diameter
 a
 
(nm) 
Hydrodynamic 
diameter
b
 
(nm) 
ζ potential 
(mV) 
In water In KPSS In water In KPSS 
Silica MNP 95±13 182.9 247.3 -30.0 -13.8 
RBITC MNP 105±13 185.8 215.5 -32.8 -17.0 
FITC MNP 109±18 183.9 227.8 -30.0 -15.6 
RBITC/ FITC MNP 105±13 202.1 227.8 -31.7 -16.0 
a
 Mean (±SD) diameter determined by SEM. 
b
Mean PCS measurement. 
 
2.4.3.1. Quantification of dye molecules within mesoporous 
nanoparticles 
The amount of dye molecules encapsulated within the MNP was quantified with 
fluorescence spectroscopy. The fluorescence spectra of known concentrations of RBITC 
were used to produce a calibration graph (Figure 2.34). The excitation wavelength of 
RBITC is 540 nm with an emission at 573 nm. FITC has an excitation wavelength of 490 
nm and an emission at 520 nm.     
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Figure 2.34:  Calibration spectra of fluorescence for A) rhodamine B isothiocyanate and B) fluorescein 
isothiocyanate dye molecules. 
 
 
The dye molecules encapsulated within the MNP were quantified by analysing the amount 
of dye molecules within the supernatant (Figure 27, 28, 29 and 30 in the appendix). Thus, 
the dye concentration within the NPs was calculated by subtracting the concentration 
within the supernatant from the actual concentration of dye used (Table 2.13). The mass of 
RBITC dye molecules within RBITC MNP were 2.35 mg, while FITC dye molecules 
within FITC MNP were 5.61 µg. The RBITC dye molecules within RBITC/ FITC MNP 
were 1.19 mg, while FITC dye molecules within RBITC/ FITC MNP were 90.8 µg. 
 
These findings demonstrate that there is a greater volume of RBITC dye molecules 
incorporated within the mesoporous matrix as compared to the FITC dye molecules. 
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TABLE 2.13:  Quantification of dye molecules within the nanoparticles. 
 
 
Fluorescence 
intensity (a.u.) 
Dye 
concentration 
in supernatant 
(mol dm
-3
) 
Moles of 
dye in 
supernatant 
(mol) 
Mass of dye in 
supernatant 
(mg) 
mass of 
dye in 
the NPs 
(mg) 
RBITC MNP 
1
st
 supernatant 
61.43 3.11×10-8 1.45×10-8 7.76×10-3 
2.35 
RBITC MNP 
2
nd
 supernatant 
1266 1.75×10-6 4.33×10-7 2.32×10-1 
RBITC MNP 
3
rd
 supernatant 
58.86 2.74×10-8 1.12×10-8 6.02×10-3 
FITC MNP 
1
st
 supernatant 
44.48 9.94×10-8 4.63×10-8 1.80×10-2 
5.61×10-3 
FITC MNP 
2
nd
 supernatant 
7866 2.62×10-5 6.36×10-6 2.48 
RBITC/ FITC MNP 
(RBITC dye) 
2
nd
 supernatant 
615.9 8.23×10-7 2.02×10-7 1.09×10-1 
1.19 
RBITC/ FITC MNP 
(RBITC dye) 
3
rd
 supernatant 
40.09 5.74×10-10 1.41×10-10 7.57×10-5 
RBITC/ FITC MNP 
(FITC dye) 
1
st
 supernatant 
34.3 6.55×10-8 3.05×10-8 1.19×10-2 
9.08×10-2 
RBITC/ FITC MNP 
(FITC dye) 
2
nd
 supernatant 
3608 1.20×10-5 2.95×10-6 1.15 
 
2.4.4. Discussion 
The fabrication of RBITC incorporated MNP of approximately 100 nm were not 
successfully synthesised via synthetic route 1, as the PCS analysis demonstrates the 
formation of much larger particles. These larger particle sizes may have resulted due to a 
greater concentration of catalyst, ammonia, within the reaction mixture. Previously, Lin et 
al. [63] suggested that the ammonia concentration and reaction temperature influences 
particle diameter. Their study suggested that as the catalyst concentration increased it in 
turn increased the particle diameter. Furthermore, at lower temperature and higher 
concentration of silica precursor the particle diameter increased.     
 
The synthesis of template intact MNP were successfully synthesised via synthetic route 2. 
However, upon template removal the MNP aggregated. Previous studies, also demonstrate 
the influences of direct calcination of surfactant intact MNP may lead to agglomeration 
[86]. 
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MNP with and without fluorophore dye molecules were successfully fabricated via 
synthetic route 3. Furthermore, the stability of the particles were confirmed with the laser 
Doppler velocimetry in both water and potassium physiological salt solution. The CTMAB 
template removal was conducted via acid wash method in order to make the NPs porous 
and remove the known cellular toxicological influence of the CTMAB molecules [87]. 
Interestingly, our findings demonstrate that there is a greater mass of RBITC dye 
molecules incorporated within the mesoporous matrix as compared to the FITC dye 
molecules. This may be due to the difference in the solubility of the fluorophore dye 
molecules. The RBITC dye molecules are readily miscible in water, however FITC require 
a polar solvent at pH greater than 6 to dissolve. Furthermore, we demonstrate that MNP 
without dye molecules have a greater total surface area (SA) volume as compared to dye 
incorporated MNP. The SA in decreasing order is as follows; MNP > FITC MNP> RBITC/ 
FITC MNP > RBITC MNP.            
 
The zeta potential values below +30 or -30 mV means the sample is unstable which may 
lead to further nucleation between NPs and growth in size. 
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2.5. Silicate-1 Nanoparticles 
2.5.1. Material 
Tetraethyl orthosilicate (TEOS), tetrapropylammonium hydroxide solution (TPAOH) and 
3-aminopropyl trimethoxysilane (APTMS) were purchased from Sigma-Aldrich (UK). 
Isopropanol (IP) was purchased from Fisher-Scientific (UK). Millipore water was used for 
all experiments.   
 
2.5.2. Methodology 
Silicate-1 NPs were synthesised via the method of Wang et al. [87] (Table 2.14). For 
synthesis of sample 1, briefly, water (5.66 mL), TEOS (19.99 g) and tetrapropylammonium 
hydroxide solution (TPAOH) (34.57 g) was stirred vigorously for 1 hour at room 
temperature until the solution becomes clear without the oil-in water consistency. The 
mixture was then placed in an autoclavable polypropylene bottle equipped with a 
condenser. The resulting mixture was aged for 20 hours in an oil bath set at 45 °C.   
 
APTMS (12 mol% with respect to Si) solution was made by mixing APTMS (2.07 g) with 
isopropanol (10 mL). The APTMS solution was added to the polypropylene bottle while 
the mixture was stirred vigorously. When the temperature of the mixture increased to 90 
°C it was allowed to heat for 6 hours. The resulting solution remained colourless. The 
colourless solution was placed in an autoclave and aged for 20 hours at 140 °C. This 
resulted in an opaque white solution which was collected by centrifugation. The template 
was removed by calcinations at 500 °C for 4 hours. 
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Table 2.14:  Overview for the fabrication of silicate-1 nanoparticles as the 
temperature and aging time alters. 
Sample 
Hydrodynamic 
sizea 
(nm) 
Water 
(g) 
TEOS 
(g) 
TPAOH 
(g) 
IPb 
(mL) 
APS 
(mol) 
Temperature 
(°C) 
Aging 
time 
(h) γ 
1 181 5.65 20 34.56 10 1.15×10
-2 140 20 
2 153 5.65 20 34.56 10 1.15×10
-2 90 96 
a
 Mean PCS measurement. 
b
Abbreviation for the solvent isopropanol. 
γ
hour. 
 
2.5.3. Results 
The NP morphology and sizes were determined by SEM (Figure 2.35). Sample 1 (Figure 
2.35A) is bimodal with an average diameter of 146 and 164 nm and sample 2 (Figure 
2.35B) is also bimodal 129±14 and 114 nm. 
 
 
 
Figure 2.35:  Scanning electron microscope images of A) sample 1 and B) sample 2. 
 
 
The NP dispersity along with size distribution was further confirmed with PCS analysis 
(Figure 2.36); the size is in close agreement with the SEM images. Both samples have a 
single peak at a hydrodynamic diameter of 180.6 and 152.5 nm for sample 1 and 2 
respectively.     
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Figure 2.36:  Photon correlation spectroscopy analysis of silicate-1; sample 1and sample 2. 
 
 
The TGA (Figure 2.37) results of sample 1 shows a small weight loss of up to 0.3 % at 
approximately 90 °C and weight loss of up to 1.4 % at approximately 350 °C. The initial 
weight loss observed can be attributed due to surface dehydration, while the latter weight 
loss is due to the decomposition and total loss of the aminopropyl groups (APTMS) from 
the material [89].    
 
 
Figure 2.37:  Thermogravimetric analysis (solid line) and derivative thermogravimetric curve (dotted 
line) of sample 1. 
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The TGA (Figure 2.38) results of sample 2 shows a small weight loss of up to 0.3 % at 
approximately 60 °C is due to surface dehydration, while the latter weight loss of up to 0.8 
% at approximately 330 °C is due to the decomposition and total loss of the aminopropyl 
groups (APTMS) from the material [89]. There was a greater weight loss in sample 1, due 
to the decomposition of aminopropyl groups, suggesting it contained more APTMS 
molecules within its matrix. 
 
 
Figure 2.38: Thermogravimetric analysis (solid line) and derivative thermogravimetric curve (dotted line) 
of sample 2. 
 
 
The N2 sorption analysis provided definite evidence of the SA and pore size distribution 
for the silicate-1 NPs (Figure 2.39). The pore size distributions deduced from the first 
condensation step clearly reflect a decrease in pore size as the amount of SA slightly 
increases. The SA of sample 1 is 339.3±4.5 m²/g with a maximum pore size distribution of 
33.3 nm (Figure 2.40A), while sample 2 is 319.0±8.3 m²/g with a maximum pore size 
distribution of 53.6 nm (Figure 2.40B). It can be seen that, sample 1 has mesoporous and 
sample 2 is macroporous and as a consequence of the increase in the aging time and 
reduction in temperature the pore diameter have enlarged.        
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Figure 2.39:  Nitrogen sorption isotherm analysis for gas adsorption (diamond curve) and desorption 
(circle curve) of silicate-1; where A) sample 1 and B) sample 2. 
 
 
2.5.4. Discussion  
The fabrications of pure silicate-1 NPs were prepared via the conventional sol-gel 
precipitation technique, where an aqueous mixture of silica precursor in the presence of 
organic template was catalysed to produce these intricate porous networks. The SEM 
images illustrates that sample 2 is smaller than sample 1 in diameter, suggesting that 
increasing the aging time and reducing the reaction temperature results in the formation of 
smaller particles. Hence, is consistent with the SA analysis; where sample 1 is larger than 
2. Interestingly, a higher aging period and lower temperature resulted in the formation of 
higher pore size, whereby sample 2 was macroporous and sample 1 is mesoporous. Wang 
et al. [87] suggested that the drying conditions influence the porosity, however as the same 
procedure for template removal was implemented; this suggest that greater aging time may 
increased the volume of TPAOH incorporated within the NP structure and hence upon 
removal leads to greater pores. Furthermore, the PCS analysis confirm for the synthesis of 
NPs are within the size-range determined by electron microscopy. Further characterisation 
using zeta potential confirms the stability of the NPs in water media. Previously, Jawor et 
al. synthesised zeolites using the conventional method and produced polydispersed NPs 
where the larger NPs were in close range to the PCS findings [22].     
0 
50 
100 
150 
200 
250 
300 
350 
0 0.5 1 
Q
u
a
n
ti
ty
 A
d
so
rb
ed
 (
cm
³/
g
 S
T
P
) 
Relative Pressure (p/p°) 
0 
50 
100 
150 
200 
250 
300 
350 
400 
450 
0 0.5 1 
Q
u
a
n
ti
ty
 A
d
so
rb
ed
 (
cm
³/
g
 S
T
P
) 
Relative Pressure (p/p°) 
 
0 
0.5 
1 
0 500 1000 
 P
o
r
e
 v
o
lu
m
e
 (
c
m
³/
g
) 
Pore diameter (Å)  
0 
0.5 
1 
1.5 
2 
0 500 1000 P
o
r
e
 V
o
lu
m
e
 (
c
m
³/
g
) 
Pore Diameter (Å) 
A B 
     Chapter 3 
  Applications                                                                                                                  
  
 
88 
 
 
 
 
 
 
 
Chapter 3 
Applications 
  
     Chapter 3 
  Applications                                                                                                                  
  
 
89 
3. APPLICATIONS 
The nanoparticles (NPs) synthesised and characterised, in Chapter 2, were utilised for 
purpose built applications as sensors and in biological applications as summarised below 
(Table 3.1).  
 
Table 3.1:  Overview of the types of nanoparticles used for specific applications. 
Sample 
type 
Nanoparticle 
abbreviation 
Size (nm) Application 
Synthesis 
page 
2 SiRBITC NPs 208±9 Dual gas sensor 45 
3 SiRu(dpp)3 NPs 192±8 Dual gas sensor 45 
1 SiNPs 27±7 
Biocompatibility;      
in vitro studies 
39 
1 SiNPs 71±6 
Biocompatibility;      
in vitro studies 
39 
2 SiRBITC NPs 31±10 
Biocompatibility;      
in vitro studies 
44 
2 SiRBITC NPs 61±7 
Biocompatibility;      
in vitro studies 
44 
1 SiNPs 71±6 
Pressurized system;  
in vitro studies 
39 
4 MNP 95±13 
Drug release;             
in vitro studies 
62 
5 RBITC MNP 105±13 
Drug release;             
in vitro studies 
63 
6 FITC MNP 109±18 
Drug release;             
in vitro studies 
64 
7 
RBITC/ FITC 
MNP 
105±13 
Drug release;             
in vitro studies 
65 
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3.1. Introduction to Fluorescence Sensing 
The engineering of devices capable of gaseous sensing has led to revolutionary 
development within the current technology. The most common and simplest methods of 
utilising such technology are via the fluorescence quenching phenomena. Previous studies, 
have demonstrated the capabilities of ruthenium complex for sensing oxygen. For instance, 
Roche et al fabricated an oxygen (O2) sensor consisting of a gold film coated with 
fluorophore encapsulated sol-gel [90]. The advancement in this field may lead to the 
incorporation of fluorophores within NPs to sense dissolved O2, which have great 
prospects within biological applications. Wang et al, fabricated core-shell ratiometric 
sensing NPs of 130±50 nm, which consist of three fluorophores encapsulated within 
polystyrene matrix [91]. Liewhiran et al developed gaseous sulphur dioxide (SO2) and 
hydrogen sulphide sensors via monitoring alterations in resistance when different 
concentrations of these gases were introduced onto a film which contains 3-20 nm tin 
oxide NPs [92]. Jorge et al, synthesised core-shell CdSe-ZnS quantum dots and placed 
them within a sol-gel matrix which contains ruthenium fluorophore to sense O2 through the 
drop in fluorescence [93].  
  
3.1.1. Fluorescence mechanics 
Fluorescence is described as the emission of light by an excited molecule. This occurs 
when an electron from its first singlet excited state is transferred to the ground state. The 
most simple and common method of describing the fluorescence process is the Jablonski 
energy level diagram (Figure 3.1).  
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Figure 3.1:  The Jablonski energy level diagram of the fluorescence mechanism. 
 
 
Fluorescent molecules usually exist in the electronic ground state (S0), in the sub-level 0. 
The electrons are capable of absorbing (A) energy from an external source to an excited 
state (first excited singlet [S1] or higher vibrational energy level). The energy can either be 
dispersed or emitting as a photon. If the molecule has been absorbed to a higher excited 
state than the first singlet, sub-level 0, than the molecules energy is lowered to this level by 
vibrational relaxation (VR). For the electron to return to its S0 it can undergo this through 
fluorescence, phosphorescence or irreversible chemical reaction. The fluorescent molecule 
undergoes relaxation by emitting the energy in the form of light, termed as photon (hν) to 
return to the S0 level. Once energy has reached the S0 level and is in a sub-level above 0 
then the residual energy is released by VR. The total energy absorbed by the molecules is 
converted into different forms, vibrational and fluorescent photon. The ratio of emitted 
photon to absorb is termed as the fluorescent quantum yield which quantifies the 
fluorescence efficiency process. Thus, dye molecules that posses high quantum yield are in 
demand in the field of fluorescence sensing as they require low energy, or excitation 
source, for high emission intensity. Furthermore, the reduced excitation source in-turn 
reduces the photobleaching effect, where the excitation energy causes the molecules to 
become irreversible non-fluorescent. The term Stokes shift is used to describe the 
difference between the excitation and emission wavelength, while lifetime refers to the 
time taken for an excited electron to emit the photon [94]. 
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3.1.2. Quenching modes 
There are two mechanisms of quenching; static and dynamic. Static quenching refers to 
when a quencher binds to the fluorescent molecule to produce a stable ground-state 
complex that can no longer undergo fluorescent emission. While, dynamic quenching 
occurs when there‟s a collision between the excited fluorophore and quencher, transferring 
energy to it, and causing it to return to the ground state without fluorescent emission. 
Therefore, dynamic quenching is also called collision quenching, and this is of more 
interest for the present study (Chapter 3; Section 3.2) as most fluorophores undergo 
dynamic fluorescence quenching in the presence of O2 [94].  
 
In static quenching, the quenching species complexes with the fluorophore and thus 
reduces the amount of molecules available for fluorescence emission. Therefore, the 
overall emission intensity is reduced. Furthermore, the non-fluorescent complex may not 
absorb photon at the same excitation wavelength as the fluorophore, thus not only reducing 
the emission intensity but also altering the optical absorption. Thus, changes in the optical 
absorption are suggestive of the possible process of static quenching occurring. Although, 
in dynamic quenching the fluorophore is capable of reaching the singlet excited state, 
however via quenching and fluorescence pathways it is returned to the ground state. 
Therefore, as some of the fluorophore have complexes with the quencher the overall 
emission intensity will reduce and also the lifetime, as the time the fluorophore exist in the 
excited state has also reduced. Dynamic quenching reduces both the fluorescence emission 
intensity and lifetime [94].        
 
3.1.3. Intensity-based fluorescent sensor vs. lifetime 
There are two methods commonly used to analyse the quencher‟s concentration through 
the reduction in the fluorescence emission intensity of the fluorophore. Lifetime-based 
sensor is commonly used to analyse O2 concentrations [12, 95]. The advantages of 
lifetime-based sensors are the minimal interference by noise from an external source, 
uninfluenced by light source and dye concentration. However, in order to improve the 
analysis it is preferable to use a dye that has a long lifetime (1-3 milliseconds) and hence 
limits the use of particular dye molecules. Therefore, this ultimately results in the reduction 
in the number of analytes (quenchers) that can be detected by lifetime fluorescent sensing. 
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Furthermore, the lifetime fluorescent sensing equipment is expensive in comparison to the 
fluorescence intensity spectrophotometer, which generally is simple equipment that 
requires a light source at a certain wavelength and a photodetection apparatus.     
         
3.1.4. The Stern-Volmer relationship to dynamic quenching 
The Stern-Volmer equation (Equation 3.1) describes the relationship between the 
fluorescence emission intensity and the concentration of the fluorophore.     
 
𝐈𝟎
𝐈
= 𝟏 + 𝐤𝐪𝛕𝟎[𝐐]      (3.1) 
 
Where, I represent the emission intensity, I0 is the emission intensity if the quencher is not 
present, kq is the bimolecular quenching constant, τ0 is the fluorescence lifetime when the 
quencher is not present and [Q] is the concentration of the quencher. The bimolecular 
quenching constant is shown below (Equation 3.2). 
                     
𝐤𝐪 = 𝛄
𝟒𝛑𝐍
𝟏𝟎𝟎𝟎
 𝐑𝐟 + 𝐑𝐪  𝐃𝐟 + 𝐃𝐪      (3.2) 
 
Where, γ is the quencher efficiency, N is Avogadro‟s constant, π is equal to 3.14, Rf is the 
molecular radii of the fluorophore, Rq is the molecular radii of the quencher, Df is the 
diffusion coefficient of the fluorophore and Dq is the diffusion coefficient of the quencher. 
The diffusion coefficient of a particle is described by the Stokes-Einstein equation 
(Equation 3.3). 
  
𝐃 =
𝐤𝐓
𝟔𝛑𝛈𝐑
                 (3.3) 
 
Where, k is the Boltzmann‟s constant, T represents the temperature, π is equal to 3.14, η is 
the viscosity and R is the molecules collision radius. The molecule‟s collision radius is 
commonly derived by the sum of the radius of both the fluorophore and quencher. 
Furthermore, as terms in Equation 3.2 and 3.3 are constants, the Stern-Volmer equation 
can be simplified from Equation 3.1 to Equation 3.4.  
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𝐈𝟎
𝐈
= 𝟏 + 𝐤𝐬𝐯[𝐐]      (3.4) 
 
Where, ksv is the Stern-Volmer constant. Therefore, the inverse relationship of O2 
concentration (quencher) to fluorescence emission intensity can be represented by a 
straight line, where the slope is the Stern-Volmer constant [94]. 
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3.2. Gas Sensor 
The illustration below represents a fluorescent nanoparticle (NP) film, consisting of a 
mixture of 2:1 ratio of ruthenium-tris (4, 7-diphenyl-1, 10-phenanthroline) dichloride 
encapsulated silica nanoparticles (SiRu(dpp)3 NPs) and rhodamine B isothiocyanate 
encapsulated silica nanoparticles (SiRBITC NPs) respectively (Figure 3.2). Gaseous O2 is 
able to quench the fluorescence of SiRu(dpp)3 NPs, while SO2 quenches SiRBITC NPs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2:  Illustration of the fluorescent nanoparticle film which is capable of sensing gaseous oxygen 
and sulphur dioxide.    
   
 
The rising air pollution problems encountered in the environment has led to the need for 
quantified detection of various gases. Gases such as SO2 are known for their toxicological 
effects where the threshold limit of human exposure to SO2 is between 5-10 parts per 
million (ppm) [96]. Furthermore, the detection of dissolved O2 is desirable; particularly in 
biological systems. For instance, the regular monitoring of O2 levels within cell culture, in 
vitro, gives vital information about the effects on metabolism [97]. 
 
The most common method of gaseous analysis is based on the principle of fluorescence 
quenching in real-time or via remote monitoring, whereby any reduction in intensity of the 
original fluorescence emission of the fluorophore can be measured. Hence, in the presence 
SO2 
O2 SO2 
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of fluorophores these gaseous molecules behave as quenchers. Furthermore, these 
fluorophores are known as optrodes because they behave as an optical device which 
measures their specific gas [98]. These fluorophores may be used as photon sources for 
biological imaging [99], optical computing [100], sensor technology [98] and targeted drug 
delivery [101]. The detection of a specific gas is dependent on the fluorophore, which can 
be quenched by the particular given gas. There are two mechanisms by which the 
fluorophore may be quenched: static or dynamic. Dynamic quenching occurs when 
external molecules collide with the fluorophore molecules (collisional quenching), while 
static quenching occurs when both molecules form a non-fluorescent complex (ground-
state complex formation) [94, 102]. Metalloporphyrins and ruthenium complexes have 
been used for O2 sensing as their fluorescence is quenched by the analyte [12, 97, 103-
105], while rhodamine B isothiocyanate (RBITC) can be used to sense SO2 [95, 105]. Both 
gases (O2 and SO2) undergo dynamic quenching with their respective reagents (Ru(dpp)3 
and RBITC) [102].  
 
A problem encountered by these organic dye molecules is their tendency to easily photo-
bleach. One way to overcome this is the encapsulation of these dye molecules within core-
shell NPs, which has been shown to significantly reduce the level of photo-degradation 
(Figure 3.3). These core-shell NPs normally consist of a molecule coated with an inorganic 
or polymer shell [107].  
 
 
 
 
 
 
 
 
 
 
Figure 3.3: Illustration of rhodamine B isothiocyanate core silica shell nanoparticle. 
 
 
The properties of these core-shell NPs can be altered by changing the shell thickness, as 
well as altering its composition [108]. Encapsulating dye molecules within a silica shell 
leads to beneificial properties. Firstly, the fluorescence signal significantly increases as 
multiple dye molecules are trapped in a single shell. Secondly, it reduces the photo-
Silica shell 
Dye molecules 
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stability problem of the dye molecules. Thirdly, the surface of the silica nanoparticles 
(SiNPs) can easily be modified and functionalised to couple with molecules suspended in 
solution. Furthermore, silica is an optically transparent material allowing dye molecules to 
fluoresce as both the excitation and emission light can diffuse through [107]. The density 
of Stöber NPs are approximately 1.9 g/ cm
-3
 [109]. Molecular structure for the schematic 
illustration of the formation of SiRBITC NPs is illustrated in Figure 3.4. There is an initial 
attachment of the APTMS molecules to tetraethyl orthosilicate (TEOS), which behave as a 
coupling agent to bind the silica shell to the RBITC fluorophore.  
 
 
 
Figure 3.4:  Schematic diagram of the incorporation of rhodamine B isothiocyanate dye within the silica 
nanoparticle and the penetration of gaseous SO2 through the silica shell.  
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The Ru(dpp)3 fluorophore complex are attracted to the negatively charged hydroxyl groups 
of the TEOS molecule leading to the formation of dye encapsulated SiNPs (Figure 3.5). 
 
 
 
Figure 3.5:  Schematic diagram of the incorporation of the ruthenium-tris (4, 7-diphenyl-1, 10-
phenanthroline) dichloride dye within the silica nanoparticle and the penetration of gaseous O2 through 
the silica shell. 
 
 
These fluorescent sensors respond by gases quenching excited molecules and result in the 
latter becoming deactivated. Thus, as the concentration of the gases increases it causes the 
excited state lifetime and intensity of the sensor molecules to decrease. If the quenching 
occurs because of collisions between the fluorophore and O2 molecules, then the 
relationship between the concentration of the quencher and lifetimes or intensities is given 
by the Stern-Volmer equation (Equation 3.4). The Stern-Volmer equation is normally valid 
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when the fluorophore is in solution or the quencher concentration is low. In most cases the 
Stern-Volmer fails to describe more complicated systems and other appropriate models 
must be employed to describe the quenching relationship [95, 102].  
 
The Ru
2+
 ion in the dye complex is coordinated to six ligands giving it an octahedral 
environment, shown in Figure 3.6.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6:  Structure of the ruthenium complex. 
 
 
The ruthenium ion is a transition metal with d
6
 electron configuration.  Figure 3.7 shows 
energy level diagram of an electron for the octahedral ruthenium complex.  The dye is 
quenched by the gas due to a metal-to-ligand-charge-transfer (MLCT).  An electron is 
promoted to the π* orbital of the dioxygen ligand from the d-orbital of the metal [96].  An 
electron may be transferred from πL to π
*
L orbital and is referred to as ligand centred 
electron transfer.  The metal centred excited state is when an electron is promoted πM to 
σ*M orbital.  The natures of these three excited states are either singlet or triplet.  However, 
the singlet and triplet states of MLCT and metal centered (MC) mixing due to spin-orbital 
mixing [110].  
  
N
NRuN
N
Ph
N N
Ph
Ph
Ph
Ph
Ph
2+
2Cl
-
 
     Chapter 3 
  Applications                                                                                                                  
  
 
100 
 
 
 
 
 
 
 
 
Figure 3.7:  Energy-level diagram of the ruthenium complex, were LC abbreviates ligand centered. 
 
 
The two reactions by which the fluorescence of Ru(dpp)3 is quenched by O2 are shown in 
Figure 3.8. The first reaction (Figure 3.8A) shows the transfer of an electron from 
Ru(dpp)3 complex to give singlet oxygen and ground state Ru(dpp)3 complex. The second 
reaction (Figure 3.7B) is of the Ru(dpp)3 complex being oxidised by an electron being 
transferred from the Ru(dpp)3 complex and superoxide anion that is being produced [110]. 
 
 
      RuL𝟑
𝟐+∗ +  𝐎𝟐 →𝐑𝐮𝐋𝟑
𝟐+ + 𝐎𝟐                  (A) 
                                         𝐑𝐮L3
2+*
+ O2 → 𝐑𝐮L3
3+
 + O2
*-
                (B) 
Figure 3.8:  Reactions of the ruthenium complex being quenched by oxygen, where * represents an 
electron. 
 
  
The fluorophore alone is not the only factor that determines the sensors properties; the 
matrix in which it exists also plays an important role. The matrix influences the response 
time as the larger the porosity, the more sensitive it will be to the fluorophore. These 
fluorophores can be immobilised in a silicone rubber [111], polyvinylchloride [112], sol-
gel [113-115] or organically modified sol-gels (ormosil) matrix [116]. Previous studies 
have shown that most of these sensors are placed in matrices such as sol-gel matrix. The 
sol-gel matrix can be prepared at room temperature unlike the silicone rubber matrix. 
Furthermore, it is highly sensitive to the gas phase. However, it has a tendency to crack 
when producing films and in the liquid phase water causes the fluorescence to quench and 
in turn reduce the effectiveness of the sensor. This is because the silane moiety of the sol-
gel has a hydroxyl group which readily forms hydrogen bonds with water. In order to 
overcome this problem the matrix needs to be hydrophobic. The rubber and 
πL 
πm 
σ*M 
MC MLCT LC 
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polyvinylchloride matrices are hydrophobic so water molecules cannot interfere with the 
quenching process. However, unlike the sol-gel the porosity cannot be altered. Chen et al. 
[116] has presented a solution by using ormosil with one or more of the hydroxyl groups 
being replaced by an aromatic or acyl chain. Another luminescent sensor produced by Al-
Jowder et al. [95] is the use of ruthenium-tris(4,7-diphenyl-1,10-phenanthroline) dichloride 
(Ru(dpp)3) dye immobilised in ormosil to sense gaseous oxygen. Other advantages of 
ormosil is that it is crack resistant, has variable porosity, thermal stability, optical clarity, 
pH stability and can be prepared at room temperature. The selection of the matrix is 
dependent on the environment in which the sensor is to be utilised [117]. 
 
 
These fluorescence sensors respond when these gases quench excited molecules and results 
in them becoming deactivated. So as the concentration of the gases increases it causes the 
excited state lifetime and intensity to decrease. If the quenching occurs because of 
collisions between the fluorophore and oxygen molecules, diffusion, then the relationship 
between the concentration of the quencher and lifetimes and intensities is given by the 
Stern-Volmer equation [118]. 
 
In this study, we focus on producing novel nanosensors which can be used as optical 
sensors of atmospheric and dissolved gases. In our work the fluorescent NPs are 
functionalised with carboxylic acid and bound to the ormosil. Furthermore, these 
nanosensors may be combined to produce a dual gas sensor and even multi-sensor systems 
for multitude of future biological and industrial applications. 
 
  
     Chapter 3 
  Applications                                                                                                                  
  
 
102 
3.2.1. Experimentation 
3.2.1.1. Nanosensor film formation 
The ormosil composition is as previously described by Roche et al. [12]. Briefly, the 
ormosil matrix consisting of a mixture of water (1.5 mL), OTEOS (1 mL), MTEOS (1 
mL), EtOH (0.5 mL), HCl (0.05 M/ 50 µL) was stirred overnight. A 1:1.5 ratio of 
SiRBITC NPs (1.01×1012 NPs) and SiRu(dpp)3 NPs (1.52×10
12
 NPs) were added to the 
mixture and further stirred for 24 hours. The film was produced by placing the mixture 
(250 µL) on a cover slip and allowing it to dry over 1-2 weeks by gravity coating.  
 
3.2.1.2. Gas sensing technique 
The real-time fluorescence quenching was analysed using a fluorescence 
spectrophotometer (Perkin Elmer LS55) (Figure 3.9). The excitation wavelength of 
Ru(dpp)3 fluorophore in the ormosil matrix was 450 nm while emission was measured at 
610 nm. For RBITC dye the two excitation wavelengths were 350 and 550 nm, with 
emission wavelength at 580 nm. Excitation using 350 nm gives less intense signal, 
however, it has been chosen to excite the dye because of the larger Stokes shift which will 
reduce or minimise light scattering. 
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Figure 3.9:  Diagram of the gas sensing instrumentation. 
 
 
3.2.2. Results and discussion 
Verhaegh et al. [72], suggested that if the RBITC dye was not functionalised with APS and 
used in an alcohol solution, it would not incorporate into the silica. APS was added to the 
RBITC dye in order to act as a coupling agent, and allow the siloxyl groups to bind to the 
silica shell and the amine group to bind to the dye [76]. After stirring for 4 hours in a 
nitrogen atmosphere under dark conditions the colour changed from intense purple to 
orange as self-quenching had occurred [72]. The synthesis of SiRu(dpp)3 NPs occurs as the 
silica is negatively charged, while the Ru(dpp)3 dye is positively charged. This causes 
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electrostatic interaction to occur between the dye and the silica and therefore leading to an 
ionic bond.  
 
The fluorescence emission spectra of SiRBITC NPs and SiRu(dpp)3 NPs alone and mixed 
shows there is no interference caused between the two dyes (Figure.10). The SiRBITC NPs 
were excited at 350 nm with an emission wavelength at 580 nm. The SiRu(dpp)3 NPs were 
excited at 450 nm with an emission at 610 nm.  
 
 
 
Figure 3.10:  Fluorescence spectra of ruthenium-tris (4, 7-diphenyl-1, 10-phenanthroline) dichloride 
encapsulated silica nanoparticles and rhodamine B isothiocyanate encapsulated silica nanoparticles alone 
and mixed. 
 
 
3.2.2.1. Dual gas sensor analysis 
As described in the experimental section, SiRBITC NPs and SiRu(dpp)3 NPs suspensions 
were added in 1:1.5 ratio to 1:1 OTEOS, MTEOS (ormosil) and the mixture was then 
deposited on a microscope cover glass and spread by gravity to produce a film of 2.4 mm 
thickness. The dry film was placed in a sealed controlled reactor environment and its 
sensing capabilities were measured using fluorescence spectroscopy. Recent studies have 
used silica matrix for optical sensing by incorporation of fluorescent dye molecules within 
a porous material. For instances, Wark et al. [119] anchored Sn-oxide into the mesopores 
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of siliceous molecular sieve (MCM-41) for alternative gas sensing via optical detection. 
Furthermore, they also loaded rhodamine B into the mesopores for detection of SO2 via 
fluorescence quenching. Zhang et al. [120] covalently grafted ruthenium (II) complex 
within mesoporous MSU-3 silica for oxygen sensing via fluorescence quenching.  
 
The dual NP film was subjected to gaseous O2 in a N2 atmosphere, and was excited at 450 
nm with the emission measured at 610 nm to target the SiRu(dpp)3 NPs (Figure 3.11).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11:  Fluorescence quenching of dual nanoparticles slide subjected to A) cycling concentration of 
oxygen in nitrogen atmosphere, B) higher oxygen concentration and C) lower oxygen concentration. 
 
 
Initially, the film was subjected to cycling oxygen concentration at 50 % (v/v) (Figure 
3.11A). The fluorescence quenching graph demonstrates that the SiRu(dpp)3 NPs are 
sensitive to gaseous O2 reversibly and are repeatable as the fluorescence quenched reaches 
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the same baseline level. Figure 3.11B shows that when the dual nanosensor slide was 
subjected to different concentrations of O2, which ranged from 100-5 %, the fluorescence 
is quenched at specific fluorescence intensity levels. The graph shows that as the O2 
concentration were decreased the fluorescence intensity increased. This is because 
reducing the quencher concentration causes less interaction with metal-ligand complexes 
and therefore there are more excited molecules showing fluorescence. Furthermore, the 
nanosensor film is also capable of detecting O2 at lower levels (5-0.018 %) (Figure 3.11C). 
The luminescence spectra of lower O2 concentrations show that the dual nanosensor is 
capable of detecting O2 levels at very low concentrations (0.018%). The last three signals 
(0.1-0.018 %) are magnified in the same graph. However, the response was slower than 
that for dye alone in ormosil, as shown previously by Al-Jowder et al. [94]. This is 
expected as the gas will have to diffuse through the silica shell as well as the ormosil 
matrix. The data distribution shown by the calibration curve of normalised fluorescence 
intensity versus O2 concentration in % (v/v) (Figure 3.12) indicates that the response of the 
system is of non-linear type, due to the silica shell surrounding the dye and the ormosil 
matrix; leading to differences in diffraction kinetics.  
 
 
 
Figure 3.12:  Calibration curve of normalised intensity versus oxygen concentration in % (v/v) for dual 
nanoparticle slide. 
 
 
Also, the gravity method employed in depositing the NPs on the slide makes the film 
thicker, causing it to be more difficult for gases to access the dye in the NPs to quench the 
fluorescence. Again, the relation deviates from linear Stern-Volmer equation indicating 
that the system requires a non-linear modelling technique. 
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The dual nanosensor film was excited at 350 nm with an emission wavelength of 580 nm 
to detect RBITC fluorescence. SO2 gas was introduced into the reactor in order to target 
the RBITC dye molecules. Initially, the film was subjected to 50 % cycling concentrations 
of SO2 (Figure 3.13A). However, the steady state was not reached completely as the 
intensity was changing at a very slow rate (approximately 3000 seconds). Furthermore, 
when the film was subjected to a higher volume of SO2 gas (100 and 60 %) the steady state 
was also not reached (Figure 3.13B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13:  Fluorescence quenching of dual nanoparticles slide subjected to A) cycling concentration of 
SO2 in nitrogen atmosphere and B) 100 and 60 % of SO2 in nitrogen atmosphere. 
 
 
3.2.3. Conclusions 
The present study describes the novel synthesis of dual gas sensors incorporated within 
SiNPs. The carboxylic functionalized SiRBITC NPs and SiRu(dpp)3 NPs nanosensor were 
successfully synthesized within an ormosil matrix. The nanosensor gave response to both 
gases by quenching fluorescence, along with fluorescence response recovery once the 
gases were removed. The dual nanosensor consisted of a mixture of RBITC and Ru(dpp)3 
core-shell NPs, which worked simultaneously without inhibiting the function of the other. 
Further research is required in order for the SO2 gas to quench the RBITC dye sufficiently 
to reach steady state along with a response recovery. In comparison to previously described 
O2 sensor, our sensor is more sensitive to lower levels of O2 detection (0.018%) although 
the response and recover time was increased as the gas has to further travel through the 
silica shell. Despite this the silica shell enabled the dual nanosensor to be more resistant to 
photobleaching.    
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3.3. Introduction to the Bioapplications 
Progress in NP fabrication techniques has opened the door for tailoring NP properties for 
the development of innovatively designed biological drug delivery vehicles [121-123]. 
Orally and intravenously administered drugs usually have a number of systemic side 
effects, often leading to poor efficiency of the drug [124].  Consequently there is a drive 
for the development of new drug delivery systems. Thus, there is a need for the 
understanding of how these particles affect biological systems. For instance, Akbar et al 
tested the biocompatibility of 100 and 200 nm SiNPs on live aortic vessels in vitro, where 
they suggest surface interaction is detrimental to vasodilation function [35]. Quignard et al 
determined the size and charge influence of fluorescein isothiocyanate (FITC) 
encapsulated silica nanoparticles on human dermal fibroblasts. They observed that smaller 
NPs had greater and faster cytotoxicity as compared to larger NPs at a similar dose. 
Furthermore, the negatively charged small NPs are more detrimental as they induced 
genotoxicity compared to positively charge ones [125]. „Smart NPs systems‟ have been 
developed; these are particles that are small enough to circulate around the body and so can 
move to targeted locations releasing the drug in a controlled manner. This approach holds 
great promise for revolutionising drug administration in the future. One promising material 
that contains many desired properties to fulfil the requirements for the design of a NP drug 
carrier system is mesoporous silica which was developed in 1991 as a molecular sieve 
[124, 126]. Mesoporous nanoparticles (MNP) were originally utilised as drug delivery 
system by Vallet-Regí et al. in 2001, whereby the release kinetics of ibuprofen was 
determined [127]. The ability of specific targeting delivery of therapeutics has led to the 
development of treatment of cancer. Gary-Bobo et al. employed fluorescein encapsulated 
mesoporous nanoparticles functionalised with galactose to target cancer cells and release 
camptothecin (anti-cancer drug) which leads to cell death [128]. Similarly, Lu et al. loaded 
MNP with camptothecin for cancer treatment. They observed that this drug delivery 
system led to suppression within mice, in vivo [129].    
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3.3.1. Aortic vessel structure 
The aortic vessel is the largest artery in vertebrates and plays an important role in the blood 
transport. They allow for the uptake of large volumes of blood with small change in 
pressure in the arterial tree [130]. The arterial wall consists of three main structures; tunica 
interna, tunica media and tunica externa (Figure 3.14). 
 
               
                        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14:  The arterial wall structure of the aortic vessel.   
 
 
The lumen is the internal hollow area of the artery where the blood flows. The inner 
surface contains a lining of endothelium cells (ECs) which influences the function of 
smooth muscle cells (SMCs) within the vascular wall. The arrangement of ECs on the 
basal lamina is connected to an internal elastic lamina (IEL) layer by mixture of 
microfibrils and collagen known as the connecting filament. This area containing the ECs 
and the subendothelium part is known as the tunica interna or initma. It has been suggested 
that the ECs are responsible for producing IEL as they are known for producing elastin 
[130, 131]. The endothelium layer plays an important part in maintaining the vascular tone 
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due to its ability of secreting substances that are responsible for the relaxation or 
constriction of the vessel [132, 133].   
 
The tunica media is normally the thickest layer as it contains SMCs and the majority of the 
elastin layer. The elastin layer is made up of elastin sheets, lamellae, with collagen fibres, 
proteoglycan-rich extracellular matrix and SMC layers positioned between them. The 
lamellae and fibres produce a continuous network. The elastin alone has a low tensile 
strength, but when incorporated in this network it allows for the even distribution of stress 
through the wall and collagen fibres. The static mechanical properties are believed not to 
be fully related to the SMCs, but the significant influence occurs due to the elastin and 
collagen matrix [130, 131]. 
  
The external layer of the vessel is known as tunica externa or adventitia. The tunica 
adventitia is connected to the tunica media layer with external elastin lamina placed 
between them. The myofibroblast cells lead to the formation of collagen that is within the 
elastin. The large volume of collagen within the adventitia prevents rupture of the vessel 
when the blood flow pressure is high. Current studies have suggested that the adventitia 
may have the ability to sense injury incurred in the vessel [130, 131]. 
 
The external surface of the vessel is covered by a layer of fat known as perivascular 
adipose tissue (PVAT). The PVAT is known to attenuate vascular contraction in the 
presence of agonists, such as phenylephrine, angiotensin ІІ, 5-HT and U 46619. However, 
the actual mechanism of interaction between PVAT resulting in the attenuation of 
contraction is not fully explained. Lӧhn et al. has suggested that the PVAT produces 
adventitium derived relaxation factor (ADRF) [134]. Goa et al. has claimed that the 
relaxation is due to PVAT and not the adventitia so it would be better termed as 
perivascular adipose tissue-derived relaxation factor (PVRF) [135]. Recent studies have 
suggested that the PVRF of the vessel occurs as a result of hyperpolarisation of the SMCs 
membrane. For instance Verlohren et al. discovered that when the PVAT remains attached 
on rat mesenteric arteries then there was an increased amount of hyperpolarisation of 
SMCs [132]. Also, when the vessel is placed in high potassium salt solution (KPSS) it not 
only causes the potassium gradient to be lowered across the membrane, but also leads to 
the removal of the relaxation response caused by PVRF [135]. This suggestion is further 
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verified by Lӧhn et al., where intact vessels in the presence of K+ channel blockers, such 
as glibenclamide, have shown to significantly inhibit the action of PVAT [134]. The 
current studies suggest that PVRF is similar to endothelium-derived hyperpolarisation 
factor (EDHF). It is common knowledge that EDHF refers to the hyperpolarisation of the 
SMCs membrane via endothelium-dependent and endothelium-independent routes. 
However, further investigation of PVRF is required to distinguish whether SMCs 
hyperpolarisation occurs via endothelium-dependent on independent mechanisms. 
 
Chemicals that cause constriction or relaxation of the vascular cells can be categorised as 
agonist, antagonist or inverse agonist. An agonist will bind to the receptor on the cell 
membrane and trigger a particular chemical process to occur in the cell; however, the 
action of the agonist can be blocked by an antagonist. An inverse agonist results in the 
opposite effect of the agonist. 
 
3.3.2. Aortic vessel function and contractility 
3.3.2.1. Vasoconstrictors 
Vessels viability can be tested using vasoconstrictors and high potassium salt solution 
(KPSS; K
+
). The mechanism of constriction caused by vasoconstrictors occurs via 
pharmacological coupling.  
 
 
NH
CH3
OH
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ClH
 
203.67 gmol
-1 
 
Figure 3.15:  Molecular structure of vasoconstrictor L-phenylephrine. 
 
 
Vasoconstrictors, such as L-phenylephrine (Phe) (Figure 3.15), will lead to the release of 
Ca
2+
 ions from two pools (extracellular Ca
2+
 and Ca from intracellular stores) into the cell 
cytosol thus resulting in the contraction of the SMCs (Figure 3.16). The exchange of ions 
● 
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in the SMCs can occur from 3Na
+
-2K
+
 pump, delayed K
+
 channel, ligand activated Ca
2+
 
channel, L-type voltage-dependent Ca
2+
 channel, a sarcolemmal Ca
2+
  pump and Na
+
-Ca
2+
 
exchanger. Phe behaves as a stimulatory ligand that binds to a receptor on the membrane 
(α1 adrenergic receptor) which is specific for G-proteins. The predominate amount of Ca
2+
 
uptake by the SMCs occurs via the ligand-gated Ca
2+
 channel (noradrenaline) and voltage-
gated Ca
2+
channel from the extracellular space. The influx of ions leads to depolarization 
of the membrane and therefore causing the Ca
2+
 ions to move into the cell. This 
depolarization further causes the voltage-gated channels to open. The binding of the 
stimulus to the reticular receptors leads to the activation of phospholipase C (PL-C). PL-C 
causes the hydrolysis of phosphatidyl insitol diphosphate (PIP2) to produce inositol 
triphosphate (IP3) and diacylglycerol (DAG). IP3 binds to a receptor on the sarcoplasmic 
reticulum which contains a pool on Ca
2+
 ions. When there is a release of Ca ions of greater 
concentration the 0.1µM the contraction occurs. The Ca
2+
 ions are moved out of the cell by 
Na
+
-Ca
2+
 exchanger (antiport) and ATP-demaning Ca
2+
 pump. The extracellular Ca
2+
 
uptake is dependent on the Na
+
 gradient of the antiport. These Na
+
 and K
+
 pumps across 
the cell membrane maintain the gradient of Na
+
 and K
+
 [136, 137]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16:  Mechanism of the contraction of the smooth muscle cells due to L-phenylephrine. 
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KPSS is used to assess the viability of the vessels by demonstrating their ability to contract 
upon its administration. The mechanism of contraction caused by KPSS is via 
electromechanical coupling. KPSS causes SMCs to contract via membrane depolarisation 
following potassium ion cellular uptake. The altered plasma membrane potential of 
vascular SMCs activates Ca
2+
 channels in the membrane leading to an increase in 
intracellular concentration of calcium. Calcium influx leads to vascular contraction. Phe 
can induce a further smooth muscle vascular contractile response after KPSS. This is partly 
due to the fact that the latter have a role in mobilising intracellular as well as extracellular 
Ca
2+
 [137, 138]. 
 
3.3.2.2. Vasodilators 
Vasodilators are chemical agonists that result in the relaxation of the SMCs (Figure 3.17). 
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Figure 3.17:  Molecular structures of vasodilator A) acetylcholine and B) sodium nitroprusside. 
 
 
The endothelium integrity may be tested by acetylcholine (ACh) vasodilator. ACh leads to 
vasodilation via several mechanisms. The most predominant mechanism includes the 
production of nitric oxide (NO) species from ECs leading to SMCs relaxation [139]. 
Therefore, ACh is known as endothelial-dependent vasodilator as it triggers a cascade of 
reactions within the ECs for the production of NO which diffuses into the SMCs. 
Alternatively, vasodilation may occur by a NO donor, such as sodium nitroprusside (SNP), 
as it is cable of causing vasorelaxation in the SMCs without the need of ECs being intact, 
thus it is referred to as the endothelial-independent vasodilator (Figure 3.18).  
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The mechanism for endothelial derived vasorelaxation can be mediated by various stimuli, 
such as ACh and bradykinin (Bk). They result in the production of prostaglandin I2 (PGI2), 
NO and EDHF. NO is a molecule synthesised by the oxidation of L-Arginine (L-Arg) 
forming L-citruline (L-Cit) and NO. This reaction is mediated by nitric oxide synthase 
(NOS), of which three isoforms exist (eNOS, nNOS and iNOS). The ECs have a basal 
production of NO to maintain the vascular tone at a relaxed state. Following it‟s diffusion 
from ECs, NO binds to soluble guanylate cyclase (sGC) in SMCs leading to the activation 
of cyclic guanosine monophosphate (cGMP) by converting the binding protein (GTP) 
[140]. The binding protein GTP may also activate cyclic adenosine monophosphate 
(cAMP) which leads to the extracellular movement of Ca
2+
 ions and thus relaxation of 
vascular SMCs [140, 141]. The activated cGMP in turn stimulate cGMP-dependent protein 
kinase G (PKG), leading to calcium (Ca
2+
) resequestration to the sacroendoplasmic 
reticulum (SR), enhanced Ca
2+
 pumping through Ca
2+
-ATPase and the inhibition of Ca
2+
 
influx. These effects are mediated by Ca
2+
 channel phosphorylation. The reduction in 
intracellular Ca
2+
 causes SMCs relaxation. PKG also produces its effects as a phosphatase 
to dephosphorylate myosin light chains of SMCs leading to vascular dilation [143]. 
 
Prostaglandins (PGs) are vasodilators derived from phospholipase A2 (PLA2) converting 
phospholipid (PL) to arachidonic acid (20:4) [144] via the enzyme action of 
cyclooxygenase (COX) 1 and 2 with prostacyclin synthase (PCS) [145, 146]. PGs serve as 
hormone-like molecules with wide variety of effects, some of which lead to SMCs 
contraction, pain, fever, and inflammation. A study by Lagaud et al. suggests the 
involvement of a prostaglandin, possibly PGI2, in the ACh-induced dilation [147]. 
 
The mechanism of relaxation of blood vessels is complex and is related to the elaboration 
of a number of dilatory pathways that depend on the vessel size and bed. NO is the major 
contributor to dilation in large vessels such as the aorta [148], however in medium- and 
small-sized vessels such as coronary arteries and mesenteric vessels, EDHF has a 
predominant role in mediating relaxation [149, 150]. Furthermore, as NO leads to the 
increased intracellular concentration of cGMP it activates the calcium-activated potassium 
channels (KCa) and the ATP-sensitive potassium channels (KATP), which are both present in 
the SMCs resulting in the vascular SMCs hyperpolarization and the relaxation [130, 131]. 
The PGI2 binds to the SMCs receptor and causes an increased concentration of intracellular 
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cAMP which in turn activates KATP. Both NO and PGI2 are capable of activating delayed 
rectifier potassium channels (Kdr), which elicit hyperpolarization and relaxation of the 
SMCs [143, 144, 151]. EDHF, cytochrome P450 2C isoenzymes, hydrogen sulphide (H2S) 
[152], and arachidonic acid-derived epoxyeicosatrienoic acids (EETs) are produced in the 
vascular endothelium and act upon vascular SMCs to cause hyperpolarisation and 
ultimately relaxation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18:  Mechanism of acetylcholine (endothelium dependent relaxation) agonist releasing nitric 
oxide from endothelium cells leading to the relaxation of smooth muscle cells; and sodium nitroprusside 
(endothelium independent relaxation) agonist which directly donates nitric oxide to the smooth muscle 
cells, leading to relaxation.  
 
 
Nω-Nitro-L-arginine (L-NNA) is a NOS inhibitor and therefore it can be used to investigate 
whether the endothelium-dependent relaxation of ACh is dependent on production of NO 
via the activation of NOS (Figure 3.19) [153]. Furthermore, Kellogg et al. suggested that 
relaxation of the SMCs may also be influenced by non-NO-dependent mechanisms or due 
to a relaxation mechanism triggered by PG [154]. 
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Figure 3.19:  Illustration of the inhibition of the production of eNOS and thus blocking acetylcholine 
induced relaxation.  
 
 
3.3.3. Cellular uptake mechanisms of nanoparticles  
It is considered that for effective uptake of materials into the cell they should range in the 
nanometer size or even smaller. The rate of entry into the cell is not only dependent on size 
but also the morphology, surface charge of NPs and the actual cell type. Jin et al. [155] 
study has shown that the majority of NPs that rapidly enter the cell take place within the 
first 5 minutes and reaches a maximum uptake after 30 minutes incubation time [155].   
 
The internal cellular solution and organelles are held together by an external plasma 
membrane that consists of a phospholipid bilayer. There are three known routes by which 
NPs may enter the cell; direct diffusion, endocytosis or via ion channels and transporter 
proteins (Figure 3.20) [66].
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Figure 3.20:  Possible uptake mechanisms of nanoparticles into cells.  
 
 
There are various types of ion channels and transporter proteins within the plasma 
membrane that allow for the entry and exit of specific materials through the cell. These 
channels are highly selective, unlikely to be open and have a very small average pore size 
of only a few Angstrom units [66].
 
 
NPs can directly diffuse into the cell via the plasma membrane. However, many variables 
have to be ascertained in order for the NPs to penetrate through the phospholipid bilayer, 
such as particle size, morphology, composition, charge and hydrophobicity. It is not only 
important to produce such purpose built NPs but also to understand how its outer surface 
interacts with the solid-liquid and nano-bio interface [66]. 
 
The most predominant mechanism of NP entry into the cell is via endocytosis. The general 
mechanism occurs by the lipid bilayer of the cell membrane wrapping around the NP. This 
follows a fission reaction where the NP bound lipid membrane is pinched off to produce a 
vesicle containing the NP. There are different pathways for endocytosis to occur. The 
Intra-cellular 
 fluid 
Extra-cellular  
fluid 
Endocytosis: Direct diffusion: Channel: 
NP 
Np 
NP 
NP NP 
NP 
NP 
NP 
NP 
NP 
NP 
     Chapter 3 
  Applications                                                                                                                  
  
 
118 
actual NP size greatly influences the strategic internalisation of the NPs into the cell. The 
pathways may occur by fluid phase or receptor mediated endocytosis. Fluid phase 
endocytosis occurs when a water soluble material diffuses into the cell by producing 
vesicle due to mass action. Receptor mediated endocytosis occurs by the material binding 
to a specific part of the cell surface that triggers the internalisation of the material within 
the cell. The receptors maybe lipid, protein or carbohydrate based which is specific to the 
material being internalised [66]. 
 
Cellular entry of NPs may occur through clathrin (Figure 3.21) or caveolae (Figure 3.22) 
mediated mechanism. The clathrin-dependent endocytosis pathway entails the movement 
of soluble clathrin, retained within the cytoplasm, to the plasma membrane. Clathrin-
binding adaptors, for instance adaptor protein-2 (AP2), will bind to the clathrin and initiate 
the process, followed by the assembly of clathrin triskelion to form clathrin-coated pits, 
which later produces a polygonal lattice at the membrane. This polygon lattice will bud 
and pinch off to produce the clathrin-coated vesicle. Furthermore, these coated-pits are also 
known to contain phospholipids, such as phosphatidylinositol-4,5-bisphosphate, which are 
known to facilitate the vesicle formation and the budding process [156]. 
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Figure 3.21:  Clathrin-mediated endocytosis mechanism. 
 
 
Alternatively, NP entry within the cell may occur via the caveolae-mediated endocytosis 
(Figure 3.22). The caveolae are flask-shaped invaginations which are found on the plasma 
membrane of many cell types. They normally appear as rounded plasma membranes with a 
diameter between 50 to 80 nm. The caveolae function and composition influences it role 
for the specific cell types. The endothelial cell may contain components, such as the mouth 
or restricted diaphragm which reduces the possibility of diffusion from occurring. Previous 
studies have shown the initialisation of virus particles (SV40) via the clathrin-independent 
pathway and thus it may be possible for small NPs to enter via this process [157].  
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Figure 3.22:  Illustration of the initialisation of nanoparticles via the caveolae-mediated pathway. 
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3.4. Biocompatibility of Silica Nanoparticles 
The illustration of the incorporation of RBITC dye molecules within silica-shell followed 
by incubation within tissue leading to the initialisation into ECs (Figure 3.23). 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.23:  Illustration of the attenuation of endothelial-dependent vasodilator responses, induced by 
dye encapsulated silica nanoparticles, in vitro. 
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NPs are useful for biotechnology engineering due to the ease of combining functional 
materials. The functionality is encompassed in a particle with dimensions small enough to 
enter into mammalian cells, while the efficiency and cellular uptake pathways can be 
altered depending on surface charge and material composition. One very popular material 
is silica, a naturally abundant compound found in glass and sand, which has been utilised 
in biomedicine due to its biocompatible properties. A key advantage of SiNPs is their 
fluorescence labelling potential. A wide range of metallo-organic and organic dyes can be 
encapsulated within SiNPs, including rhodamine, fluorescein, cyanine and their derivatives 
[73-159]. By encapsulating dye molecules in a silica shell, it is possible to overcome 
problems encountered by many fluorescent labelling probes, such as fluorophore, including 
cytotoxicity [115, 78, 160], thus leading to improved photostability and increased 
fluorescence signal, due to the large number of dye molecules within a single NP. SiNPs 
encapsulated with fluorescent trimethine indocyanine dyes have been demonstrated to 
display an overall three fold enhanced photoemission intensity [8]. Additionally, two-
photon adsorbing fluorophores, which employ near infra-red emission, have gained 
particular attention for in vivo bio-imaging applications, as they show no cytotoxicity at 
low concentrations [161]. The silica surface can, furthermore, be easily modified to target 
specific cell surface groups, making them ideal for imaging diagnostics and targeted 
therapeutics [162, 163]. For example, SiRBITC NPs have been used for the imaging and 
detection of early stage apoptotic cells [78]. Dye encapsulated SiNPs (28 ± 4 nm), that 
were surface functionalised with anti-human IgG antibody, have been used for the 
detection of B lymphocyte subpopulations in the blood of Systemic Lupus Erythematosis 
patients [163].  
 
Evidence from in vitro cell culture studies; however, suggest that dye encapsulated SiNPs 
may be toxic to cells and that their influence is dependent on their size, surface charge and 
particular cell type [165, 166]. While uptake of dye encapsulated SiNPs had no overall 
effect on the proliferation and death rate of lung epithelial cells at a concentration below 
0.1 mg/ mL [155], they induced apoptosis in hepatoma cells [167] and were cytotoxic to 
mouse keratinocytes [168]. It remains difficult, however, to ascertain whether the dye itself 
within the NPs has contributed to this toxicity. Indeed, the bonding between the silica 
matrix and dye molecules greatly influences its properties. Dye molecules can either be 
covalently bonded to the silica matrix or attracted by electrostatic non-covalent bonding. 
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Where the attraction between the dye and silica is non-covalent, there are possibilities of 
dye leakage [169]. Fluorophores, such as ruthenium complex, demonstrate a unique 
fluorescence quenching phenomenon and have been thus utilised as „gas sensors‟ in the 
detection of gaseous and dissolved gases, including O2 and SO2. Additionally, we have 
recently demonstrated that it is possible for gaseous molecules to diffuse through silica 
shells and quench fluorescence of dye molecules incorporated within the dye encapsulated 
SiNPs (Chapter 3; Section 3.2).  
 
Of particular relevance to imaging diagnostics, is the influence of SiNP infusion on ECs 
lining blood vessels. Recent studies suggest a size dependant cytotoxic affect of SiNPs. 
Napierska et al. [170] subjected human ECs in culture to SiNPs of different sizes (14-335 
nm) and compared the mass concentration at which NPs cause 50 % reduction in cell 
viability (TC50). They concluded that smaller NPs (33-47 µg/ mL) resulted in TC50 at lower 
mass compared to larger NPs (1087 µg/ mL). Furthermore, Liu et al. [170] demonstrated 
that exposing 20 nm SiNPs (100-200 µg/ mL) to human umbilical vein ECs results in the 
production of intracellular reactive oxygen species (ROS), such as superoxide free radicals, 
leading to oxidative stress and consequently dysfunction of ECs. As ECs are modulators of 
vascular function, it is hence unclear how intravascularly infused SiNPs are likely to 
modulate function. Akbar et al. demonstrated that 100 and 200 nm SiNPs are rapidly taken 
up by ECs lining of aortic vessels incubated in vitro, with no detrimental effect on vascular 
function [35]. The objective of the present study is to investigate the size dependent 
influence of SiNPs, smaller than 100 nm (medium [70 nm] and small [30 nm] size ranges) 
on aortic vessel function, in vitro, and whether dye encapsulation of these SiNPs alters 
their uptake by ECs and hence influences vascular responses. Results will inform the future 
fabrication of biocompatible SiNPs for use in imaging diagnostics. 
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3.4.1. Experimentation 
3.4.1.1. Tissue preparation 
The thoracic aortic arteries of male Wistar rats were used for the in vitro studies (n=37 
animals; one vessel from each animal). The rats of approximately 150-250 g weight were 
humanly killed by stunning followed by cervical dislocation following institutional 
approval and in accordance with guidelines issued by the European Commission Directive 
86/609/EEC. The PVAT was removed from the vessel while being gassed (95 % O2:5 % 
CO2) in cold physiological salt solution (PSS) (Figure 3.24).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
Figure 3.24:  Image of the aortic vessel A) attached to organelles, B) with perivascular adipose tissue 
intact, C) with perivascular adipose tissue removed and D) magnified 3 mm ring.  
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3.4.1.2. Organ-bath setup 
The organ-bath setup (Figure 3.25) is used for large arteries (aortic vessels) with a 
diameter in the range of 1-4 mm [172]. The vessels were dissected into 3-4 mm aortic rings 
and mounted in an organ-bath system filled with oxygenated PSS solution (37 
oC) by 
threading the rings through a U-shaped hook, which is screwed in position via the plastic 
support that is attached to a micrometer, and ascending wire attached to an isometric force 
transducer, as previously described by Akbar et al. [35]. The transducer arms contain 
springs that when there is large distorting force on the isometric contraction, which are 
minimal changes in the length, allowing changes in vessel diameter to be maintained. The 
micrometer gives readings on the distance between the two wires from touching and the 
distance when the vessel is stretched. The tension between the two wires was recorded 
using Labchart 6 (Powerlab, AD Instruments, UK). The aortic rings were placed under a 
constant 2 g tension throughout the experimentation as preliminary results have determined 
this to be the optimal tension value. Vessels were equilibrated for approximately 1 hour, 
followed by pre-constriction with high K⁺ (60 mM, KCl) to test vessel viability and 
achieve stable contraction. Responses to endothelium-dependent and independent dilator 
agonists were examined by adding cumulative doses of acetylcholine (ACh; 0.01-200 µM) 
and sodium nitroprusside (SNP; 0.001-10 µM), before and after incubation with SiNPs for 
30 minutes. The final concentration of SiNPs placed in the organ-bath experiments were 
1.31×1011 NP/ mL and 1.96×1012 NP/ mL.   
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Figure 3.25:  Organ-bath system for the endothelium-dependent and independent vasodilation 
experimentation of aortic vessel.  
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From the data acquisition system attached to the organ-bath setup, a trace will be acquired 
Figure 3.26. 
 
 
 
 
 
Figure 3.26:  Example of a trace that was obtained when evaluating the influence of constrictor and 
dilator effects on the aortic ring. 
 
 
3.4.1.3. Tissue fixation and processing  
Vessels were fixed immediately after the functional studies. Fixation solution consisted of 
2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer at pH 7.3. The vessels were 
allowed to stand in the solution for 2 hours at 22 ˚C. The samples were postfixed with 
reduced osmium (OsO4 1 % + K4Fe(CN)6 1.5 %) for 1 hour, then dehydrated in a series of 
alcohols, infiltrated with TAAB LV resin and polymerized for 24 hours at 60 ˚C, as 
previously described [39]. Ultrathin 70 nm sections were cut with Leica „Ultracut S‟ 
ultramicrotome and placed on copper grids. The grids were observed in Tecnai 12 Biotwin 
TEM at 80 kV, a cross-section of an aortic vessel is illustrated in Figure 3.27. 
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Figure 3.27:  Transmission electron microscope image of the aortic vessel where the layers are illustrated. 
 
    
3.4.2. Results 
Amorphous SiNPs (71±6 and 27±7 nm) and SiRBITC NPs (31±10 and 61±7 nm) (Chapter 
2; Figure 2.2 and 2.6) were tested for biocompatibility via in vitro studies. These studies 
will allow for an understanding whether these NPs affect the endothelium-dependent and 
independent vasodilation or vasoconstriction.   
 
3.4.2.1. Detection of silica nanoparticles within vascular tissue 
NP uptake was observed with TEM transverse sections through vessels following SiNP 
incubation. NPs of both size-ranges with and without RBITC dye molecules have entered 
the cytoplasm of the ECs. None were seen in the nucleus of the cells. The images of 
medium-size SiNP (71±6) uptake show that the NPs have acquired a transparent ring 
around them suggestive of the presence of a membrane due to their endocytosis into the 
cell (Figure 3.28).  
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Figure 3.28:  Transmission electron microscope images of 71±6 nm silica nanoparticles within the 
endothelial cell lining of the aortic vessel. 
 
 
Furthermore, medium-sized SiRBITC NPs (61±7 nm) were also observed to be initialised 
into the ECs and had also acquired a transparent ring around them (Figure 3.29). 
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Figure 3.29:  Transmission electron microscope image of 61±7 nm rhodamine B isothiocyanate 
encapsulated silica nanoparticles within the endothelial cell lining of the aortic vessel. 
 
 
The smaller SiNPs (27±7 nm) were also taken up by the ECs into the cytoplasm (Figure 
3.30). Unlike the medium-size SiNPs, they did not seem to have a membrane coating, but 
seemed to accumulate within membrane invaginations suggestive of caveolae; it is thus 
likely that they may have entered the cell via alternative pathways. There was no evidence 
of NP uptake, of either size, into the adventitial or smooth muscle cell layers with no 
evidence of migration through the elastic lamina. 
 
 
 
 
Figure 3.30:  Transmission electron microscope images of 27±7 silica nanoparticles within the endothelial 
cell lining of the aortic vessel. 
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The TEM images also confirm the initialisation of smaller SiRBITC NPs of 31±10 nm 
(Figure 3.31). 
 
 
 
 
Figure 3.31:  Transmission electron microscope images of 31±10 nm rhodamine B isothiocyanate 
encapsulated silica nanoparticles within the endothelial cell lining of the aortic vessel. 
 
 
Temperature is pivotal factor on cellular uptake mechanism. The inhibition of one or 
several pathway (s) allows for a greater understanding of the mechanism by which the NPs 
enter the cells. A common method used for the assessment of endocytosis as the possible 
pathway of entry is conducted by setting the temperature of the incubation medium to 4 
°C, as all the energy-dependent pathways are inhibited [173]. A non-functional study of 
71±6 nm SiNPs incubated in a vessel at 4 
oC results in the inhibition of NP uptake, 
suggestive of endocytosis as a possible mechanism of entry (Figure 3.32). 
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Figure 3.32:  Transmission electron microscope images of 71±6 nm silica nanoparticles incubated at 4 °C 
in the presence of an aortic vessel. 
 
 
3.4.2.2. Influence of silica nanoparticles on vasoconstrictor responses 
of aortic vessels 
All vessels constricted in high potassium solution (60 mM KCl). There was no significant 
difference in the level of constriction after the vessels were incubated in 71±6 nm SiNPs 
(1.82 ± 0.19 g/tension, n=5), 27±7 nm SiNPs (2.70±0.23 g/tension, n=5), 61±7 nm 
SiRBITC NPs (2.67 ± 0.37 g/tension, n=4) or 31±10 nm SiRBITC NPs (2.35 ± 0.21 
g/tension, n=5) in comparison to PSS alone (2.32 ± 0.26 g/tension, n=4).  
 
The effects of vasoconstrictor response were investigated by observing whether there is a 
significant difference on constriction levels due to vasodilators and or the NPs. A 
histogram of the average difference in constriction before and after incubation is illustrated 
in Figure 3.33 in accordance to ACh traces. There is no significant difference in 
constriction after the vessels are incubated in PSS alone, SiNPs or SiRBITC NPs, as the p 
values are greater than 0.05.  
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Figure 3.33:  The influence on potassium physiological salt solution constrictor response of the aortic 
vessels before and after incubation, where p ˃ 0.05 for all the experiments. ‘n’ is the number of vessels. 
 
 
3.4.2.3. Aortic vessel responses to vasodilation agonists 
The dose dependent responses of aortic vessels to vasodilators were first investigated. The 
endothelium-dependent and independent vasodilation was investigated using ACh and 
SNP respectively. The repeatability of responses was then investigated by repeating the 
dose response after 30 minutes incubation in PSS, these represented the control 
experiments. All vessels dilated to ACh in a dose dependent manner and there was no 
significant difference in dilation after the incubation period (Figure 3.34). The dose 
response of ACh for before and after 30 minutes incubation in PSS alone shows it is 
repeatable. 
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Figure 3.34:  The influence on acetylcholine dilator responses of the aortic vessels before and after 
incubation in physiological salt solution. ‘n’ is the number of vessels, where p ˃ 0.05 for all the 
experiments. 
 
 
All vessels dilated to SNP in a dose dependent manner and there was no significant 
difference in dilation after the incubation period (Figure 3.35). The dose response of SNP 
directly donating NO to the smooth muscle cells before and after 30 minute incubation in 
PSS alone shows it is repeatable. 
 
 
 
Figure 3.35:  The influence on sodium nitroprusside dilator responses of the aortic vessels before and 
after incubation in physiological salt solution. ‘n’ is the number of vessels, where p ˃ 0.05 for all the 
experiments. 
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3.4.2.4. Influence of silica nanoparticles on endothelium-dependent 
and independent vasodilator responses 
All pre-constricted vessels dilated to the endothelial-dependent agonist (ACh) and the 
endothelial-independent agonist (SNP) in a dose dependent manner. The influence of NP 
number and size on these dilator responses is shown in Figure 3.36. 
 
 
 
Figure 3.36:  The influence of both amorphous (SiNPs) and rhodamine B isothiocyanate encapsulated 
silica nanoparticles (SiRIBTC NPs) on endothelium-dependent vasodilator responses. The control is 
incubation in PSS alone. A) Effect of medium-size SiNP number at 1.31×1011 NP/ mL and 1.96×1012 NP/ 
mL. B) Effect of SiNP size at 1.96×1012 NP/ mL; medium-size SiNPs and small-size SiNPs. C) Effect of 
medium-size SiRBITC NPs at 1.96×1012 NP/ mL; medium-size SiNPs and medium-size SiRBITC NPs.  D) 
Effect of small-size SiRBITC NPs at 1.96×1012 NP/ mL; small-size SiNPs and small-size SiRBITC NPs. 
‘n’ is number of vessels. *=p<0.05, #=p<0.01 and §=p<0.001, error bars=S.E.M. 
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3.4.2.5. Effect of nanoparticle number on vascular function 
Medium-size SiNPs were firstly utilized to examine whether NP number, per se, 
influenced responses. Thus, the effect of medium-size (71±6 nm) SiNPs incubation at 
1.31×1011 nanoparticle (NP)/ mL and at 1.96×1012 NP/ mL were investigated for influence 
on both endothelium-dependent (ACh) and independent (SNP) vasodilator responses. 
Generally, there was a slight attenuation in endothelium-dependent dilation after exposure 
to medium-sized SiNPs at 1.31×1011 NP/ mL (47 µg/ mL; at a calculated exposure surface 
area of 0.0021 m
2
; Table 3.2) in comparison to PSS alone.  
 
TABLE 3.2: Calculated surface area and mass of nanoparticles added to an 
experiment. 
Nanoparticle type 
Total nanoparticle 
number  
(NP/ mL) 
Surface area/ 
unit mass 
(m
2
) 
Total 
exposure of 
surface area 
(m
2
) 
Total 
mass of 
NP added 
(µg/ mL) 
medium-size 
SiNPs 
1.31×1011 1.5837×10-14 0.0021 47 
medium-size 
SiNPs 
1.96×1012 1.5837×10-14 0.0310 700 
small-size SiNPs 1.96×10
12
 2.2902×10-15 0.0045 38 
medium-size 
SiRBITC NPs 
1.96×1012 1.1690×10-14 0.0229 443 
small-size 
SiRBITC NPs 
1.96×1012 2.8274×10-15 0.0055 53 
 
However, incubation in higher numbers of medium-size SiNPs (1.96×1012 NP/ mL; 700 
µg/ mL; 0.0310 m
2
) led to a significant attenuation in dilator responses (Figure 36A). 
Furthermore, the pD2 value after incubation in medium-size SiNPs suggest that sensitivity 
to ACh is significantly reduced (p<0.01; Table 3.3).  
 
  
     Chapter 3 
  Applications                                                                                                                  
  
 
137 
TABLE 3.3:  The half-maximal relaxation to the endothelial-dependent vasodilator 
(acetylcholine). 
Incubation pD2
 a
  n
 b
 
PSS -6.32±0.09 4 
Medium-size SiNPs low -6.08±0.18 7 
Medium-size SiNPs high -5.03±0.27 4 
small-size SiNPs high -6.15±0.16 6 
Medium-size SiRBITC NPs high -6.03±0.12 4 
Small-size SiRBITC NPs high -6.35±0.19 4 
Small-size SiNPs (high) + SOD -5.53±0.15 4 
Small-size SiRBITC NPs (high) + SOD -6.13±0.13 6 
a
 pD2 is the acetylcholine concentration that produces the half-maximal relaxation, expressed as negative 
logarithm of concentration (mol/ L) with mean values ± SEM..  
b 
n is the number of vessels. 
 
Vessel incubation in medium-size 71±6 nm SiNPs (at both 1.31×1011 NP/ mL and 
1.96×1012 NP/ mL) had no overall influence on SNP dilator responses at any of the 
concentrations tested (Figure 3.37; Table 3.2; Table 3.4). 
 
 
 
Figure 3.37:  The influence of medium-size silica nanoparticles on sodium nitroprusside dilator responses 
of the aortic vessels; where A) 1.31×1011 NP/ mL and B) 1.96×1012 NP/ mL. ‘n’ is the number of vessels, 
where p ˃ 0.05 for all the experiments. 
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TABLE 3.4: Half-maximal relaxation of aortic vessels due to the endothelial-
independent vasodilator, sodium nitroprusside, before and after incubation with 
different types of nanoparticles. 
 
 
 
 
 
 
 
 
 
 
 
 
a
 pD2 is the acetylcholine concentration that produces the half-maximal relaxation, expressed as negative 
logarithm of concentration (mol/ L) with mean values ± SEM. 
b 
n is the number of vessels. 
 
3.4.2.6. Effect of nanoparticle size on vascular function 
NPs of two size ranges, medium and small-size NPs of 70 nm and 30 nm respectively, at 
1.96×1012 NP/ mL, were utilised to examine their influence on endothelium-dependent and 
independent dilator responses.   
 
Incubation in the small-size SiNPs led to a significant reduction in endothelium-dependent 
dilator responses, while medium-size SiNPs of the same nanoparticle number/ mL led to a 
further reduction in dilator response (Figure 3.36B). The mass of small-size SiNPs 
incubated in the vessel was 38 µg/ mL (total exposure surface area=0.0045 m
2
, at 2.29×10-
15
 SA/ unit mass) and the medium-size SiNPs mass was 700 µg/ mL for the same number 
of NPs (1.96×1012 NP/ mL; 0.0310 m2, at 1.58×10-14 SA/ unit mass), suggesting that it is 
the mass and/or surface area of SiNPs that influences dilator responses, and not the 
individual NP size (Table 3.2). At the initial two ACh doses (1×10-5 and 2×10-5 mM) there 
was no significant difference in dilation when compared to the control. However, at higher 
ACh concentration (4×10-5 to 2×10-1 mM) there was significant reduction in dilation 
Nanoparticles pD2
 a
 n
b
 
Control 
Before incubation -7.73±0.12 4 
After incubation -7.78±0.05 4 
Medium SiNPs low 
Before incubation -7.64±0.06 6 
After incubation -7.76±0.08 6 
Medium SiNPs high 
Before incubation -7.57±0.04 4 
After incubation -7.58±0.11 4 
small SiNPs high 
Before incubation -7.55±0.21 4 
After incubation -7.57±0.13 4 
Medium SiRBITC NPs 
Before incubation -7.36±0.15 4 
After incubation -7.52±0.18 4 
Small SiRBITC NPs 
Before incubation -7.78±0.12 4 
After incubation -7.85±0.10 4 
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(p<0.05). Neither the small-size nor medium-size SiNPs altered SNP dilator responses in 
comparison to the control. 
 
SNP dilator responses were unaltered after vessel incubation in either 71±6 nm SiNPs 
(1.96×1012 NP/ mL) or 27±7 nm SiNPs (1.96×1012 NP/ mL), at any of the concentrations 
(10
-6
 - 10
-2
 mM; Figure 3.38).  
 
 
 
Figure 3.38:  The influence on sodium nitroprusside dilator responses of the aortic vessels when incubated 
with A) medium-size silica nanoparticles and B) small-size silica nanoparticles at 1.96×1012 NP/ mL. ‘n’ is 
the number of vessels, where p ˃ 0.05 for all the experiments. 
 
 
3.4.2.7. Effect of dye encapsulated SiNPs on vascular responses 
Incubation in the medium-size SiNPs (700 µg/ mL; 0.0310 m
2
) led to a greater reduction in 
endothelium-dependent dilator responses than the medium-sized SiRBITC NPs (443 µg/ 
mL; 0.0229 m
2
) (Figure 3.36C), further supporting a role for the mass and/or surface area 
of SiNPs in attenuating dilation. Due to amorphous SiNPs being 10 nm larger than the dye 
encapsulated SiNPs, this may have led to an additional reduction in ACh vasodilator 
responses, being significant at higher ACh log concentrations (4×10-5 to 2×10-2 mM).  
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SNP dilator responses were unaltered after vessel incubation in either 71±6 nm SiNPs 
(1.96×1012 NP/ ml) or 61±7 nm SiRBITC NPs (1.96×1012 NP/ ml) at all concentrations 
tested (10
-6
 - 10
-2
 mM; Figure 3.39). 
 
Both amorphous SiNPs and dye encapsulated small-size SiRIBTC NPs led to a significant 
reduction in endothelium-dependent vasodilator response at similar levels in comparison to 
the control (Figure 3.35D). The small-size SiRIBTC NPs (53 µg/ mL; 0.0055 m
2
) led to 
greater reduction in dilation at higher ACh concentrations compared to the small-size 
SiNPs (38 µg/ mL; 0.0045 m
2
). 
 
 
 
Figure 3.39:  The influence on sodium nitroprusside dilator responses of the aortic vessels when incubated 
with A) medium-size silica nanoparticles and B) medium-size rhodamine B isothiocyanate encapsulated 
silica nanoparticles at 1.96×1012 NP/ mL. ‘n’ is the number of vessels, where p ˃ 0.05 for all the 
experiments. 
 
  
SNP dilator responses were unaltered after vessel incubation in either 27±7 nm SiNPs 
(1.96×1012 NP/ mL) or 31±10 nm SiRBITC NPs (1.96×1012 NP/ mL), at any of the 
concentrations tested (10
-6
 - 10
-2
 mM; Figure 3.40).  
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Figure 3.40:  The influence on sodium nitroprusside dilator responses of the aortic vessels when incubated 
with A) small-size silica nanoparticles and B) small-size rhodamine B isothiocyanate encapsulated silica 
nanoparticles at 1.96×1012 NP/ mL. ‘n’ is the number of vessels, where p ˃ 0.05 for all the experiments. 
 
 
3.4.2.8. Restoration of dilator response using SOD 
To examine whether the reduction in vasodilator responses induced by SiRBITC and 
SiNPs is due to the generation of reactive oxygen species (ROS), vessels were co-
incubated with superoxide dismutase (SOD) (300 U/ mL), which reacts with ROS to 
produce oxygen and hydrogen peroxide. There was a significant improvement in 
vasodilation when small-size SiRIBTC NPs were co-incubated with SOD (Figure 3.41A). 
At 2×10-1 mM dose concentration of ACh the SOD improved dilation by 16.28 %. The co-
incubation of SOD (300 U/ mL) with small-size SiNPs alone did not improve vasodilator 
responses but caused a further reduction in dilation (Figure 3.41B); being significant at 
2×10-5 to 2×10-1 mM when compared to PSS. Furthermore, the pD2 value for after 
incubation in small-size SiNPs co-incubated with SOD suggests that sensitivity to ACh 
was significantly reduced (p<0.01; Table 3.3). 
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Figure 3.41:  The influence on acetylcholine dilator responses after: A) small-size rhodamine B 
isothiocyanate encapsulated silica nanoparticle co-incubation with superoxide dismutase in comparison to 
small-size rhodamine B isothiocyanate encapsulated silica nanoparticles alone, or PSS, B) small-size 
silica nanoparticle co-incubation with superoxide dismutase in comparison to small-size silica 
nanoparticles alone, or PSS and C) Nω-Nitro-L-arginine incubation in PSS alone.  ‘n’ is number of 
vessels. *=p<0.05, #=p<0.01 and §=p<0.001, error bars=S.E.M.  
 
 
When vessels were pre-incubated in the nitric oxide synthase (NOS) inhibitor Nω-Nitro-L-
arginine (L-NNA) and the ACh dose response repeated in the continued presence of the 
inhibitor, dilation was significantly reduced at most concentrations examined (Figure 
3.41C). Thus, suggesting that the major dilator component in rat aortic vessels is due to 
nitric oxide.  
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Detailed analysis of the data generated, using the linear mixed model, confirmed that 
incubation in PSS alone led to the greatest degree of relaxation, followed by medium-size 
SiNPs (1.31×1011 NP/ mL) > small-size SiRBITC NPs+SOD > medium-size SiRBITC 
NPs > small-size SiNPs > small-size SiRBITC NPs > small-size SiNPs+SOD >medium-
size SiNPs. 
 
3.4.3. Discussion 
We demonstrate that silica nanoparticles (SiNPs), less than 100 nm size, attenuate 
endothelial-dependent (ACh), but not endothelial-independent (SNP) dilator responses in 
isolated viable vessels, in vitro. Evidence of nanoparticle uptake is shown by the lining 
endothelial cells but not by the smooth muscle cells or the adventitial layer. We show that 
the degree of attenuation is related to the surface area of the nanoparticles, rather than their 
size, confirming previous nanotoxicological studies using cell cultures [174]. We further 
demonstrate that the attenuated dilation, due to dye encapsulated silica nanoparticles 
(SiRIBTC NPs), but not SiNPs, can be partially restored using superoxide dismutase, 
suggesting that the mechanism of attenuated dilation is different for the SiNPs and 
SiRIBTC NPs.  
 
The in vitro exposure of viable aortic vessels to the 71±6 nm SiNPs, resulted in their rapid 
uptake into the cytoplasm of endothelial cells. The small-size SiNPs (27±7 nm) also 
seemed to accumulate in the cytoplasm of the endothelial cells. No uptake was evident 
when vessels were exposed to SiNPs at 4 ˚C, suggesting that uptake is an active process. 
Endocytosis is a well documented pathway by which NPs are internalised into cells. This 
includes clathrin-mediated endocytosis, caveolae-mediated endocytosis or clathrin–
caveolae and dynamin-independent endocytosis mechanism [175]. Our TEM findings 
suggest that the mechanism of uptake of small-size SiNPs may be different from that of the 
medium-size NPs. Indeed, one recent study (using A549 cell line) suggests that at any one 
time, cells can use multiple pathways simultaneously, depending on the surface chemistry 
of the NPs [176]. 
 
The NPs were fabricated and carefully characterised within our laboratories. The zeta 
potential values demonstrate that the NPs were stable in both water and PSS. In the case of 
SiRIBTC NPs the zeta potential in water was more negative that the non dye encapsulated 
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SiNPs. When suspended in PSS, attraction of salt ions led to reduced negativity. Such 
charge attraction may have led to modification of the surface chemistry of the SiRIBTC 
NPs, in comparison to the SiNPs. Consequently, this may have affected the mechanism of 
uptake into the endothelial cells, with less SiRIBTC NPs being taken up overall. The 
hydrodynamic diameter of our fabricated NPs is approximately 20 nm above the actual 
size measured from the TEM images. Generally, the zeta potentials for amorphous SiNPs 
and SiRBITC NPs confirm they are stable in both water and PSS. When the NP 
suspensions (1.64×1012 NP/ mL) were placed in PSS the potential slightly decreased, as 
compared to a suspension in water, due to their presence in high ionic solution (PSS), as 
follows: briefly, when these NPs are in water, the counter ions (water molecules) surround 
the particle‟s surface and produce a structured hydration layer, known as the Stern layer. 
Other counter-ions that are not directly bound to the particle surface are still attracted to 
the negative particle, even though there is repulsion from the „Stern layer‟ as well as other 
counter-ions attracted towards the particle, known as the diffuse layer. The electrical 
potential at the point where the Stern layer meets the diffused layer is known as the zeta 
potential. However, the introduction of ions into the solution (PSS) not only reduced the 
amount of water molecules but resulted in competition between the ions and silica surface 
for the water molecules. This leads to a less structured hydration layer as the positively 
charged salt counter-ions and water molecules surround the NP, causing the short-range 
repulsive forces to reduce, thus lowering the zeta potential [35, 52]. The smaller SiNPs 
demonstrate non-DLVO behaviour with additional forces present. It has been proposed that 
there is short range repulsion from a hairy layer present on the surface of small-size SiNPs. 
The layer is thought to consist of covalently bonded polymeric chains of silicilic acid 
protruding from the surface [52].  
 
Aortic vessels were incubated in nanoparticles at 1.31×1011 NP/ mL and also at a higher 
concentration of 1.96×1012 NP/ mL, over a 30 minute acute exposure time period. This 
exposure time and concentration is representative of that utilised in pre-clinical trials. For 
example, Michalak et al. [177] estimated the circulation half life of near-infrared 
nanoparticles in mice to be between 3-43 minutes at an estimated relative concentration of 
4.98 x 10 
9
 NP/ mL in the blood of these mice. Although there is little information 
available on the number of nanoparticles expected in the blood during in vivo imaging, 
however, the study by Casciaro et al. [177] has provided some insight into the ideal 
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nanoparticle number that is necessary for successful imaging diagnostics. They 
investigated the acoustic behaviour of silica nanoparticles for diagnostic ultrasound 
identification, using a range of nanoparticles sizes (160, 330, 660 nm) and concentrations 
(10 
10
 – 10 13 NP/ mL). They determined that the use of 330 nm silica nanoparticles at 1-2 
x 10 
11
 NP/ mL were ideal for ultrasound imaging at conventional diagnostic frequencies 
[178].  
 
Our findings suggest that the degree of attenuated dilation by the NPs is based on 
dosimetry, as the greater the number of NPs (and /or mass) the lower % relaxation of the 
vessels. For instance, there is a small attenuation in dilation for the medium-size SiNPs at 
1.31×1011 NP/ mL (47 µg/ mL; 0.0021 m2) while at a higher dose (1.96×1012 NP/ mL; 700 
µg/ mL; 0.0310 m
2
) of the same SiNPs led to a greater significant attenuation in 
vasodilation. Similarly, Lin et al. [179] have shown that a reduction in cell viability by 
SiNPs was both time and dose-dependent, in bronchoalveolar carcinoma-derived cells. 
Furthermore, when NP number were kept constant (1.96×1012 NP/ mL), we observed that 
the medium-size NP (700 µg/ mL; 0.0310 m
2
) had a greater attenuation effect than the 
small-size NPs (38 µg/ mL; 0.0045 m
2
). As the mass and surface area of the medium-size 
SiNPs is greater compared to that of the small-size SiNPs, it suggests that both components 
may play an important role. The mass of small-size SiNPs (1.96×1012 NP/ mL; 38 µg/ mL; 
0.0045 m
2
) is lower compared to medium-size SiNPs at 1.31×1011 NP/ mL (47 µg/ mL; 
0.0021 m
2
); however, the small-size SiNPs have a greater attenuation effect on 
vasodilation, suggesting that the vital component reducing  vasodilation is surface area and 
not mass per se. Previous studies have confirmed the production of ROS by amorphous 
SiNPs [171, 179-181]. Lin et al. [179] synthesised amorphous SiNPs (15 nm) which lead 
to the generation of ROS (hydroxyl radicals) in cultured human bronchoalveolar 
carcinoma-derived cells. Bhattachjee et al. [166] further suggest the possibility of NPs 
interacting with organelles, in particular the mitochondria, which lead to the production of 
ROS. These ROS may lead to oxidative stress in cells and possibly cell death. The 
mechanism of attenuated endothelial-dependent dilation by the SiNPs may thus relate to 
the generation of ROS at the surface of the NPs. Hence, a greater surface area/ unit mass, 
can lead to greater exposure of the cell to reactive oxygen species (ROS), such as hydroxyl 
radicals (
·
OH) and superoxide anions, which are able to quench NO.   
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The degree of attenuated endothelial-dependent vasodilation is similar for both dye 
encapsulated (SiRIBTC NPs) and non-dye encapsulated small-size SiNPs. The TEM 
images for the small-size SiNPs shows a large accumulation of NPs at the surface of the 
endothelial layer within caveolae structures along the cell membrane. This could lead to 
disruption of the caveoli and alter activity of the eNOS enzyme which is normally coupled 
to caveolae proteins. This may be one mechanism of attenuated dilation due to non-dye 
encapsulated SiNP since SOD co-incubation, did not improve dilation. In comparison, 
lower levels of NP uptake were observed by TEM, for the small-size SiRIBTC NPs than 
the SiNPs. Despite reduced uptake of the SiRIBTC NPs, the attenuation in dilation is at a 
similar level for both small-size SiRIBTC NPs and SiNPs, suggesting that there may be 
more than one factor affecting dilation of vessels incubated in the small-size SiRIBTC 
NPs. Numerous gases are known to quench the fluorescence of a number of fluorophores, 
including rhodamine. Indeed, a number of fluorescent probes have been developed that can 
detect NO in cellular systems, based on the principle of fluorescence quenching [181], 
where rhodamine chromophore has been shown to enable detection of NO release (as low a 
7nM) from bovine aortic endothelial cells, in vitro [183]. We have demonstrated that the 
major component of the dilator response in aortic vessels is due to NO release (L-NNA 
inhibition studies), supporting previous studies [184, 185]. Consequently, incubating 
vessels in SiRIBTC NPs will have contributed to the reduced ACh-induced dilator 
responses. When vessels were co-incubated in SiRIBTC NPS and SOD, it was possible to 
partially restore the dilator responses, suggesting that indeed, leakage of the dye itself may 
quench NO. The cellular components are protected by SOD by preventing them being 
oxidized by ROS. However, as the dye molecules are covalently bonded to silica matrix it 
is more probable that the dye molecules were quenched by NO diffusing through the silica-
shell, thus affecting dilation. In the case of non-dye encapsulated SiNPS, when SOD was 
co-incubated with SiNPs, it did not contribute to restoring dilation, as it had for SiRIBTC 
NPs, but it led to a further attenuation in relaxation.  This may be explained by the fact that 
dismutation of small amounts of ROS to hydrogen peroxide, can have a small added 
constrictor effect on aortic vessels [186].   
 
3.4.4. Conclusions 
In conclusion, we show that uptake of silica nanoparticles of less than 100 nm in diameter 
can attenuate endothelial-dependent but not endothelial-independent vasodilator function 
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in rat aortic vessels, depending on their surface area/ unit mass. We further show that dye 
doping of the SiNPs, can further influence the dilator response. Our findings have 
implications for the future fabrication of biocompatible silica nanoparticles for use in 
medical therapeutics and imaging diagnostics.   
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3.5. Pressurised System for the Aortic Vessel 
Small isolated vessels under near physiological conditions may be examined using 
pharmacological or physiological stimuli using a pressure or perfusion myograph system. 
In these systems, as with the aortic vessels, the small vessels are dissected in order to 
remove the perivascular adipose and connective tissue surrounding the vessels. The vessel 
is then mounted by placing each end of the vessel through a cannula and securing it in 
position by tying knots at each end. The small arteries are then intravascularly pressurised 
to 60 mmHg [185]. Previously, such systems have been used to assess the effect of various 
substances including ouabain upon cerebral arteries [187]. For the organ-bath aortic vessel 
experiment the vessel is not pressurised and in order to mimic physiological conditions 
more accurately it is important for the vessels to be pressurised. Furthermore, the present 
study will demonstrate attempts to pressurise aortic vessels for the delivery of 
nanoparticles and examine its influence on structure and function.   
   
3.5.1. Experimentation 
The heart attached to the aortic vessel from a male Wistar rat was placed in an ice-cold 
petri dish containing oxygenated physiological salt solution in order to maintain the tissue 
in a viable state. The perivascular adipose tissue surrounding the vessels (4 mm length) 
was removed. In order to produce a pressurised system a delicate surgical procedure was 
required where the endothelial cell integrity was maintained. Initially, aortic vessel arch 
(directly connected to the heart) was dissected to allow a glass pipette to be inserted 
followed by tying a knot to secure it in position. The other end of the pipette was attached 
to a pressurised system containing mercury. The other end of the vessel was securely 
attached to a needle with a knot; the needle contained 71±6 nm silica nanoparticles (SiNPs) 
(1.31×1011 nanoparticle (NP)/ mL) (Figure 3.42). Upon injection of the SiNPs (1.5 mL) 
the pressure rose to 60 mmHg and was maintained at that pressure for three minutes. Once 
the intravascular incubation period had completed a 4 mm length fragment was dissected 
and placed in the organ bath system containing physiological salt solution at 37 °C. The 
aortic ring was then mounted between two fine steel wires and passively stretched to 2 
gram tension. After a one hour calibration the smooth muscle cell integrity was tested with 
high potassium salt solution followed by an endothelium-dependent vasodilation dose 
response using acetylcholine.    
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Figure 3.42:  Image of the pressurised system set-up for the large aortic vessels. 
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3.5.2. Results 
3.5.2.1. Detection of silica nanoparticles within vascular tissue 
The exposure of isolated viable aortic vessel to medium-size silica nanoparticles under a 
pressurised system has led to the endothelial cells being sloughed (Figure 3.43). Therefore, 
it was not possible to examine the nanoparticle uptake by the cells. There was no evidence 
of nanoparticle uptake by the underlying smooth muscle cells.   
 
 
 
Figure 3.43:  Transmission electron microscope images of 71±6 nm silica nanoparticles pressurised into 
the aortic vessel. 
 
 
 
3.5.2.2. Influence of silica nanoparticles on endothelium-dependent 
vasodilator responses 
All vessels were pre-constricted with potassium physiological salt solution (KPSS) and the 
influences of the pressurised system were compared to the passive process by examining 
the uptake of medium-size silica nanoparticles. Previously shown (Chapter 3, Section 3.4), 
a greater initialisation of silica nanoparticles within endothelial cells attenuated 
endothelial-dependent dilation. Thus, the affect of medium-size (71±6 nm) SiNPs 
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incubation at 1.31×1011 NP/ mL under a passive process were investigated in comparison 
to the pressurised system for influence on endothelium-dependent (ACh) vasodilator 
responses (Figure 3.44). 
 
 
 
Figure 3.44:  The influence on acetylcholine dilator responses after incubation in 71±6 nm silica 
nanoparticles at 1.31×1011 NP/ mL under pressurised system in comparison to the passive process.  ‘n’ is 
number of vessels. *=p<0.05, #=p<0.01 and §=p<0.001, error bars=S.E.M.  
 
 
3.5.3. Discussion 
This study investigated the influence of pressure on increased initialisation of nanoparticles 
within large isolated aortic vessels. The endothelium-dependent vasodilation was analysed 
using acetylcholine (ACh) on constricted vessels with high potassium salt solution (KPSS). 
Initially, the repeatability of the dose responses after the incubation period in PSS was 
investigated, which was used as the control. The dose responses of ACh agonist on the 
control vessels are repeatable after an incubation period of thirty minutes. The influence of 
71±6 nm silica nanoparticle uptake at 1.31×1011 NP/ mL via the non-pressurised organ 
bath system was compared to the vessels that were initially pressurised during the 
intravascular injection procedure. The pressurised system led to a greater attenuation of 
vasodilation compared to the conventional uptake of nanoparticle in the organ bath system. 
However, the electron microscopy image indicates that the attenuation in vasodilation was 
due to the damaged endothelial cell, which may be due to the pipette when attaching the 
vessel. Therefore, a more controlled pressurised system whereby the pipette is controlled 
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by small increment mechanical movement should remove any damage caused to the 
endothelial layer.  
 
Pressure myography systems are commonly used for the study of structure and function of 
small vessels, in particularly for studying hypertension [188].  
  
3.5.4. Conclusions 
This study represents an attempt to investigate the influence of pressure on nanoparticle 
uptake by aortic vessels. The system produced was capable of pressuring the vessels at 60 
mmHg; however modification of the system would be necessary system where the pipettes 
is held in place.  
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3.6. Drug Release Study of Mesoporous Nanoparticles 
The illustration below is a schematic representation of the drug release within isolated 
viable vessels (Figure 3.45). The mesoporous nanoparticles are initialised within the 
endothelial cells while sodium nitroprusside (SNP) is released into the cell.  
 
 
 
     
Figure 3.45:  Schematic illustration of the relaxation of constricted aortic vessels via the release of 
endothelial-independent vasodilators, in vitro. 
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The easy design of smart nanocarriers makes them valuable vehicles for drug delivery 
systems. In particular, mesoporous nanoparticles (MNP) have large surface area, ordered 
mesoporous structures along with their physical and chemical properties. The potential 
advantages of these nanocarriers within medicinal applications have given rise to the 
exploitation of these materials in nanotechnology. The surface functionalisation of the 
MNP (host) in addition to the introduction of guest molecules within theses pores such as 
protein biomolecules or drugs allows for targeted therapy of intracellular areas [189]. The 
large surface area results in high pore volume and consequently allowing for uptake of 
large quantities of biomolecules [81]. Furthermore, unlike quantum dots and carbon 
nanotubes that are known to have cytotoxicological effects, MNP are well documented for 
their potential advantageous influence on both the environment and human health [186]. 
The pore size may be tuned depending on the size of the guest molecule by selecting a 
specific template. Previous studies have used host (such as MCM-41and SBA-15) and 
guest (such as drug, enzymes, DNA and luminescent [190]) molecules to produce effective 
systems in which the host-guest interaction plays a vital role in their application [190]. The 
pore size influences the accessibility of the guest molecules adsorbed within the pores of 
the host material. The larger the pore size the larger the adsorption of guest molecules in 
the pores. However, if the interaction between the host and the guest molecules is weak, 
this can lead to the rapid leaching of the guest molecules [190]. 
 
Monodispersive mesoporous silica nanoparticles with diameters around 100 nm can be 
fabricated using colloidal methods. Regular pore structure is produced during synthesis by 
incorporation of surfactant molecules which self assemble into ordered arrays [191]. Once 
the structure is produced the surfactant template is removed by calcining or dissolution. 
The remaining nanoparticles comprise of an ordered silica framework with defined regular 
nanochannels that are aligned parallel to each other, resulting in a very high surface to 
volume ratio.  The chain length of the surfactant molecule used as a template directs the 
size of the pore produced therefore careful choice allows control of particle porosity. 
Typical surface area measurements are around 1000 m
2
 per gram with narrow pore size 
distribution that is controllable between sizes of 2-15 nm diameters [9, 192, 193]. The pore 
size can be tailored to allow accommodation of drug molecules of various sizes [191]. 
Mesoporous silica offers a mechanism for controlling the rate and period of drug delivery. 
The ordered pore network allows fine control of the drug loading and release kinetics, 
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while the large surface area afforded by the pore assemblies allows adsorption of the 
required dosage of drug [191]. Furthermore, there are two surfaces available for 
modification, the internal pore surface and the external surface of the nanoparticle.  The 
internal surface is usually utilized for harbouring the drug, while the external surface is 
functionalised to direct the nanoparticles to the area for release and drug action. Once the 
nanoparticles have been drug loaded, the release is governed by constrained pore diffusion 
[9]. The drug release into cells is influenced by structural characteristics, specifically the 
confined diffusion of the drug to the pore entrance [126]. The diffusion rate is governed by 
the size of the pores and it is this property that makes this material ideally suited for 
allowing controlled sustained drug release. Release kinetics has been demonstrated from 
mesoporous silica using luminescent molecules and ibuprofen as a model drug [126, 9, 
194-196]. One study showed that 80 % of ibuprofen was released after only 50 minutes 
from mesoporous silica with pore size 3.4nm and particle diameter of 50 microns [197]. 
Another study demonstrated that it took 31 hours for the release of 60 % of ibuprofen 
loaded into mesoporous silica (diameter 950 nm and pore size 2.5 nm) in a solution with 
composition similar to human body plasma. The ibuprofen loaded particles were developed 
for oral administration and so the release in simulated gastric fluid and simulated intestinal 
fluid was investigated which showed the release rate was increased to 60 % released after 
11 hours [198]. It has been shown that the dynamic release rate is dependent on pore size 
with a more controlled sustained delivery from mesoporous silica with small pore size for 
up to 60 hours.  
 
Controlled release of sodium nitroprusside from mesoporous silica nanoparticles is a 
promising avenue leading to the development of therapeutic intervention for treatments of 
diseases such as hypertension. The versatility of nanoparticles allows them to be utilised as 
drug loading vehicles. There are various procedures by which drugs maybe attached within 
the nanoparticle matrix, for instance encapsulation, surface attachment or entrapment 
[199].  
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3.6.1. Diffusion of drug release 
The release of a drug from the mesoporous matrix is influenced by factors such as the pore 
architecture, pore diameter, drug to pore wall interaction (s) and the physical state of the 
drug. The qualitative and/ or quantitative changes of the drug may not only result in 
changes to the release rate but also affect the in vitro and in vivo biological systems, thus 
this has led to the development of numerous kinetic models describing the drug release, 
referred to as the drug release profile. These kinetic models include the i) zero order rate 
where drug release is independent of the concentration of drug used, ii) first order rate 
where drug release is dependent of the concentration of drug used, iii) Higuchi model 
describes the drug release from an insoluble material, such as mesoporous silica 
nanoparticles, as the square root of time based on the Fickian diffusion and iv) Hixson-
Crowl cube root law is for profiles where the drug release occurs by the matrix 
encapsulating or holding the drug changes in surface area [199]. 
 
Commonly, the release of drugs from mesoporous nanoparticles follows Fick‟s first law of 
diffusion [200], which postulates the movement of diffusive flux from high concentration 
gradient to low concentration gradient at a steady state.                    
       
3.6.2. Sodium nitroprusside 
Sodium nitroprusside (Na2[Fe(CN)5(NO)].2H2O) is also known by the chemical name of 
disodium pentacyanonitrosylferrate consists of a central transition metal in an octahedral 
arrangement. Its crystalline structure is orthorhombic with D2h
12
-Pnnm space group. 
Through the extensive investigation of SNP using X-ray diffraction by Manoharan et al. 
[201] it was established that SNP has a cell constant of a = 6.17±0.03, b = 11.84±0.06 and 
c = 15.43±0.08 Å. SNP molecules are capable to enter microporous channels due to their 
size, and thus will be able to enter the mesopores.  
 
In this present study, we report the release profile of endothelium-independent vasodilator 
sodium nitroprusside (SNP). Follow, by the determination of the dynamics of drug-loading 
silica MNP on isolated live blood vessels in vitro.  
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3.6.3. Experimentation 
3.6.3.1. Materials 
Mesoporous nanoparticles (MNP), rhodamine B isothiocyanate (RBITC) MNP, fluoroscein 
isothiocyanate (FITC) MNP and RBITC/ FITC MNP were prepared in our laboratories 
(Chapter 2, Section 2.4). Salt solutions were prepared using sodium chloride (NaCl), 
potassium chloride (KCl), magnesium sulphate heptahydrate (MgSO4.7H2O), potassium 
phosphate monobasic (KH2PO4), calcium chloride (CaCl2.2H2O), 
ethylenediaminetetraacetic acid dipotassium salt dihydrate (K2EDTA.2H2O) purchased 
from Fisher-Scientific (UK). Sodium nitroprusside (SNP) was purchased from Sigma-
Aldrich (UK). Millipore water was used for all experiments.    
 
3.6.3.2. Release profile of sodium nitroprusside from mesoporous 
nanoparticles 
The drug of interest for our biological application was sodium nitroprusside (SNP). For the 
release profile, the drug was loaded into the mesopores by dispersing the 392 mg RBITC 
MNP in 25 mL of sodium nitroprusside (SNP) solution (1×10-5 M). The mixture was 
stirred for 48 hours at room temperature (Figure 3.46).   
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Figure 3.46:  Schematic illustration of the interaction between sodium nitroprusside and the mesopore 
channel. 
 
 
The MNP-SNP solution was centrifuged at 6000 rpm for 40 minutes. The supernatant was 
collected and the concentration of SNP within the supernatant was measured with atomic 
absorption spectroscopy (AAS). The MNP-SNP pellet was dispersed in 5 mL of water and 
placed in dialysis tubing, as shown in Figure 3.47. The resulting dialysis membrane was 
placed in a beaker containing KPSS (375 mL). The solution was heated to 37 °C in order 
to mimic the release of SNP while in the organ bath system.             
 
 
Figure 3.47:  Image of the experimental set-up for the drug release study of rhodamine B isothiocyanate 
encapsulated mesoporous nanoparticles. 
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The release of SNP was examined by taking 1 mL aliquots of the solution contained within 
the beaker and replacing the solution with 1 mL of KPSS at regular intervals. This process 
was repeated for FITC MNP, RBITC/ FITC MNP and MNP. Furthermore, the release 
profile for different concentrations of SNP loaded within the MNP was also analysed 
(summarised in Table 3.5). 
 
Table 3.5:  Summary of the reactant concentration used for the release profile.   
SNP concentration 
used for loading (M) 
Mass of NP used for release profile (mg) Volume of 
KPSS in 
beaker (ml) 
MNP 
RBITC 
MNP 
FITC 
MNP 
RBITC/ 
FITC MNP 
1×10-5 392 392 392 392 375 
1×10-3 250 300 250 250 100 
 
The concentration of SNP within the aliquots was quantified with AAS. Initially, the 
method was validated by ascertained linearity of standard curves; five standard curves of 
known concentrations (100, 200, 400, 600, 800, 1000 ppm) of SNP in high physiological 
salt solutions were calibrated. The stability of the auto-sampler was established with three 
replicates of each sample. For the release study of the more concentrated SNP adsorption a 
more concentrated calibration graph was ascertained (500, 1000, 1500, 2000, 2500, 5000 
ppm).  
 
Initially, the parameters for optimal drug loading, release and decomposition under 
simulated biological conditions were determined. Followed by the determination of the 
dynamics of drug-loading MNP on isolated live blood vessels in vitro. Two parameters 
were used to calculate the efficiency of the drug loaded within MNP; the drug 
encapsulation efficiency (DLE; Equation 3.5) and drug loading capacity (DLC; Equation 
3.6) [199]. 
 
3.6.3.2.1. Drug loading efficiency 
The MNP drug loading efficiency was determined with atomic absorption spectroscopy. 
MNP at low (1.31×1011 NP/ mL) and high (1.96×1012 NP/ mL) concentrations were 
dispersed in 2 mL of known concentrations of SNP (1×10-5 M) and stirred for 48 hours. 
The mixtures were centrifuged and the concentration of SNP within the supernatant was 
measured using atomic absorption spectroscopy in order to determine the maximal loading 
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capacity of the MNP. The percentage of drug loading efficiency at each known SNP 
concentration was calculated as the ratio difference between the total drug concentration 
from the drug concentration within the supernatant over the total drug concentration.      
 
𝑬𝒏𝒄𝒂𝒑𝒔𝒖𝒍𝒂𝒕𝒊𝒐𝒏 𝒆𝒇𝒇𝒊𝒄𝒊𝒆𝒏𝒄𝒚 (%) =
 𝐭𝐨𝐭𝐚𝐥 𝐝𝐫𝐮𝐠 −[𝐟𝐫𝐞𝐞 𝐝𝐫𝐮𝐠]
[𝐭𝐨𝐭𝐚𝐥 𝐝𝐫𝐮𝐠]
× 𝟏𝟎𝟎                    (3.5) 
 
3.6.3.2.2. Drug loading capacity 
The drug loading capacity was determined based on the release profile and in vitro studies, 
where mg of MNP was stirred in 2 mL of sodium nitroprusside (SNP) solution (1×10-4 M). 
The supernatant was removed from the mixture and the percentage drug loading capacity 
was determined as the ratio of the mass of drug in the nanoparticle over the mass of the 
nanoparticle. 
 
𝑫𝒓𝒖𝒈 𝒍𝒐𝒂𝒅𝒊𝒏𝒈 𝒄𝒂𝒑𝒂𝒄𝒊𝒕𝒚  % =
𝐦𝐚𝐬𝐬 𝐨𝐟 𝐝𝐫𝐮𝐠 𝐢𝐧 𝐧𝐚𝐧𝐨𝐩𝐚𝐫𝐭𝐢𝐜𝐥𝐞𝐬
𝐦𝐚𝐬𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐧𝐚𝐧𝐨𝐩𝐚𝐫𝐭𝐢𝐜𝐥𝐞
× 𝟏𝟎𝟎                      (3.6) 
   
3.6.3.3. Release of sodium nitroprusside from mesoporous 
nanoparticles in vitro 
Aortic vessels from male Wistar rats were incubated in drug loaded MNP for 3 hours using 
an organ bath set-up and a data acquisition system. Details of dissection of the tissue and 
organ bath system is given in Chapter 3; Section 3.4. Aortic vessel smooth muscle cells 
integrity was tested with high potassium salt solution (KPSS).    
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3.6.4. Results 
3.6.4.1. Detection of mesoporous nanoparticles within vascular tissue 
The exposure of isolated viable aortic vessels to mesoporous nanoparticles have led to their 
initialisation into the cytoplasm of endothelial cells (Figure 3.48). However, they were not 
observed in the nucleus of the cells, elastic lamina, smooth muscle or adventitial layers.   
 
 
 
 
 
Figure 3.48:  Transmission electron microscope image of mesoporous nanoparticles within the endothelial 
cell lining of the aortic vessel. 
 
 
3.6.4.2. Sodium nitroprusside release from mesoporous nanoparticles 
The DLC of the different types of mesoporous nanoparticles were determined by soaking 
the NPs in different concentrations of SNP (1×10-6 to 1×10-2 M), as shown in Figure 3.49. 
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Figure 3.49:  The drug loading capacity altering as the sodium nitroprusside concentration increases. 
 
 
Overall, it is observed that the introduction of dye molecules within the MNP matrix has 
led to a reduction in the drug loading capacity.  
 
Mesoporous nanoparticles, without dye encapsulation, when loaded with SNP (1×10-5 M) 
have a drug loading capacity of 9.66 % and an encapsulation efficiency of 93.47 % for low 
and 93.76 % for high dose. FITC MNP when loaded with SNP (1×10-5 M) have a drug 
loading capacity of 4.82 % and an encapsulation efficiency of 92.97 % for low and 92.70 
% for high dose. RBITC MNP when loaded with SNP (1×10-5 M) have a drug loading 
capacity of -1.21 %. RBITC/ FITC MNP when loaded with SNP (1×10-5 M) have a drug 
loading capacity of 2.79 %. However, determination of the iron concentration within the 
aliquots, attained from the SNP drug release profile at 1×10-5 M to mimic the in vitro 
release, was ineffective at the most sensitive wavelength (248 nm) due to the possible 
interference caused by the salt ions. Therefore, a release profile was achieved by the use of 
a more concentrated solution of SNP in the drug soaking stage.     
 
The kinetic release of sodium nitroprusside (SNP) from MNP, FITC MNP, RBITC MNP 
and RBITC/ FITC MNP was investigated (Figure 3.50). The time course of SNP release 
demonstrates that there is a rapid initial release for approximately 400 minutes, which is 
similar for all types of MNP. The SNP concentration released at approximately 500 
minutes was greater for the MNP as it reaches 4.2×10-1 mol dm-3, while the FITC MNP 
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was 3.6×10-1 mol dm-3, RBITC MNP was 4.0×10-1 mol dm-3 and RBITC/ FITC MNP was 
2.8 ×10-1 mol dm-3. This may either be due to a greater capacity of SNP loaded within the 
MNP or a greater release rate. For the RBITC MNP there was a greater concentration of 
NPs during the release study, thus overall it follows a similar trend to the bare MNP. The 
drug loading capacity for RBITC MNP along with the release studies of the other MNP‟s 
suggest that the SNP release would be lowest overall release. The MNP reaches a release 
of 4.5×10-1 mol dm-3 at 895 minutes and no further release is observed until approximately 
2500 minutes, where the release reaches 5.3×10-1 mol dm-3. However, for the dye 
encapsulated MNP there is a gradual increase in release of SNP from 520 minutes till 802 
minutes for RBITC MNP and till 1040 minutes for FITC and RBITC/ FITC MNP. The 
release of SNP from RBITC MNP at 3692 minutes was 4.5×10-1 mol dm-3. Overall the rate 
of SNP release for the FITC MNP is greater than the RBITC/ FITC MNP. Furthermore, 
FITC MNP leads to three small jumps at 1080, 1200 and 1320 minutes followed by 
gradual increases. The final SNP concentration releases at 2515 minutes was 6.0×10-1 mol 
dm
-3
, where the trend suggests that further release of SNP would be observed over a longer 
period of time. For  the RBITC/ FITC MNP from 1080 minutes there is an gradual increase 
in SNP release which has a small jump at 1320 minutes followed by a gradual increases to 
5.3×10-1 mol dm-3, the trend also suggests that further release of SNP would be observed 
over a longer period of time.    
 
 
 
Figure 3.50:  Release profile of sodium nitroprusside from mesoporous nanoparticles using atomic 
absorption spectroscopy. 
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3.6.4.3. Drug release study of sodium nitroprusside in vitro 
Mesoporous nanoparticles (MNP) and FITC MNP at high (1.96×1012 NP/ mL) and low 
(1.31×1011 NP/ mL) concentration were placed in the organ bath system. The density of 
the MNP was utilised as 0.83 g/ cm
-3
 [202]. The trend observed for the vasodilation of 
aortic vessels when incubated in low dose of MNP loaded with SNP (48.81 µg/ mL) led to 
the slight reduction in vasoconstrictor levels as compared to the control (Figure 3.51; Table 
2 in the appendix).    
   
 
 
Figure 3.51:  An example trace of the influence of sodium nitroprusside loaded mesoporous nanoparticles 
at low concentration on constricted aortic vessels in real-time.  
 
 
However, at high dose of MNP loaded with SNP (730.30 µg/ mL) has led to a significant 
reduction in constriction (Figure 3.52; Table 2 in the appendix). Furthermore, the 
constriction level has been sustained for the control over a 3 hour period. 
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Figure 3.52:  An example trace of the influence of sodium nitroprusside loaded mesoporous nanoparticles 
at high concentration on constricted aortic vessels in real-time.   
 
When aortic vessels were incubated with low dose of FITC MNP loaded with SNP (73.73 
µg/ mL) there was also a slight decline in constriction (Figure 3.53; Table 2 in the 
appendix); as previously observed with the dye free MNP. Furthermore, after 
approximatley 50 minutes the vessel starts to re-constrict. Intrestingly, the incubation of 
the vessels in 1.31×1011 NP/ mL of FITC MNP also leads to re-constriction of the aortic 
vessel after approximatley 50 minutes. The aortic vessels are normally under a basal 
relaxation state, and the increased constriction levels is suggestive that the FITC MNP 
distrupt the basal NO production. It is possible that these FITC MNP disrupt eNOS 
function.     
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Figure 3.53:  An example trace of the influence of sodium nitroprusside loaded fluorescein isothiocyanate 
encapsulated mesoporous nanoparticles at low concentration on constricted aortic vessels in real-time.  
 
 
Furthermore, at high dose of FITC MNP loaded with SNP (1103.09 µg/ mL) resulted in 
significant rapid relaxation of the constricted vessels (Figure 3.54; Table 2 in the 
appendix). However, it is obsevered that the relaxation was not sustained for the 3 hour 
period, as after approximately 120 minutes the vessel start to re-constrict. 
 
 
Figure 3.54:  An example trace of the influence of sodium nitroprusside loaded fluoresein isothiocyanate 
encapsulated mesoporous nanoparticles at high concentration on constricted aortic vessels in real-time.   
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Data from the in vitro real-time release studies were used to construct percentage 
relaxation graphs in order to interpret the statistical significance. The percentage relaxation 
graph of the in vitro release of SNP from MNP is shown in Figure 3.55. There is no 
statistical significance over the three hour exposure time period between the KPSS control 
and low and high concentration of MNP (Table 2 in the appendix). Furthermore, the 
exposure of viable aortic vessels to low concentration of MNP loaded with SNP has no 
significance difference over the incubation period. However, high concentration MNP 
loaded with SNP has led to a rapid relaxation of the vessels. The high concentration of 
MNP loaded with SNP has led to an initial sharp release of SNP within the first 20 minutes 
leading to 57.74 % relaxation. The maximum relaxation was 77.08 % and was reached at 
125 minutes.  
 
 
 
Figure 3.55:  The influence of sodium nitroprusside loaded mesoporous nanoparticles on endothelium-
independent vasodilator responses.  ‘n’ is number of vessels. 
 
 
Similarly, to the percentage relaxation graphs of  MNP, there is no statistical difference 
over the three hour exposure time period between the KPSS control, low and high 
concentration of FITC MNP and low concentration of FITC MNP loaded with SNP 
(Figure 3.56; Table 2 in the appendix). Also, when high concentration MNP loaded with 
SNP, led to a rapid relaxation of the vessels. The high concentration of FITC MNP loaded 
with SNP has led to an initial sharp release of SNP within the first 20 minutes leading to 
61.93 % relaxation. The maximum relaxation was 64.16 % and was reached at 35 minutes.  
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Figure 3.56:  The influence of sodium nitroprusside loaded fluoresein isothiocyanate encapsulated 
mesoporous nanoparticles on endothelium-independent vasodilator responses.  ‘n’ is number of vessels. 
 
 
In order, to calculate the SNP release in real-time under physiological conditions a 
calibration plot was produced of known concentrations of SNP against % relaxation 
(Figure 3.57). This calibration graph was obtained from control experiments of known 
concentration of SNP leading to a particular relaxation of aortic vessels.    
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Figure 3.57:  Calibration spectra of endothelium-independent vasodilator response against known 
concentrations of sodium nitroprusside. 
 
The logarithm equation, determined in Figure 3.57, allows one to calculate SNP 
concentration released at a given time (refer to Table 1 in the appendix). The validation of 
the calculated SNP release using the in vitro studies was conducted by subtracting the total 
concentration of SNP released from the initial concentration of SNP used for drug loading. 
Thus this value was compared to the SNP concentration within the supernatant determined 
with atomic absorption spectroscopy. Interestingly, the SNP concentration within the 
supernatant was similar to the concentration calculated using the in vitro studies (Table 
3.6).         
Table 3.6:  The total concentration of SNP released from the MNP matrix, in vitro.   
 MNP FITC MNP 
Total SNP released in the in 
vitro study (mol dm
-3
)
 a
 
1.55×10-5 3.70×10-6 
SNP remained within the 
supernatant; calculated via in 
vitro study (mol dm
-3
)
β
 
8.45×10-5 9.63×10-5 
SNP remained within the 
supernatant from MNP (mol 
dm
-3
)
γ
 
9.38×10-5 9.27×10-5 
a
 Calculated from the  in vitro control studies of SNP (Chapter 3, Section 3.4.2.3 ). 
β
 Calculated by subtracting the total concentration of SNP release in vitro from the total concentration of 
SNP used . 
γ 
Determined from atomic absorption spectroscopy. 
y = 9.6806ln(x) + 214.82 
R² = 0.9103 
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3.6.5. Discussion 
In this current study, we demonstrate that the exposure of live aortic vessels to mesoporous 
nanoparticles (MNP) and fluoroscein isothiocyanate encapsulated (FITC) MNP of 
approximately 100 nm leads to their initialisation into the cytoplasm of the endothelial 
cells. Furthermore, the MNP have a greater drug loading capacity as compared to the dye 
encapsulated MNP; where MNP> FITC MNP> RBITC/ FITC MNP> RBITC MNP. Thus, 
the dye molecules may influence the incorporation of SNP within the mesopores. The 
FITC MNP has a greater DLC than RBITC MNP, which further supports the influence of 
dye molecules as it was quantified that a greater volume of RBITC dye molecules were 
incorporated within the mesoporous matrix as compared to FITC dye molecules. The 
mesopore sizes are similar for the different types of MNP; however the total surface area 
reduces as higher volume of dye molecules are incorporated within the nanoparticle. The 
encapsulation efficiency of the MNP is slightly higher than the FITC MNP. 
 
The initial dosage of mesoporous nanoparticles exposed to the aortic vessels was 
1.31×1011 NP/ mL, as previous results from the biocompatibility study (Chapter 3, Section 
3.4) of amorphous silica nanoparticles (71±6 nm) confirm that at this given concentration 
SiNPs are biocompatible. Furthermore, Akbar et al also confirm that incubation of aortic 
vessels in 1.1×1011 NP/ mL was biocompatible for both 97±7.6 and 197±7.5 nm SiNPs, as 
there was no significance difference in the attenuation of vasodilation when compared to 
the control [35]. Furthermore, the biocompatibility testing of silica nanoparticles (Chapter 
3, Section 3.4) confirms that a greater surface area will ultimately reduce biocompatibility. 
However, as the surface area of MNP are lower than amorphous silica nanoparticles of the 
same size range, thus greater concentration of MNP may lead to less detrimental effect as 
observed by the amorphous SiNPs. In Slowing et al. study, human cervical cancer cells 
(HeLa) were exposed to 100 µg/ mL of FITC MNP and there was no difference between 
the control and the FITC MNP cell growth profile thus confirming they are not cytotoxic 
[82]. The Singh et al. in vitro study on the assessment of the biocompatibility of HeLa cells 
was performed by measuring the mitrochondrial activity when incubated in 70±8 nm 
MNP, the as-synthesised MNP at 1000 µg/ mL showed signs of cytotoxicity but not 
significantly [203].   
To the best of our knowledge, this study is the first to compare the drug loading capacity 
and the kinetic release of vasodilator drug, sodium nitroprusside, from mesoporous 
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nanoparticles with and without incorporated fluorophore dye molecules. We further 
demonstrate that the incorporation of fluorophore dye molecules within the mesoporous 
matrix results in a lower volume of SNP released. Furthermore, to our knowledge this is 
the first study where live isolated aortic vessels are exposed to these SNP loaded MNP and 
SNP loaded FITC MNP. The in vitro real-time exposure of MNP loaded with and without 
SNP at 1.31×1011 NP/ mL shows a small observable attenuation in constriction as 
compared with the control over a 3 hour time period. However, at higher concentration 
(1.96×1012 NP/ mL) the real-time exposure of MNP without SNP results in a small 
attenuation in constriction that occurs after approximately 1 hour. The MNP loaded with 
SNP have led to a rapid relaxation of aortic vessels along with relaxation sustained over 
the three hour period. The statistical analysis confirms that the relaxation is significant only 
for SNP loaded MNP at 1.96×1012 NP/ mL. 
 
The exposure of FITC MNP loaded with and without SNP at 1.31×1011 NP/ mL shows 
that the FITC MNP constriction level is similar to the KPSS control. Furthermore, the SNP 
loaded FITC MNP result in a small observable relaxation as compared with the control 
over a 3 hour time period. At higher concentration (1.96×1012 NP/ mL) the real-time 
exposure of FITC MNP without SNP has a similar observable constriction level as the 
control. The FITC MNP loaded with SNP leads to a rapid relaxation of aortic vessels 
however the relaxation was sustained for 120 minutes followed by re-constriction. The 
statistical analysis confirms that the relaxation is significant for the SNP loaded FITC 
MNP at 1.96×1012 NP/ mL.                                                                  
  
3.6.6. Conclusions 
In conclusion, we have designed a drug delivery system allowing for the release of SNP 
agonist from mesoporous matrix. We further placed these systems in isolated aortic vessels 
to record the release profile, in vitro. It was observed that the incorporation of fluorophores 
within the MNP led to lower drug loading ability, and thus relaxation was not maintained 
for the 3 hour incubation period, while MNP without dye molecules was capable of 
maintaining relaxation for the duration of the incubation period. Therefore the dye 
molecules used within the MNP matrix plays a significant role in the release kinetics. This 
has therapeutic implications for the use of appropriately fabricated nanoparticles for drug 
loading potential.       
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4. CONCLUSIONS 
Well dispersed silica nanoparticles of various sizes and structure were successfully 
prepared. The nanoparticles were pure or dye encapsulated non-porous and mesoporous 
silica with sizes in the range 30-200 nm. The materials were extensively characterised with 
TEM, SEM, PCS, zeta potential, DRIFTS, TGA, AAS and fluorescence spectroscopy. The 
200 nm dye encapsulated non-porous silica nanoparticles were incorporated within silica 
sol-gel matrix. Films were casted on glass cover slips and used as sensors for gaseous 
oxygen and sulphur dioxide molecules.  These nanoparticles have great potential for the 
detection of pollutant gases and oxygen levels within biological systems. The 
biocompatibilities of non-porous silica nanoparticles with and without fluorescent dye 
molecules were determined. The nanoparticles at 71±6 nm were found to be biocompatible 
at 1.31×1011 NP/ mL. Furthermore, the dye encapsulated non-porous silica nanoparticles 
interact with the NO molecules contained within the endothelial cells and thus attenuate 
vasodilation; these findings have important implication for the therapeutic and imaging 
diagnostic. Finally, the influence of dye molecules contained within mesoporous 
nanoparticle was assessed upon different drug loadings. The results obtained provide 
prospects for developing fluorescent nanoparticles for diagnostics and drug delivery in 
biomedical applications.  
 
4.1. Future work 
Silica nanoparticles are utilized for therapeutic intervention for the development of 
therapeutic agents and for imaging diagnostics. However, our study suggests that non-
porous silica nanoparticles may affect vessel function depending on the actual dosimetry 
and the influence of dye molecules encapsulated within non-porous silica nanoparticles. 
Furthermore, we have demonstrated that non-porous silica nanoparticles influences 
vascular function by affecting the cascade of NO production within the endothelial cells. 
Future investigation may involve assessing the pathways where non-porous nanoparticles 
with and without dye encapsulation are initialised into the cell, and their impact on cell 
function. 
Preliminary, data acquired from the pressured study of large vessels have found that 
endothelial layer was damaged, thus preventing uptake of nanoparticles. Future study will 
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involved the development of a chamber used for mounting large isolated vessels for a 
pressure system in order to preserve the vessel integrity. Additionally, the influence of 
nanoparticle uptake delivered within the vessel structure will be assessed with pressure.      
 
The synthesising of nanocarriers for therapeutic purposes produced via a triggered slow 
release mechanism. Initially, the surface of the mesoporous nanoparticles (MNP) loaded 
with sodium nitroprusside (SNP) may be functionalized in order to target a specific site, so 
the drug delivery is aimed for a precise cells and receptors. Exploring how the surface 
modified nanoparticles behave when the drug delivery is in circulation by carrying out in 
vivo studies. Therefore, future studies will involve:  
 
Cell culture studies:  Aortic endothelial cells will be cultured in growth medium with 
nanoparticles using the standard cell culture techniques. The effect of pure or dye 
encapsulated non-porous and mesoporous silica nanoparticles uptake on cell proliferation 
will be determined. In addition, different concentrations of the rhodamine B isothiocyanate 
dye on cell proliferation will be analysed. The influence of concentration and size of silica 
nanoparticles in comparison to dye encapsulated silica nanoparticles will be established for 
use in the functional studies.  
 
Functional studies:  Initialisation of nanoparticles and their influence on arterial function 
will be further investigated using the organ bath and pressure myography techniques, in 
order to determine the slow release of drug from mesoporous nanoparticles.  
 
Histology:  The visualization of fluorescent dye encapsulated nanoparticles within cells 
will be determined using confocal microscopy. 
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Figure 1:  The hydrodynamic diameter and stability of 71±6 nm silica nanoparticles determined with A) 
photon correlation spectroscopy analysis in water, B) zeta potential in water, C) photon correlation 
spectroscopy analysis in physiological salt solution and D) zeta potential in physiological salt solution. 
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Figure 2:  The hydrodynamic diameter and stability of 27±7 nm silica nanoparticles determined with A) 
photon correlation spectroscopy analysis in water, B) zeta potential in water, C) photon correlation 
spectroscopy analysis in physiological salt solution and D) zeta potential in physiological salt solution. 
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Figure 3:  The hydrodynamic diameter and stability of 61±7 nm rhodamine B isothiocyanate encapsulated 
silica nanoparticles determined with A) photon correlation spectroscopy analysis in water, B) zeta 
potential in water, C) photon correlation spectroscopy analysis in physiological salt solution and D) zeta 
potential in physiological salt solution. 
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Figure 4:  The hydrodynamic diameter and stability of 31±10 nm rhodamine B isothiocyanate 
encapsulated silica nanoparticles determined with A) photon correlation spectroscopy analysis in water, B) 
zeta potential in water, C) photon correlation spectroscopy analysis in physiological salt solution and D) 
zeta potential in physiological salt solution. 
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Figure 5:  Photon correlation spectroscopy analysis of A) rhodamine B isothiocyanate encapsulated silica 
nanoparticles and B) ruthenium-tris (4, 7-diphenyl-1, 10-phenanthroline) dichloride encapsulated silica 
nanoparticles in water media. 
 
 
  
Figure 6:  Zeta potential of A) rhodamine B isothiocyanate encapsulated silica nanoparticles and B) 
ruthenium-tris (4, 7-diphenyl-1, 10-phenanthroline) dichloride encapsulated silica nanoparticles in water 
media. 
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Figure 7:  Zeta potential of amine modified A) rhodamine B isothiocyanate encapsulated silica 
nanoparticles and B) ruthenium-tris (4, 7-diphenyl-1, 10-phenanthroline) dichloride encapsulated silica 
nanoparticles in water media. 
 
 
 
 
  
Figure 8:  Zeta potential of carboxylic acid modified A) rhodamine B isothiocyanate encapsulated silica 
nanoparticles and B) ruthenium-tris (4, 7-diphenyl-1, 10-phenanthroline) dichloride encapsulated silica 
nanoparticles in water media. 
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Figure 9:  Fluorescence spectroscopy of known concentrations of rhodamine B isothiocyanate within 
ethanol media.   
 
 
 
 
 
Figure 10:  Fluorescence spectroscopy of the supernatant retrieved from the fabrication of rhodamine B 
isothiocyanate encapsulated silica nanoparticles, which were used for the production of a gas nanosensor 
film. 
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Figure 11:  Fluorescence spectroscopy of known concentrations of ruthenium-tris (4, 7-diphenyl-1, 10-
phenanthroline) dichloride within ethanol media.   
 
 
 
 
Figure 12:  Fluorescence spectroscopy of the supernatant retrieved from the fabrication of ruthenium-tris 
(4, 7-diphenyl-1, 10-phenanthroline) dichloride encapsulated silica nanoparticles, which were used for the 
production of a gas nanosensor film. 
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Figure 13:  The hydrodynamic diameter and stability of 48±4 nm rhodamine B isothiocyanate 
encapsulated silica nanoparticles (sample 1) fabricated via microemulsion determined with A) photon 
correlation spectroscopy analysis in water and B) zeta potential in water. 
 
 
 
 
Figure 14:  The hydrodynamic diameter and stability of 54±9 nm rhodamine B isothiocyanate 
encapsulated silica nanoparticles (sample 2) fabricated via microemulsion determined with A) photon 
correlation spectroscopy analysis in water and B) zeta potential in water. 
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Figure 15:  The hydrodynamic diameter and stability of 66±4 nm rhodamine B isothiocyanate 
encapsulated silica nanoparticles (sample 3) fabricated via microemulsion determined with A) photon 
correlation spectroscopy analysis in water and B) zeta potential in water. 
 
 
 
 
Figure 16:  The hydrodynamic diameter and stability of 65±5 nm rhodamine B isothiocyanate 
encapsulated silica nanoparticles (sample 4) fabricated via microemulsion determined with A) photon 
correlation spectroscopy analysis in water and B) zeta potential in water. 
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Figure 17:  The hydrodynamic diameter and stability of 847.3 nm rhodamine B isothiocyanate 
encapsulated mesoporous nanoparticles (sample 1) was determined with A) photon correlation 
spectroscopy analysis and B) zeta potential in water. 
 
 
  
A B 
      
 
 
  
 
  206 
 
   
   
 
Figure 18:  Photon correlation spectroscopy analysis of mesoporous nanoparticles, where A) 292.3 nm 
(sample 2), B) 173.6 nm (sample 3), C) 160.7 nm (sample 4), D) 106.7 nm (sample 5) and E) 123.2 nm 
(sample 6) in water. 
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Figure 19:  Zeta potential of mesoporous nanoparticles for A) 106.7 nm (sample 5) and B) 123.2 nm 
(sample 6) in water media. 
 
 
 
  
Figure 20:  The hydrodynamic diameter and stability of mesoporous nanoparticles 8139 nm (sample 5) 
after calcination was determined with A) photon correlation spectroscopy analysis and B) zeta potential in 
water. 
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Figure 21:  The hydrodynamic diameter and stability of 95±13 nm mesoporous nanoparticles determined 
with A) photon correlation spectroscopy analysis in water, B) zeta potential in water, C) photon correlation 
spectroscopy analysis in physiological salt solution and D) zeta potential in physiological salt solution. 
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Figure 22:  The hydrodynamic diameter and stability of 105±13 nm rhodamine B isothiocyanate 
encapsulated mesoporous nanoparticles determined with A) photon correlation spectroscopy analysis in 
water, B) zeta potential in water, C) photon correlation spectroscopy analysis in physiological salt solution 
and D) zeta potential in physiological salt solution. 
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Figure 23:  The hydrodynamic diameter and stability of 109±18 nm fluorescein isothiocyanate 
encapsulated mesoporous nanoparticles determined with A) photon correlation spectroscopy analysis in 
water, B) zeta potential in water, C) photon correlation spectroscopy analysis in physiological salt solution 
and D) zeta potential in physiological salt solution. 
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Figure 24:  The hydrodynamic diameter and stability of 105±13 nm rhodamine B isothiocyanate and 
fluorescein isothiocyanate encapsulated mesoporous nanoparticles determined with A) photon correlation 
spectroscopy analysis in water, B) zeta potential in water, C) photon correlation spectroscopy analysis in 
physiological salt solution and D) zeta potential in physiological salt solution. 
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Figure 25:  Fluorescence spectroscopy of known concentrations of rhodamine B isothiocyanate in ethanol 
solutions (higher concentration) for calculating amount of dye molecules within mesoporous 
nanoparticles. 
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Figure 26:  Fluorescence spectroscopy of known concentration of fluorescein isothiocyanate in ethanol 
solutions for calculating amount of dye molecules within mesoporous nanoparticle  
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Figure 27:  Fluorescence spectroscopy of supernatant from rhodamine B isothiocyanate mesoporous 
nanoparticles; where A) 1
st
 supernatant, B) 2
nd
 supernatant, C) 3
rd
 supernatant, D) 4
th
 supernatant, E) 5
th
  
supernatant and F) 6
th
  supernatant. 
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Figure 28:  Fluorescence spectroscopy of supernatant from fluorescein isothiocyanate encapsulated 
mesoporous nanoparticles; where A) 1
st
 supernatant, B) 2
nd
 supernatant and C) 3
rd
 supernatant. 
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Figure 29:  Fluorescence spectroscopy of rhodamine B isothiocyanate  supernatant from rhodamine B 
isothiocyanate/ fluorescein isothiocyanate encapsulated mesoporous nanoparticles; where A) 1
st
 
supernatant, B) 2
nd
 supernatant, C) 3
rd
 supernatant and D) 4
th
 supernatant. 
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Figure 30:  Fluorescence spectroscopy of fluorescein isothiocyanate supernatant from rhodamine B 
isothiocyanate/ fluorescein isothiocyanate encapsulated mesoporous nanoparticles; where A) 1
st
 
supernatant, B) 2
nd
 supernatant and C) 3
rd
 supernatant. 
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Figure 31:  The hydrodynamic diameter and stability of silicate-1; where A) the photon correlation 
spectroscopy analysis of 180.6 nm, B) zeta potential of 180.6 nm, C) photon correlation spectroscopy 
analysis of 152.5 nm and D) zeta potential of 152.5 nm in water media. 
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Figure 32:  The acetylcholine control traces used for the average percentage relaxation graphs of the 
control. 
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Figure 33:  The sodium nitroprusside control traces used for the average percentage relaxation graphs of 
the control. 
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Figure 34:  Acetylcholine response to vasodilation after incubation in 72 nm silica nanoparticles low dose 
traces used for the average percentage relaxation graphs. 
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Figure 35:  Acetylcholine response to vasodilation after incubation in 72 nm silica nanoparticles high 
dose traces used for the average percentage relaxation graphs. 
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Figure 36:  Acetylcholine response to vasodilation after incubation in 24 nm silica nanoparticles traces 
used for the average percentage relaxation graphs. 
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Figure 37:  Acetylcholine response to vasodilation after incubation in 60 nm rhodamine B isothiocyanate 
encapsulated silica nanoparticles traces used for the average percentage relaxation graphs. 
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Figure 38:  Acetylcholine response to vasodilation after incubation in 27 nm rhodamine B isothiocyanate 
encapsulated silica nanoparticles traces used for the average percentage relaxation graphs. 
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Figure 39:  Acetylcholine response to vasodilation after incubation in 24nm rhodamine silica 
nanoparticles co-incubated with superoxide dismutase traces used for the average percentage relaxation 
graphs. 
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Figure 39:  Acetylcholine response to vasodilation after incubation in 24 nm rhodamine silica 
nanoparticles co-incubated with superoxide dismutase traces used for the average percentage relaxation 
graphs. 
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Figure 40:  Acetylcholine response to vasodilation after incubation in Nω-Nitro-L-arginine traces used for 
the average percentage relaxation graphs. 
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Figure 41:  Sodium nitroprusside response to vasodilation after incubation in 72 nm silica nanoparticles 
high dose traces used for the average percentage relaxation graphs. 
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Figure 42:  Sodium nitroprusside response to vasodilation after incubation in 24 nm silica nanoparticles 
traces used for the average percentage relaxation graphs. 
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Figure 43:  Sodium nitroprusside response to vasodilation after incubation in 60 nm rhodamine B 
isothiocyanate encapsulated silica nanoparticles traces used for the average percentage relaxation graphs. 
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Figure 44:  Sodium nitroprusside response to vasodilation after incubation in 27 nm rhodamine B 
isothiocyanate encapsulated silica nanoparticles traces used for the average percentage relaxation graphs. 
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Figure 45:  Acetylcholine response to vasodilation after incubation in 71±6 nm silica nanoparticles under 
pressurised system traces used for the average percentage relaxation graphs. 
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Figure 46:  The vasoconstriction level of the aortic vessel over a three hour period. 
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Figure 47:  The vasoconstriction level of the aortic vessel while incubated in low concentration of 
mesoporous nanoparticles over a three hour period. 
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Figure 48:  The vasoconstriction level of the aortic vessel while incubated in low concentration of 
mesoporous nanoparticles loaded with sodium nitroprusside over a three hour period. 
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Figure 49:  The vasoconstriction level of the aortic vessel while incubated in high concentration of 
mesoporous nanoparticles over a three hour period. 
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Figure 50:  The vasoconstriction level of the aortic vessel while incubated in high concentration of 
mesoporous nanoparticles loaded with sodium nitroprusside over a three hour period. 
 
 
 
 
Figure 51:  The vasoconstriction level of the aortic vessel while incubated in low concentration of 
fluorescein isothiocyanate encapsulated mesoporous nanoparticles over a three hour period. 
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Figure 52:  The vasoconstriction level of the aortic vessel while incubated in low concentration of 
fluorescein isothiocyanate encapsulated mesoporous nanoparticles loaded with sodium nitroprusside over 
a three hour period. 
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Figure 53:  The vasoconstriction level of the aortic vessel while incubated in high concentration of 
fluorescein isothiocyanate encapsulated mesoporous nanoparticles over a three hour period. 
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Figure 54:  The vasoconstriction level of the aortic vessel while incubated in high concentration of 
fluorescein isothiocyanate encapsulated mesoporous nanoparticles loaded with sodium nitroprusside over 
a three hour period. 
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Table 1:  The concentration of SNP released from the MNP matrix in vitro, calculated 
from the logarithmic equation derived from the SNP control relaxation calibration 
graph.   
Time (min) 
Concentration of SNP releases from 
the MNP in vitro 
Concentration of SNP releases 
from the FITC MNP in vitro 
1 8.82×-10 6.09×-09 
2 3.25×-09 1.71×-08 
3 5.08×-09 2.32×-08 
4 7.62×-09 2.50×-08 
5 1.00×-08 3.14×-08 
6 1.52×-08 3.42×-08 
7 1.75×-08 4.02×-08 
8 2.19×-08 5.28×-08 
9 2.57×-08 5.56×-08 
10 3.17×-08 6.13×-08 
15 5.84×-08 1.12×-07 
20 8.97×-08 1.38×-07 
25 1.23×-07 1.72×-07 
30 1.52×-07 1.73×-07 
35 1.77×-07 1.74×-07 
40 2.19×-07 1.74×-07 
45 2.33×-07 1.62×-07 
50 2.76×-07 1.47×-07 
55 3.05×-07 1.23×-07 
60 3.60×-07 1.23×-07 
65 3.76×-07 1.17X-07 
70 4.04×-07 1.16x-07 
75 4.62×-07 1.19×-07 
80 4.44×-07 1.07×-07 
85 5.21×-07 1.05×-07 
90 5.63×-07 1.08×-07 
95 5.50×-07 8.35×-08 
100 5.67×-07 7.59×-08 
105 6.22×-07 6.94×-08 
110 6.20×-07 7.27×-08 
115 6.52×-07 9.48×-08 
120 6.16×-07 8.60×-08 
125 6.62×-07 7.36×--08 
130 6.53×-07 7.19×-08 
135 6.01×-07 6.63×-08 
140 6.21×-07 6.67×-08 
145 6.13×-07 7.23×-08 
150 5.55×-07 5.74×-08 
155 6.15×-07 5.54×-08 
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160 5.97×-07 5.27×-08 
165 5.28×-07 4.86×-08 
170 5.42×-07 4.86×-08 
175 5.09×-07 4.64×-08 
180 4.91×-07 4.51×-08 
 
Table 2: One-way Anova with Bonferroni correction for relaxation of aortic vessels 
due to incubation in MNP and MNP loaded.   
Time 
(min) 
Significance difference in relaxation in comparison to KPSS control 
low 
MNP 
low 
MNP+ 
SNP 
high 
MNP 
high 
MNP+
SNP 
low 
FITC 
MNP 
low FITC 
MNP+SNP 
High 
FITC 
MNP 
high FITC 
MNP+SNP 
1 
p>0.05 p>0.05 
p>0.05 
# p>0.05 p>0.05 p>0.05 
§ 
2 
p>0.05 p>0.05 
p>0.05 
§ p>0.05 p>0.05 p>0.05 
§ 
3 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
4 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
5 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
6 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
7 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
8 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
9 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
10 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
15 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
20 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
25 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
30 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
35 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
40 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
45 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
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50 
p>0.05 p>0.05 
p>0.05 § 
p>0.05 p>0.05 p>0.05 
§ 
55 
p>0.05 p>0.05 
p>0.05 § p>0.05 
* p>0.05 
§ 
60 
p>0.05 p>0.05 
p>0.05 § p>0.05 
* * 
§ 
65 
p>0.05 p>0.05 
p>0.05 § p>0.05 
* * 
§ 
70 
p>0.05 p>0.05 
p>0.05 § p>0.05 
* * 
§ 
75 
p>0.05 p>0.05 
p>0.05 § p>0.05 
* * 
§ 
80 
p>0.05 p>0.05 
p>0.05 § p>0.05 
* * 
§ 
85 
p>0.05 p>0.05 
p>0.05 § p>0.05 
* * 
§ 
90 
p>0.05 p>0.05 
p>0.05 § p>0.05 
* * 
§ 
95 
p>0.05 p>0.05 
p>0.05 § p>0.05 
* p>0.05 
§ 
100 
p>0.05 p>0.05 
p>0.05 § p>0.05 
* 
p>0.05 § 
105 
p>0.05 p>0.05 
p>0.05 § p>0.05 
* 
p>0.05 § 
110 
p>0.05 p>0.05 
p>0.05 § p>0.05 
* 
p>0.05 § 
115 
p>0.05 p>0.05 
p>0.05 § p>0.05 
p>0.05 
p>0.05 § 
120 
p>0.05 p>0.05 
p>0.05 § p>0.05 p>0.05 p>0.05 § 
125 
p>0.05 p>0.05 
p>0.05 § p>0.05 p>0.05 p>0.05 § 
130 
p>0.05 p>0.05 
p>0.05 § p>0.05 p>0.05 p>0.05 § 
135 
p>0.05 p>0.05 
p>0.05 § p>0.05 p>0.05 p>0.05 § 
140 
p>0.05 p>0.05 
p>0.05 § p>0.05 p>0.05 p>0.05 § 
145 
p>0.05 p>0.05 
p>0.05 § p>0.05 p>0.05 p>0.05 § 
150 
p>0.05 p>0.05 
p>0.05 § p>0.05 p>0.05 p>0.05 § 
155 
p>0.05 p>0.05 
p>0.05 § p>0.05 p>0.05 p>0.05 § 
160 
p>0.05 p>0.05 
p>0.05 § p>0.05 p>0.05 p>0.05 § 
165 
p>0.05 p>0.05 
p>0.05 § p>0.05 p>0.05 p>0.05 § 
170 
p>0.05 p>0.05 
p>0.05 § p>0.05 p>0.05 p>0.05 § 
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175 
p>0.05 p>0.05 
p>0.05 § p>0.05 p>0.05 p>0.05 § 
180 
p>0.05 p>0.05 
p>0.05 § p>0.05 p>0.05 p>0.05 § 
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    𝑉 =
4
3
𝜋𝑟3     [1] 
Equation 3.1:  This equation is used to calculate the volume of a sphere 
 
In equation 3.1 v is the volume of sphere πis 3.14 and r is the radius of the nanoparticles 
in cm.   This is used to derive the number of particles per mL.    
 
    𝑚 = 𝑉 × 𝐷     [2] 
Equation 3.2:  This equation is used to work out mass of a nanoparticles sphere 
 
M is mass of a nanoparticles sphere, v is volume of a sphere and d is the density of a given 
material the nanoparticles is made of. 
 
 
    𝑁 =
𝑚
𝑉
       [3] 
Equation 3.3:  This equation is used to obtain the number of particles within a given solution 
  
V is the volume of a sphere at a given diameter, m is the mass of dry nanoparticle product 
in 1 mL. 
 
 
 
 
 
